<?xml version="1.0" encoding="UTF-8"?><search-results xmlns="http://www.w3.org/2005/Atom" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:opensearch="http://a9.com/-/spec/opensearch/1.1/" xmlns:dc="http://purl.org/dc/elements/1.1/"><opensearch:totalResults>2992343</opensearch:totalResults><opensearch:startIndex>400</opensearch:startIndex><opensearch:itemsPerPage>100</opensearch:itemsPerPage><opensearch:Query role="request" searchTerms="heart" startPage="400"/><link ref="self" href="http://api.elsevier.com:80/content/search/index:scopus?start=400&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="first" href="http://api.elsevier.com:80/content/search/index:scopus?start=0&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="prev" href="http://api.elsevier.com:80/content/search/index:scopus?start=300&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="next" href="http://api.elsevier.com:80/content/search/index:scopus?start=500&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="last" href="http://api.elsevier.com:80/content/search/index:scopus?start=4900&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929315427"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929315427?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929315427&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929315427&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S016752731500827X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929315427</prism:url><dc:identifier>SCOPUS_ID:84929315427</dc:identifier><eid>2-s2.0-84929315427</eid><dc:title>Uninterrupted dabigatran versus warfarin in the treatment of intracardiac thrombus in patients with non-valvular atrial fibrillation</dc:title><dc:creator>Hao L.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>63-66</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.104</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60092862</affiliation-url><afid>60092862</afid><affilname>Qilu Hospital of Shandong University</affilname><name-variant>Shandong University</name-variant><affiliation-city>Jinan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031031</affiliation-url><afid>60031031</afid><affilname>Shandong University</affilname><name-variant>Shandong University</name-variant><affiliation-city>Jinan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56430417100</author-url><authid>56430417100</authid><authname>Hao L.</authname><surname>Hao</surname><given-name>Li</given-name><initials>L.</initials><afid>60092862</afid><afid>60031031</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56430417100</author-url><authid>56430417100</authid><authname>Hao L.</authname><surname>Hao</surname><given-name>Li</given-name><initials>L.</initials><afid>60092862</afid><afid>60031031</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35314162700</author-url><authid>35314162700</authid><authname>Zhong J.</authname><surname>Zhong</surname><given-name>Jing Quan</given-name><initials>J.Q.</initials><afid>60092862</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56263778400</author-url><authid>56263778400</authid><authname>Zhang W.</authname><surname>Zhang</surname><given-name>Wei</given-name><initials>W.</initials><afid>60092862</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56052053900</author-url><authid>56052053900</authid><authname>Rong B.</authname><surname>Rong</surname><given-name>Bing</given-name><initials>B.</initials><afid>60092862</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56430528900</author-url><authid>56430528900</authid><authname>Xie F.</authname><surname>Xie</surname><given-name>Fei</given-name><initials>F.</initials><afid>60092862</afid><afid>60031031</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56430528900</author-url><authid>56430528900</authid><authname>Xie F.</authname><surname>Xie</surname><given-name>Fei</given-name><initials>F.</initials><afid>60092862</afid><afid>60031031</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56412318000</author-url><authid>56412318000</authid><authname>Wang J.</authname><surname>Wang</surname><given-name>Jun Tao</given-name><initials>J.T.</initials><afid>60092862</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56051188700</author-url><authid>56051188700</authid><authname>Yue X.</authname><surname>Yue</surname><given-name>Xin</given-name><initials>X.</initials><afid>60092862</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:36122198500</author-url><authid>36122198500</authid><authname>Zheng Z.</authname><surname>Zheng</surname><given-name>Zhao Tong</given-name><initials>Z.T.</initials><afid>60092862</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56412303900</author-url><authid>56412303900</authid><authname>Zhu Q.</authname><surname>Zhu</surname><given-name>Qing</given-name><initials>Q.</initials><afid>60092862</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:55929455500</author-url><authid>55929455500</authid><authname>Zhang Y.</authname><surname>Zhang</surname><given-name>Yun</given-name><initials>Y.</initials><afid>60092862</afid></author><authkeywords>Dabigatran | Intracardiac thrombus | Non-valvular atrial fibrillation | Transesophageal echocardiography | Warfarin</authkeywords><intid>535946215</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928952956"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928952956?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928952956&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928952956&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0928493115300035"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928952956</prism:url><dc:identifier>SCOPUS_ID:84928952956</dc:identifier><eid>2-s2.0-84928952956</eid><dc:title>Local administration of stromal cell-derived factor-1 promotes stem cell recruitment and bone regeneration in a rat periodontal bone defect model</dc:title><dc:creator>Liu H.</dc:creator><prism:publicationName>Materials Science and Engineering C</prism:publicationName><prism:issn>09284931</prism:issn><prism:volume>53</prism:volume><prism:pageRange>83-94</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.msec.2015.04.002</prism:doi><pii>S0928493115300035</pii><dc:description>Â© 2015 Elsevier B.V.All rights reserved. Stromal cell-derived factor-1 (SDF-1) recruits adult stem/progenitor cells via its specific receptor, C-X-C motif receptor 4 (CXCR4), to promote heart, kidney and tendon regeneration, but little is known about the effects of SDF-1 on bone regeneration in periodontal diseases. The objective of this study was to investigate whether local administration of SDF-1 in a collagen membrane scaffold enhanced the recruitment of host stem cells and improved periodontal bone defect repair. To this end, bone defects were established on the buccal side of bilateral mandibles in Wistar rats. After application of collagen membranes loaded with SDF-1 or phosphate-buffered saline (PBS) to the defects, the effects of SDF-1 on stem cell recruitment, inflammatory cell responses, angiogenesis, osteoclastogenesis, scaffold degradation, and bone regeneration were evaluated. It showed that SDF-1 recruited host-derived mesenchymal stem cells and hematopoietic stem cells to the wound area and significantly reduced the CD11b + inflammatory cell response. Moreover, SDF-1 increased vascular formation, induced early bone osteoclastogenesis, accelerated scaffold degradation, and promoted the quality and quantity of regenerated bone. Our results suggest that this cell-free approach by local administration of SDF-1 may be an effective strategy for development as a simple and safe technique for periodontal bone regeneration.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031031</affiliation-url><afid>60031031</afid><affilname>Shandong University</affilname><name-variant>Shandong University</name-variant><affiliation-city>Jinan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031031</affiliation-url><afid>60031031</afid><affilname>Shandong University</affilname><name-variant>Shandong University</name-variant><affiliation-city>Jinan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55914951300</author-url><authid>55914951300</authid><authname>Liu H.</authname><surname>Liu</surname><given-name>Hongrui</given-name><initials>H.</initials><afid>60031031</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56201570700</author-url><authid>56201570700</authid><authname>Li M.</authname><surname>Li</surname><given-name>Minqi</given-name><initials>M.</initials><afid>60031031</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55061651000</author-url><authid>55061651000</authid><authname>Du L.</authname><surname>Du</surname><given-name>Lingqian</given-name><initials>L.</initials><afid>60031031</afid><afid>60031031</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55061651000</author-url><authid>55061651000</authid><authname>Du L.</authname><surname>Du</surname><given-name>Lingqian</given-name><initials>L.</initials><afid>60031031</afid><afid>60031031</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7403931706</author-url><authid>7403931706</authid><authname>Yang P.</authname><surname>Yang</surname><given-name>Pishan</given-name><initials>P.</initials><afid>60031031</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7201714413</author-url><authid>7201714413</authid><authname>Ge S.</authname><surname>Ge</surname><given-name>Shaohua</given-name><initials>S.</initials><afid>60031031</afid></author><authkeywords>Chemotaxis | Mesenchymal stem cells | Periodontal bone regeneration | SDF-1 | Tissue engineering</authkeywords><intid>2035871560</intid><source-id>17813</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84921534753"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84921534753?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84921534753&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84921534753&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915014012313"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84921534753</prism:url><dc:identifier>SCOPUS_ID:84921534753</dc:identifier><eid>2-s2.0-84921534753</eid><dc:title>How to balance cardiorenometabolic benefits and risks of statins</dc:title><dc:creator>Lim S.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>235</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>644-648</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2014.06.001</prism:doi><pii>S0021915014012313</pii><dc:description>Â© 2014 Elsevier Ireland Ltd. Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are important for preventing adverse cardiovascular events not only in patients with a high risk of vascular disease but also in those with a low risk, by reducing the levels of low-density lipoprotein cholesterol. Statin is associated with deteriorating glucose homeostasis and an increased risk of diabetes mellitus. Moreover, these off-target effects are dose-dependent; it has also been suggested that renal insult can be caused dose-dependently by statin treatment, in contrast to previous studies showing a renoprotective effect. The 2013 American College of Cardiology/American Heart Association guidelines recommend the use of high-intensity statin therapy, and extend its use to more people at risk of vascular diseases. However, a European committee has expressed concerns about the potential side effects of using statins in a large fraction of the population for extended periods. This is true of Asian people, for whom the disease burden from cardiovascular disorders is not as great as among Western ethnic groups. There are still many unanswered questions on how to balance the cardiovascular benefits with the potential renometabolic risks of statins. Therefore, genetic or pharmacogenetic approaches are needed to define who is more vulnerable to developing diabetes mellitus or acute kidney injury. In particular, more information is required regarding the metabolism of statins, and their off-target or unknown actions and overall impact. These different renometabolic effects of statins should help in formulating optimal therapeutic strategies for patients for reducing overall morbidity and mortality and not just those associated with cardiovascular diseases.</dc:description><citedby-count>2</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60098516</affiliation-url><afid>60098516</afid><affilname>Seoul National University Bundang Hospital</affilname><name-variant>Seoul National University College of Medicine</name-variant><affiliation-city>Seongnam</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60080734</affiliation-url><afid>60080734</afid><affilname>Gachon University</affilname><name-variant>Gachon University</name-variant><affiliation-city>Seongnam-si, Gyeonggi-do</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114142851</affiliation-url><afid>114142851</afid><affilname>Gachon Cardiovascular Research Institute</affilname><name-variant>Gachon Cardiovascular Research Institute</name-variant><affiliation-city>Incheon</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112587656</affiliation-url><afid>112587656</afid><affilname>Hokko Memorial Clinic</affilname><name-variant>Hokko Memorial Clinic</name-variant><affiliation-city>Sapporo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><pubmed-id>24973595</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56489066700</author-url><authid>56489066700</authid><authname>Lim S.</authname><surname>Lim</surname><given-name>Soo</given-name><initials>S.</initials><afid>60098516</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56472424200</author-url><authid>56472424200</authid><authname>Oh P.</authname><surname>Oh</surname><given-name>Pyung Chun</given-name><initials>P.C.</initials><afid>60080734</afid><afid>114142851</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56472424200</author-url><authid>56472424200</authid><authname>Oh P.</authname><surname>Oh</surname><given-name>Pyung Chun</given-name><initials>P.C.</initials><afid>60080734</afid><afid>114142851</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56490066200</author-url><authid>56490066200</authid><authname>Sakuma I.</authname><surname>Sakuma</surname><given-name>Ichiro</given-name><initials>I.</initials><afid>112587656</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55664351200</author-url><authid>55664351200</authid><authname>Koh K.</authname><surname>Koh</surname><given-name>Kwang Kon</given-name><initials>K.K.</initials><afid>60080734</afid><afid>114142851</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55664351200</author-url><authid>55664351200</authid><authname>Koh K.</authname><surname>Koh</surname><given-name>Kwang Kon</given-name><initials>K.K.</initials><afid>60080734</afid><afid>114142851</afid></author><authkeywords>Benefits and risks | Cardiovascular disease | Diabetes | Renal injury | Statins</authkeywords><intid>1534653415</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929306388"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929306388?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929306388&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929306388&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S016752731500741X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929306388</prism:url><dc:identifier>SCOPUS_ID:84929306388</dc:identifier><eid>2-s2.0-84929306388</eid><dc:title>A single center three-arm parallel-group, randomized controlled study to evaluate antihypertensive effects of frequent immersion in thermoneutral water</dc:title><dc:creator>Naumann J.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>73-75</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.022</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025641</affiliation-url><afid>60025641</afid><affilname>Universitat Freiburg im Breisgau</affilname><name-variant>UniversitÃ¤t Freiburg</name-variant><affiliation-city>Freiburg im Breisgau</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025641</affiliation-url><afid>60025641</afid><affilname>Universitat Freiburg im Breisgau</affilname><name-variant>UniversitÃ¤t Freiburg</name-variant><affiliation-city>Freiburg im Breisgau</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025641</affiliation-url><afid>60025641</afid><affilname>Universitat Freiburg im Breisgau</affilname><name-variant>UniversitÃ¤t Freiburg</name-variant><affiliation-city>Freiburg im Breisgau</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007892</affiliation-url><afid>60007892</afid><affilname>Europa-Universitat Viadrina Frankfurt (Oder)</affilname><name-variant>European University Viadrina</name-variant><affiliation-city>Frankfurt/Oder</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:10439932200</author-url><authid>10439932200</authid><authname>Naumann J.</authname><surname>Naumann</surname><given-name>Johannes</given-name><initials>J.</initials><afid>60025641</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644528300</author-url><authid>56644528300</authid><authname>Bureau N.</authname><surname>Bureau</surname><given-name>Nina</given-name><initials>N.</initials><afid>60025641</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56643763000</author-url><authid>56643763000</authid><authname>Schmidt S.</authname><surname>Schmidt</surname><given-name>Stefan</given-name><initials>S.</initials><afid>60025641</afid><afid>60007892</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56643763000</author-url><authid>56643763000</authid><authname>Schmidt S.</authname><surname>Schmidt</surname><given-name>Stefan</given-name><initials>S.</initials><afid>60025641</afid><afid>60007892</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8084412400</author-url><authid>8084412400</authid><authname>Sadaghiani C.</authname><surname>Sadaghiani</surname><given-name>Catharina</given-name><initials>C.</initials><afid>60025641</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56643942600</author-url><authid>56643942600</authid><authname>Huber R.</authname><surname>Huber</surname><given-name>Roman</given-name><initials>R.</initials><afid>60025641</afid></author><authkeywords>Balneology | Baths | Hydrotherapy | Hypertension | Immersion</authkeywords><intid>35943588</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929329261"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929329261?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929329261&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929329261&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006361"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929329261</prism:url><dc:identifier>SCOPUS_ID:84929329261</dc:identifier><eid>2-s2.0-84929329261</eid><dc:title>Effects of hemolysis on the diagnostic accuracy of cardiac troponin I for the diagnosis of myocardial infarction</dc:title><dc:creator>Puelacher C.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>313-315</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.378</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000100</affiliation-url><afid>60000100</afid><affilname>Institut Municipal d'Investigacio Medica</affilname><name-variant>Institut Municipal d'InvestigaciÃ³ MÃ¨dica</name-variant><affiliation-city>Barcelona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000100</affiliation-url><afid>60000100</afid><affilname>Institut Municipal d'Investigacio Medica</affilname><name-variant>Institut Municipal d'InvestigaciÃ³ MÃ¨dica</name-variant><affiliation-city>Barcelona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023506</affiliation-url><afid>60023506</afid><affilname>Hospital del Mar</affilname><name-variant>Hospital del Mar</name-variant><affiliation-city>Barcelona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028287</affiliation-url><afid>60028287</afid><affilname>Universitatsspital Basel</affilname><name-variant>University Hospital Basel</name-variant><affiliation-city>Basel</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Kantonsspital Olten</affilname><affiliation-city/><affiliation-country>Switzerland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">33</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56222163700</author-url><authid>56222163700</authid><authname>Puelacher C.</authname><surname>Puelacher</surname><given-name>Christian</given-name><initials>C.</initials><afid>60000100</afid><afid>60000100</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56222163700</author-url><authid>56222163700</authid><authname>Puelacher C.</authname><surname>Puelacher</surname><given-name>Christian</given-name><initials>C.</initials><afid>60000100</afid><afid>60000100</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:34067894400</author-url><authid>34067894400</authid><authname>Twerenbold R.</authname><surname>Twerenbold</surname><given-name>Raphael</given-name><initials>R.</initials><afid>60000100</afid><afid>60000100</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:34067894400</author-url><authid>34067894400</authid><authname>Twerenbold R.</authname><surname>Twerenbold</surname><given-name>Raphael</given-name><initials>R.</initials><afid>60000100</afid><afid>60000100</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55326122600</author-url><authid>55326122600</authid><authname>Mosimann T.</authname><surname>Mosimann</surname><given-name>Tamina</given-name><initials>T.</initials><afid>60000100</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55418659300</author-url><authid>55418659300</authid><authname>Boeddinghaus J.</authname><surname>Boeddinghaus</surname><given-name>Jasper</given-name><initials>J.</initials><afid>60000100</afid><afid>60000100</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55418659300</author-url><authid>55418659300</authid><authname>Boeddinghaus J.</authname><surname>Boeddinghaus</surname><given-name>Jasper</given-name><initials>J.</initials><afid>60000100</afid><afid>60000100</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55326114700</author-url><authid>55326114700</authid><authname>Gimenez M.</authname><surname>Gimenez</surname><given-name>Maria Rubini</given-name><initials>M.R.</initials><afid>60000100</afid><afid>60000100</afid><afid>60023506</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55326114700</author-url><authid>55326114700</authid><authname>Gimenez M.</authname><surname>Gimenez</surname><given-name>Maria Rubini</given-name><initials>M.R.</initials><afid>60000100</afid><afid>60000100</afid><afid>60023506</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55326114700</author-url><authid>55326114700</authid><authname>Gimenez M.</authname><surname>Gimenez</surname><given-name>Maria Rubini</given-name><initials>M.R.</initials><afid>60000100</afid><afid>60000100</afid><afid>60023506</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:37102901200</author-url><authid>37102901200</authid><authname>Wildi K.</authname><surname>Wildi</surname><given-name>Karin</given-name><initials>K.</initials><afid>60000100</afid><afid>60000100</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:37102901200</author-url><authid>37102901200</authid><authname>Wildi K.</authname><surname>Wildi</surname><given-name>Karin</given-name><initials>K.</initials><afid>60000100</afid><afid>60000100</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56222001300</author-url><authid>56222001300</authid><authname>Jaeger C.</authname><surname>Jaeger</surname><given-name>CÃ©dric</given-name><initials>C.</initials><afid>60000100</afid><afid>60000100</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56222001300</author-url><authid>56222001300</authid><authname>Jaeger C.</authname><surname>Jaeger</surname><given-name>CÃ©dric</given-name><initials>C.</initials><afid>60000100</afid><afid>60000100</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:24451019600</author-url><authid>24451019600</authid><authname>Reichlin T.</authname><surname>Reichlin</surname><given-name>Tobias</given-name><initials>T.</initials><afid>60000100</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:55533350100</author-url><authid>55533350100</authid><authname>Schneider J.</authname><surname>Schneider</surname><given-name>Jeannine</given-name><initials>J.</initials><afid>60000100</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56066472500</author-url><authid>56066472500</authid><authname>Honegger U.</authname><surname>Honegger</surname><given-name>Ursina</given-name><initials>U.</initials><afid>60000100</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56644512800</author-url><authid>56644512800</authid><authname>Max W.</authname><surname>Max</surname><given-name>Wagener</given-name><initials>W.</initials><afid>60000100</afid><afid>60000100</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56644512800</author-url><authid>56644512800</authid><authname>Max W.</authname><surname>Max</surname><given-name>Wagener</given-name><initials>W.</initials><afid>60000100</afid><afid>60000100</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56222046800</author-url><authid>56222046800</authid><authname>Schumacher C.</authname><surname>Schumacher</surname><given-name>Carmela</given-name><initials>C.</initials><afid>60000100</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:55245957900</author-url><authid>55245957900</authid><authname>Nestelberger T.</authname><surname>Nestelberger</surname><given-name>Thomas</given-name><initials>T.</initials><afid>60000100</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:56222093500</author-url><authid>56222093500</authid><authname>Hillinger P.</authname><surname>Hillinger</surname><given-name>Petra</given-name><initials>P.</initials><afid>60000100</afid><afid>60000100</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:56222093500</author-url><authid>56222093500</authid><authname>Hillinger P.</authname><surname>Hillinger</surname><given-name>Petra</given-name><initials>P.</initials><afid>60000100</afid><afid>60000100</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:56644240700</author-url><authid>56644240700</authid><authname>Grimm K.</authname><surname>Grimm</surname><given-name>Karin</given-name><initials>K.</initials><afid>60000100</afid><afid>60000100</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:56644240700</author-url><authid>56644240700</authid><authname>Grimm K.</authname><surname>Grimm</surname><given-name>Karin</given-name><initials>K.</initials><afid>60000100</afid><afid>60000100</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:56222451900</author-url><authid>56222451900</authid><authname>Kreutzinger P.</authname><surname>Kreutzinger</surname><given-name>Philipp</given-name><initials>P.</initials><afid>60000100</afid></author><author seq="17"><author-url>http://api.elsevier.com/content/author/author_id:56221662000</author-url><authid>56221662000</authid><authname>Weidmann Z.</authname><surname>Weidmann</surname><given-name>Zoraida Moreno</given-name><initials>Z.M.</initials><afid>60000100</afid></author><author seq="18"><author-url>http://api.elsevier.com/content/author/author_id:7004197043</author-url><authid>7004197043</authid><authname>Rentsch K.</authname><surname>Rentsch</surname><given-name>Katharina</given-name><initials>K.</initials><afid>60028287</afid></author><author seq="19"><author-url>http://api.elsevier.com/content/author/author_id:56222442100</author-url><authid>56222442100</authid><authname>Arnold C.</authname><surname>Arnold</surname><given-name>Christiane</given-name><initials>C.</initials><afid/></author><author seq="20"><author-url>http://api.elsevier.com/content/author/author_id:55825305800</author-url><authid>55825305800</authid><authname>Osswald S.</authname><surname>Osswald</surname><given-name>Stefan</given-name><initials>S.</initials><afid>60000100</afid><afid>60000100</afid></author><author seq="20"><author-url>http://api.elsevier.com/content/author/author_id:55825305800</author-url><authid>55825305800</authid><authname>Osswald S.</authname><surname>Osswald</surname><given-name>Stefan</given-name><initials>S.</initials><afid>60000100</afid><afid>60000100</afid></author><author seq="21"><author-url>http://api.elsevier.com/content/author/author_id:55694346400</author-url><authid>55694346400</authid><authname>Mueller C.</authname><surname>Mueller</surname><given-name>Christian</given-name><initials>C.</initials><afid>60000100</afid><afid>60000100</afid></author><author seq="21"><author-url>http://api.elsevier.com/content/author/author_id:55694346400</author-url><authid>55694346400</authid><authname>Mueller C.</authname><surname>Mueller</surname><given-name>Christian</given-name><initials>C.</initials><afid>60000100</afid><afid>60000100</afid></author><authkeywords>Diagnosis | Hemolysis | Investigative techniques | Myocardial infarction | Troponin I</authkeywords><intid>35943945</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929312509"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929312509?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929312509&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929312509&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008669"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929312509</prism:url><dc:identifier>SCOPUS_ID:84929312509</dc:identifier><eid>2-s2.0-84929312509</eid><dc:title>Influence factors might elevate blood red cell distribution width levels in postoperative atrial fibrillation patients</dc:title><dc:creator>Wang C.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>53</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.143</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010432</affiliation-url><afid>60010432</afid><affilname>Soochow University</affilname><name-variant>Suzhou University</name-variant><affiliation-city>Suzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55941619800</author-url><authid>55941619800</authid><authname>Wang C.</authname><surname>Wang</surname><given-name>Chang Guo</given-name><initials>C.G.</initials><afid>60010432</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55241283800</author-url><authid>55241283800</authid><authname>Lei W.</authname><surname>Lei</surname><given-name>Wei</given-name><initials>W.</initials><afid>60010432</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56270102800</author-url><authid>56270102800</authid><authname>Huang J.</authname><surname>Huang</surname><given-name>Jian An</given-name><initials>J.A.</initials><afid>60010432</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:21733833700</author-url><authid>21733833700</authid><authname>Zeng D.</authname><surname>Zeng</surname><given-name>Da Xiong</given-name><initials>D.X.</initials><afid>60010432</afid></author><authkeywords>Influence factor | Postoperative atrial fibrillation | Red cell distribution width</authkeywords><intid>1035941723</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929340076"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929340076?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929340076&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929340076&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007998"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929340076</prism:url><dc:identifier>SCOPUS_ID:84929340076</dc:identifier><eid>2-s2.0-84929340076</eid><dc:title>The importance of vasodilator therapy before or during angiography, is ICD necessary or not?: A response to MichaÅ Chyrchel et al</dc:title><dc:creator>Kirat T.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>239-240</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.439</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112985623</affiliation-url><afid>112985623</afid><affilname>YÃ¼celen Hospital</affilname><name-variant>YÃ¼celen Hospital</name-variant><affiliation-city/><affiliation-country>Turkey</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55262961900</author-url><authid>55262961900</authid><authname>Kirat T.</authname><surname>Kirat</surname><given-name>Tamer</given-name><initials>T.</initials><afid>112985623</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7003978185</author-url><authid>7003978185</authid><authname>KÃ¶se N.</authname><surname>KÃ¶se</surname><given-name>Nuri</given-name><initials>N.</initials><afid>112985623</afid></author><authkeywords>Implantable cardioverter-defibrillator | Intracoronary nitroglycerin | Vasospastic angina</authkeywords><intid>1535945116</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929454304"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929454304?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929454304&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929454304&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008086"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929454304</prism:url><dc:identifier>SCOPUS_ID:84929454304</dc:identifier><eid>2-s2.0-84929454304</eid><dc:title>The protective effect of GLP-1 analogue in arterial calcification through attenuating osteoblastic differentiation of human VSMCs</dc:title><dc:creator>Zhan J.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>188-193</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.086</prism:doi><dc:description>Â© 2015 Elsevier Ireland Ltd. All rights reserved. Background: Arterial calcification is a common event in cardiovascular pathogenesis. Osteoblastic differentiation of vascular smooth muscle cells (VSMCs) is the most important cytopathologic foundation of arterial calcification. Glucagon-like peptide-1 (GLP-1) exerts multiple cardioprotective actions beyond insulinotropic effects through GLP-1 receptor (GLP-1R). However, whether GLP-1 regulates osteoblastic differentiation of VSMCs and associated molecular mechanisms has not been clarified. Methods: The human VSMC differentiation model was established by beta-glycerophosphate (Î²-GP) induction. The mineralization was measured by Alizarin Red S staining. Protein expression and phosphorylation were detected by Western blot or immunofluorescence. GLP-1R gene expression was silenced by siRNA. Results: The GLP-1 analogue liraglutide dose- and time-dependently inhibited the protein expression of osteoblastic differentiation markers alkaline phosphatase (ALP), osteocalcin (OC), and Runt-related transcription factor 2 (Runx2), phosphorylation of PI3K, Akt, mTOR, and S6K1. Silencing of GLP-1R gene expression by siRNA significantly blocked the effects of liraglutide in ALP protein expression and PI3K/Akt phosphorylation. Conclusion: GLP-1 analogue liraglutide attenuates the osteoblastic differentiation and calcification of human VSMCs through its receptor and subsequent activation of PI3K/Akt/mTOR/S6K1 signaling. GLP-1 analogues may be potential agents for the treatment of cardiovascular diseases.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60082822</affiliation-url><afid>60082822</afid><affilname>Second Xiangya Hospital of Central-South University</affilname><name-variant>Central South University</name-variant><affiliation-city>Changsha</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:37562274100</author-url><authid>37562274100</authid><authname>Zhan J.</authname><surname>Zhan</surname><given-name>Jun Kun</given-name><initials>J.K.</initials><afid>60082822</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:22982350900</author-url><authid>22982350900</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Yan Jiao</given-name><initials>Y.J.</initials><afid>60082822</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56638782100</author-url><authid>56638782100</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Yi</given-name><initials>Y.</initials><afid>60082822</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7403305830</author-url><authid>7403305830</authid><authname>Tang Z.</authname><surname>Tang</surname><given-name>Zhi Yong</given-name><initials>Z.Y.</initials><afid>60082822</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55637545000</author-url><authid>55637545000</authid><authname>Tan P.</authname><surname>Tan</surname><given-name>Pan</given-name><initials>P.</initials><afid>60082822</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55636673200</author-url><authid>55636673200</authid><authname>Huang W.</authname><surname>Huang</surname><given-name>Wu</given-name><initials>W.</initials><afid>60082822</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:16401841500</author-url><authid>16401841500</authid><authname>Liu Y.</authname><surname>Liu</surname><given-name>You Shuo</given-name><initials>Y.S.</initials><afid>60082822</afid></author><authkeywords>Akt | Calcification | Glucagon-like peptide-1 | mTOR | Osteoblastic differentiation | PI3K | SiRNA | Vascular smooth muscle cells</authkeywords><intid>1785963828</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929340499"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929340499?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929340499&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929340499&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006336"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929340499</prism:url><dc:identifier>SCOPUS_ID:84929340499</dc:identifier><eid>2-s2.0-84929340499</eid><dc:title>Endogenous vascular endothelial growth factor produces tonic facilitation of cardiac vagal baroreflex via fetal liver kinase-1 in medulla oblongata</dc:title><dc:creator>Tsai C.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>421-425</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.375</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:101359592</affiliation-url><afid>101359592</afid><affilname>Chang Gung Memorial Hospital</affilname><name-variant>Kaohsiung Chang Gung Memorial Hospital</name-variant><affiliation-city>Kaohsiung</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014982</affiliation-url><afid>60014982</afid><affilname>National Cheng Kung University</affilname><name-variant>National Cheng Kung University</name-variant><affiliation-city>Tainan</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55110580100</author-url><authid>55110580100</authid><authname>Tsai C.</authname><surname>Tsai</surname><given-name>Ching Yi</given-name><initials>C.Y.</initials><afid>101359592</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56643643700</author-url><authid>56643643700</authid><authname>Su C.</authname><surname>Su</surname><given-name>Chia Hao</given-name><initials>C.H.</initials><afid>101359592</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56432367500</author-url><authid>56432367500</authid><authname>Leu S.</authname><surname>Leu</surname><given-name>Steve</given-name><initials>S.</initials><afid>101359592</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56431949500</author-url><authid>56431949500</authid><authname>Chang A.</authname><surname>Chang</surname><given-name>Alice Y W</given-name><initials>A.Y.W.</initials><afid>60014982</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56431855900</author-url><authid>56431855900</authid><authname>Chan J.</authname><surname>Chan</surname><given-name>Julie Y H</given-name><initials>J.Y.H.</initials><afid>101359592</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:8054383600</author-url><authid>8054383600</authid><authname>Chan S.</authname><surname>Chan</surname><given-name>Samuel H H</given-name><initials>S.H.H.</initials><afid>101359592</afid></author><authkeywords>Cardiac vagal baroreflex | Diffusion tensor imaging | Flk-1 | Magnetic resonance imaging | Neurogenic hypertension | Nucleus ambiguus | Nucleus tractus solitarii | VEGF</authkeywords><intid>2035939942</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929334533"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929334533?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929334533&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929334533&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007251"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929334533</prism:url><dc:identifier>SCOPUS_ID:84929334533</dc:identifier><eid>2-s2.0-84929334533</eid><dc:title>Plausible speculations on the pathophysiology of Takotsubo syndrome</dc:title><dc:creator>Madias J.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>19-21</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.015</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012981</affiliation-url><afid>60012981</afid><affilname>Icahn School of Medicine at Mount Sinai</affilname><name-variant>Mount Sinai School of Medicine</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016846</affiliation-url><afid>60016846</afid><affilname>Elmhurst Hospital Center</affilname><name-variant>City Hospital Center at Elmhurst</name-variant><affiliation-city>Elmhurst</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7006186911</author-url><authid>7006186911</authid><authname>Madias J.</authname><surname>Madias</surname><given-name>John E.</given-name><initials>J.E.</initials><afid>60012981</afid><afid>60016846</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7006186911</author-url><authid>7006186911</authid><authname>Madias J.</authname><surname>Madias</surname><given-name>John E.</given-name><initials>J.E.</initials><afid>60012981</afid><afid>60016846</afid></author><authkeywords>Autonomic nervous sytem and Takotsubo syndrome | Coronary vasospasm and Takotsubo syndrome | Left ventricular outflow tract obstruction and Takotsubo syndrome | Pathophysiology of Takotsubo syndrome | Postmenopausal state and Takotsubo syndrome | Takotsubo syndrome</authkeywords><intid>1035940423</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929302721"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929302721?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929302721&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929302721&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007901"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929302721</prism:url><dc:identifier>SCOPUS_ID:84929302721</dc:identifier><eid>2-s2.0-84929302721</eid><dc:title>Myocarditis in a young man with adult onset Still's disease successfully treated with Il-1 blocker</dc:title><dc:creator>Luconi N.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>220-222</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.071</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020606</affiliation-url><afid>60020606</afid><affilname>CHU de Nancy</affilname><name-variant>CHU</name-variant><affiliation-city>Nancy</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644743300</author-url><authid>56644743300</authid><authname>Luconi N.</authname><surname>Luconi</surname><given-name>N.</given-name><initials>N.</initials><afid>60020606</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644365000</author-url><authid>56644365000</authid><authname>Risse J.</authname><surname>Risse</surname><given-name>J.</given-name><initials>J.</initials><afid>60020606</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56644678900</author-url><authid>56644678900</authid><authname>Busato T.</authname><surname>Busato</surname><given-name>T.</given-name><initials>T.</initials><afid>60020606</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56644387500</author-url><authid>56644387500</authid><authname>Galland J.</authname><surname>Galland</surname><given-name>J.</given-name><initials>J.</initials><afid>60020606</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:23028300100</author-url><authid>23028300100</authid><authname>Mandry D.</authname><surname>Mandry</surname><given-name>D.</given-name><initials>D.</initials><afid>60020606</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55625935900</author-url><authid>55625935900</authid><authname>Voilliot D.</authname><surname>Voilliot</surname><given-name>D.</given-name><initials>D.</initials><afid>60020606</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55607387700</author-url><authid>55607387700</authid><authname>Mohamed S.</authname><surname>Mohamed</surname><given-name>S.</given-name><initials>S.</initials><afid>60020606</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:23007097100</author-url><authid>23007097100</authid><authname>Zuily S.</authname><surname>Zuily</surname><given-name>S.</given-name><initials>S.</initials><afid>60020606</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7102119175</author-url><authid>7102119175</authid><authname>Wahl D.</authname><surname>Wahl</surname><given-name>D.</given-name><initials>D.</initials><afid>60020606</afid></author><authkeywords>Adult onset still's disease | Interleukin | Myocarditis</authkeywords><intid>1535944434</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928574626"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928574626?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928574626&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928574626&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1096495915000500"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928574626</prism:url><dc:identifier>SCOPUS_ID:84928574626</dc:identifier><eid>2-s2.0-84928574626</eid><dc:title>Molecular characterization and mRNA expression of HIF-prolyl hydroxylase-2 (phd2) in hypoxia-sensing pathways from Megalobrama amblycephala</dc:title><dc:creator>Wang H.</dc:creator><prism:publicationName>Comparative Biochemistry and Physiology Part - B: Biochemistry and Molecular Biology</prism:publicationName><prism:issn>10964959</prism:issn><prism:eIssn>18791107</prism:eIssn><prism:volume>186</prism:volume><prism:pageRange>28-35</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cbpb.2015.04.001</prism:doi><pii>S1096495915000500</pii><dc:description>Â© 2015 Elsevier Inc. HIF-prolyl-hydroxylase-2 (Phd2), amember of the iron (II) and 2-oxoglutarate-dependent dioxygenase family, is one of the key enzymes in hypoxia-sensing pathways. In this study, thephd2cDNA sequence (1231bp), including an open reading frame (ORF) and encoding 358 amino acid residues was identified inMegalobrama amblycephala(Wuchang bream). The predicted Phd2 protein contained three conserved domains, MYND type zinc finger domain with critical regulatory activity, Fe&lt;sup&gt;2+&lt;/sup&gt;-dependent 2OG-Fe (II) oxygenase superfamilydomain with prolyl hydroxylase function, and P4Hc (prolyl 4-hydroxylase alphasubunit homologues) domain for catalyzing proline hydroxylation. The real-time PCR results showed thatphd2mRNA was ubiquitously expressed in all detected tissues with higher levels in the peripheral blood, heart and brain, and all embryogenesis stages, especially in mid-blastula stage. In larvaeM. amblycephala, the expression trend of thephd2and hypoxia-inducible factor 1 alpha (hif-1Î±) mRNA was opposite during hypoxia with an increase (hypoxia for 4h) and then decrease (hypoxia for 12h) forphd2. Whereas in adult fish, thephd2mRNA appeared a transient increase under hypoxia for 4h (DO: 3.46Â±0.59mg/L), and dramatically reduced with further hypoxia exposure to 12h in the peripheral blood, muscle, head kidney, liver and brain, but showed an opposite expression trend in the heart and gill. The hif-1Î±expression was contrary withphd2in the peripheral blood, while it gradually decreased in the heart, but increased in the liver with continuous hypoxia treatment. Additionally,hif-1Î±also showed lower mRNA levels thanphd2in all detected tissues under normoxia and hypoxia conditions.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032955</affiliation-url><afid>60032955</afid><affilname>Huazhong Agricultural University</affilname><name-variant>Huazhong Agricultural University</name-variant><affiliation-city>Wuhan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113650296</affiliation-url><afid>113650296</afid><affilname>Freshwater Aquaculture Collaborative Innovation Center of Hubei Province</affilname><name-variant>Freshwater Aquaculture Collaborative Innovation Center of Hubei Province</name-variant><affiliation-city>Wuhan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115191590</affiliation-url><afid>115191590</afid><affilname>Hubei BaiRong Improved Aquatic Seed Co., Ltd</affilname><name-variant>Hubei BaiRong Improved Aquatic Seed Co., Ltd</name-variant><affiliation-city/><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56025097500</author-url><authid>56025097500</authid><authname>Wang H.</authname><surname>Wang</surname><given-name>Huijuan</given-name><initials>H.</initials><afid>60032955</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55795293100</author-url><authid>55795293100</authid><authname>Huang C.</authname><surname>Huang</surname><given-name>Chunxiao</given-name><initials>C.</initials><afid>60032955</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55007878800</author-url><authid>55007878800</authid><authname>Chen N.</authname><surname>Chen</surname><given-name>Nan</given-name><initials>N.</initials><afid>60032955</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35786743100</author-url><authid>35786743100</authid><authname>Zhu K.</authname><surname>Zhu</surname><given-name>Kecheng</given-name><initials>K.</initials><afid>60032955</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55917628000</author-url><authid>55917628000</authid><authname>Chen B.</authname><surname>Chen</surname><given-name>Boxiang</given-name><initials>B.</initials><afid>60032955</afid><afid>113650296</afid><afid>115191590</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55917628000</author-url><authid>55917628000</authid><authname>Chen B.</authname><surname>Chen</surname><given-name>Boxiang</given-name><initials>B.</initials><afid>60032955</afid><afid>113650296</afid><afid>115191590</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55917628000</author-url><authid>55917628000</authid><authname>Chen B.</authname><surname>Chen</surname><given-name>Boxiang</given-name><initials>B.</initials><afid>60032955</afid><afid>113650296</afid><afid>115191590</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35086878600</author-url><authid>35086878600</authid><authname>Wang W.</authname><surname>Wang</surname><given-name>Weimin</given-name><initials>W.</initials><afid>60032955</afid><afid>113650296</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35086878600</author-url><authid>35086878600</authid><authname>Wang W.</authname><surname>Wang</surname><given-name>Weimin</given-name><initials>W.</initials><afid>60032955</afid><afid>113650296</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:8139890200</author-url><authid>8139890200</authid><authname>Wang H.</authname><surname>Wang</surname><given-name>Huanling</given-name><initials>H.</initials><afid>60032955</afid><afid>113650296</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:8139890200</author-url><authid>8139890200</authid><authname>Wang H.</authname><surname>Wang</surname><given-name>Huanling</given-name><initials>H.</initials><afid>60032955</afid><afid>113650296</afid></author><authkeywords>Expression | Hif-1Î± | Hypoxia | Megalobrama amblycephala | Phd2</authkeywords><intid>35803205</intid><source-id>9700153210</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930216562"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930216562?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930216562&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930216562&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0166445X15001484"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930216562</prism:url><dc:identifier>SCOPUS_ID:84930216562</dc:identifier><eid>2-s2.0-84930216562</eid><dc:title>Developmental exposures to waterborne abused drugs alter physiological function and larval locomotion in early life stages of medaka fish</dc:title><dc:creator>Liao P.</dc:creator><prism:publicationName>Aquatic Toxicology</prism:publicationName><prism:issn>0166445X</prism:issn><prism:eIssn>18791514</prism:eIssn><prism:volume>165</prism:volume><prism:pageRange>84-92</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.aquatox.2015.05.010</prism:doi><pii>S0166445X15001484</pii><dc:description>Â© 2015. Environmental pollution by neuroactive pharmaceuticals from wastewater discharge is a major threat to aquatic ecosystems. However, the ecotoxicologic effect of waterborne abused drugs remains unclear. Embryos of medaka fish (. Oryzias latipes) were exposed to aqueous solutions of 2 hallucinogenic drugs, ketamine (KET) and methamphetamine (MET) (0.004-40. Î¼M) to assess developmental toxicity, oxidative stress and behavioral alteration in early life stages. The environmentally relevant concentration (0.004. Î¼M) of both KET and MET significantly delayed blood circulation and hatching time in embryos and altered larval swimming behavior (e.g., maximum velocity and relative turn angle). KET and MET induced similar oxidative stress responses in embryos, which were unrecoverable in hatchlings in drug-free solutions. Early life exposure to the 2 drugs conferred distinct patterns in larval locomotion: KET induced hyperactivity and a less tortuous swimming path, but MET-treated larvae showed hypoactivity and a clockwise swimming direction at high doses. The alteration in locomotor responses were generally similar in mammals and zebrafish. We report sensitive biomarkers (e.g., heartbeat, hatching and swimming behavior) by developmental stage of medaka that reflect environmentally relevant exposures of abused drugs. They could be useful for ecological risk assessment of waterborne neuroactive drugs. The toxicity results implicate a potential ecotoxicological impact of controlled or abused drugs on fish development and populations in aquatic environments.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005429</affiliation-url><afid>60005429</afid><affilname>National Taiwan University</affilname><name-variant>National Taiwan University</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60072397</affiliation-url><afid>60072397</afid><affilname>National Museum of Marine Biology and Aquarium Taiwan</affilname><name-variant>National Museum of Marine Biology and Aquarium</name-variant><affiliation-city>Checheng</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56050466500</author-url><authid>56050466500</authid><authname>Liao P.</authname><surname>Liao</surname><given-name>Pei Han</given-name><initials>P.H.</initials><afid>60005429</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56662673100</author-url><authid>56662673100</authid><authname>Hwang C.</authname><surname>Hwang</surname><given-name>Chiu Chu</given-name><initials>C.C.</initials><afid>60005429</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56662567900</author-url><authid>56662567900</authid><authname>Chen T.</authname><surname>Chen</surname><given-name>Te Hao</given-name><initials>T.H.</initials><afid>60072397</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56140665500</author-url><authid>56140665500</authid><authname>Chen P.</authname><surname>Chen</surname><given-name>Pei Jen</given-name><initials>P.J.</initials><afid>60005429</afid></author><authkeywords>Developmental toxicity | Ketamine | Locomotion | Medaka (Oryzias latipes) | Methamphetamine</authkeywords><intid>1786088285</intid><source-id>24602</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929484664"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929484664?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929484664&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929484664&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007640"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929484664</prism:url><dc:identifier>SCOPUS_ID:84929484664</dc:identifier><eid>2-s2.0-84929484664</eid><dc:title>Warfarin resistance due to VKORC1 gene mutation in a patient following mechanical aortic valve replacement with an ON-X valve</dc:title><dc:creator>O'Sullivan K.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>63-64</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.045</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019449</affiliation-url><afid>60019449</afid><affilname>Mater Misericordiae Hospital, Dublin</affilname><name-variant>Mater Misericordiae Hospital</name-variant><affiliation-city>Dublin</affiliation-city><affiliation-country>Ireland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112638200</affiliation-url><afid>112638200</afid><affilname>University Hospital Limerick</affilname><name-variant>University Hospital Limerick</name-variant><affiliation-city>Limerick</affiliation-city><affiliation-country>Ireland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7005875247</author-url><authid>7005875247</authid><authname>O'Sullivan K.</authname><surname>O'Sullivan</surname><given-name>Katie E.</given-name><initials>K.E.</initials><afid>60019449</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6507541306</author-url><authid>6507541306</authid><authname>Meany B.</authname><surname>Meany</surname><given-name>Brendan</given-name><initials>B.</initials><afid>112638200</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7202996976</author-url><authid>7202996976</authid><authname>Hurley J.</authname><surname>Hurley</surname><given-name>John P.</given-name><initials>J.P.</initials><afid>60019449</afid></author><authkeywords>Mutation | ON-X valve | VKORC1 | Warfarin</authkeywords><intid>535964850</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926324757"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926324757?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926324757&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926324757&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022096515000363"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926324757</prism:url><dc:identifier>SCOPUS_ID:84926324757</dc:identifier><eid>2-s2.0-84926324757</eid><dc:title>A person-centered approach to adolescent emotion regulation: Associations with psychopathology and parenting</dc:title><dc:creator>Turpyn C.</dc:creator><prism:publicationName>Journal of Experimental Child Psychology</prism:publicationName><prism:issn>00220965</prism:issn><prism:volume>136</prism:volume><prism:pageRange>1-16</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jecp.2015.02.009</prism:doi><pii>S0022096515000363</pii><dc:description>Â© 2015 Elsevier Inc. Adolescence is a unique period of heightened emotional arousal and still-developing regulatory abilities. Adolescent emotion regulation patterns may be critically involved in adolescents' psychosocial development, but patterns of emotion regulation in youths are not well understood. The current study used latent profile analysis (LPA) to elucidate patterns of emotion expression, experience, and emotion-related physiological arousal in adolescents. A sample of 198 adolescents and their primary caregivers participated in an emotionally arousing parent-adolescent conflict interaction. Adolescents' observed emotion expressions, emotion experiences, and heart rate (HR) and caregiver parenting behaviors were assessed during and/or after the interaction. Parents reported on adolescents' internalizing and externalizing symptoms, and youths reported on depressive symptoms. The LPA revealed four emotion regulation profiles: a moderate HR and high expression profile, a suppression profile (with low negative emotion expression and high emotion experience), a low reactive profile, and a high reactive profile. The moderate HR and high expression profile was associated with lower conduct disorder symptoms, the suppression profile was related to lower anxiety symptoms, and the high reactive profile was associated with higher adolescent depressive symptoms. The high reactive profile and moderate HR and high expression profile were associated with more negative/critical parenting behaviors. Findings suggest that profiles of adolescent emotion regulation can be empirically identified and may be significant risk factors for psychopathology.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018319</affiliation-url><afid>60018319</afid><affilname>George Mason University</affilname><name-variant>George Mason University</name-variant><affiliation-city>Fairfax</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007475</affiliation-url><afid>60007475</afid><affilname>Rhode Island College</affilname><name-variant>Rhode Island College</name-variant><affiliation-city>Providence</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56582564000</author-url><authid>56582564000</authid><authname>Turpyn C.</authname><surname>Turpyn</surname><given-name>Caitlin C.</given-name><initials>C.C.</initials><afid>60018319</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8234566200</author-url><authid>8234566200</authid><authname>Chaplin T.</authname><surname>Chaplin</surname><given-name>Tara M.</given-name><initials>T.M.</initials><afid>60018319</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:25030191000</author-url><authid>25030191000</authid><authname>Cook E.</authname><surname>Cook</surname><given-name>Emily C.</given-name><initials>E.C.</initials><afid>60007475</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56581279200</author-url><authid>56581279200</authid><authname>Martelli A.</authname><surname>Martelli</surname><given-name>Alexandra M.</given-name><initials>A.M.</initials><afid>60018319</afid></author><authkeywords>Adolescence | Developmental Psychopathology | Emotion | Emotion regulation | Multimethod | Person-centered approach</authkeywords><intid>1035425993</intid><source-id>15472</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930196921"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930196921?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930196921&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930196921&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0378427415001800"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930196921</prism:url><dc:identifier>SCOPUS_ID:84930196921</dc:identifier><eid>2-s2.0-84930196921</eid><dc:title>Autophagy plays an important role in triptolide-induced apoptosis in cardiomyocytes</dc:title><dc:creator>Zhou J.</dc:creator><prism:publicationName>Toxicology Letters</prism:publicationName><prism:issn>03784274</prism:issn><prism:eIssn>18793169</prism:eIssn><prism:volume>236</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>168-183</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.toxlet.2015.05.013</prism:doi><pii>S0378427415001800</pii><dc:description>Â© 2015 Elsevier Ireland Ltd. Triptolide (TP), a major bioactive component isolated from the traditional Chinese herb Tripterygium wilfordii Hook f. (TWHF), has been shown to exert various pharmacological effects. However, the severe toxicity of TP prevents wide clinical use. In a previous study, we reported that TP-induced mitochondria-dependent apoptosis in cardiomyocytes is mediated by reactive oxygen species (ROS). Autophagy is a cellular self-digestion process and is one of the first lines of defense against oxidative stress. Additionally, recent evidence suggests that autophagy can selectively eliminate damaged mitochondria. This study investigated the role of autophagy in TP-induced cardiotoxicity. We investigated the effects of autophagy in combination with TP on apoptosis, ROS and mitochondrial function. Rat cardiomyocytes were pre-treated with chloroquine or rapamycin followed by TP. The augmentation of autophagy with rapamycin in the presence of TP substantially ameliorated the detrimental effects induced by TP, while suppression of autophagy by chloroquine accelerates TP-induced cellular damage. In addition, pre-treated with rapamycin before TP administration also attenuated TP-induced damage in Balb/c mice heart tissues. Taken together, these results suggest that TP-induced cell death can be modified by autophagy. Furthermore, induction of autophagy by rapamycin may be a potential cardioprotective role against TP-induced cardiotoxicity by facilitating removal of dysfunctional mitochondria.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021182</affiliation-url><afid>60021182</afid><affilname>Sun Yat-Sen University</affilname><name-variant>Sun Yat-Sen University</name-variant><affiliation-city>Guangzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021182</affiliation-url><afid>60021182</afid><affilname>Sun Yat-Sen University</affilname><name-variant>Sun Yat-Sen University</name-variant><affiliation-city>Guangzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60102075</affiliation-url><afid>60102075</afid><affilname>First Affiliated Hospital of Zhengzhou University</affilname><name-variant>First Affiliated Hospital of Zhengzhou University</name-variant><affiliation-city>Zhengzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56367887600</author-url><authid>56367887600</authid><authname>Zhou J.</authname><surname>Zhou</surname><given-name>Jie</given-name><initials>J.</initials><afid>60021182</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36187598900</author-url><authid>36187598900</authid><authname>Xi C.</authname><surname>Xi</surname><given-name>Chen</given-name><initials>C.</initials><afid>60021182</afid><afid>60102075</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36187598900</author-url><authid>36187598900</authid><authname>Xi C.</authname><surname>Xi</surname><given-name>Chen</given-name><initials>C.</initials><afid>60021182</afid><afid>60102075</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36115812100</author-url><authid>36115812100</authid><authname>Wang W.</authname><surname>Wang</surname><given-name>Wenwen</given-name><initials>W.</initials><afid>60021182</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56662733800</author-url><authid>56662733800</authid><authname>Yang Y.</authname><surname>Yang</surname><given-name>Yanqin</given-name><initials>Y.</initials><afid>60021182</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:54943059100</author-url><authid>54943059100</authid><authname>Qiu Y.</authname><surname>Qiu</surname><given-name>Yuwen</given-name><initials>Y.</initials><afid>60021182</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35620347900</author-url><authid>35620347900</authid><authname>Huang Z.</authname><surname>Huang</surname><given-name>Zhiying</given-name><initials>Z.</initials><afid>60021182</afid><afid>60021182</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35620347900</author-url><authid>35620347900</authid><authname>Huang Z.</authname><surname>Huang</surname><given-name>Zhiying</given-name><initials>Z.</initials><afid>60021182</afid><afid>60021182</afid></author><authkeywords>Apoptosis | Autophagy | Cardioprotective | Mitochondrion | Rapamycin | Triptolide</authkeywords><intid>1536088327</intid><source-id>25240</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929576529"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929576529?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929576529&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929576529&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1050464815001941"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929576529</prism:url><dc:identifier>SCOPUS_ID:84929576529</dc:identifier><eid>2-s2.0-84929576529</eid><dc:title>Immunolocalization of tumor necrosis factor alpha in turbot (Scophthalmus maximus, L.) tissues</dc:title><dc:creator>Ronza P.</dc:creator><prism:publicationName>Fish and Shellfish Immunology</prism:publicationName><prism:issn>10504648</prism:issn><prism:eIssn>10959947</prism:eIssn><prism:volume>45</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>470-476</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.fsi.2015.04.032</prism:doi><pii>S1050464815001941</pii><dc:description>Â© 2015 Elsevier Ltd. Tumor necrosis factor alpha (TNFÎ±) is a cytokine involved in a broad spectrum of cellular and organismal responses. Its main function, as a potent pro-inflammatory mediator, has been demonstrated in numerous teleost species and there are many reports on the modulation of TNFÎ± gene expression under pathological conditions. Nevertheless, there is still scarce knowledge about the tissue distribution and type of cells that express this cytokine in fish species, which would help to further investigate its biological activities. These studies are hampered by the lack of molecular markers for teleost that hinder the development of morphological techniques, like immunohistochemistry. The aim of this work was to develop an immunohistochemical technique for the detection of TNFÎ± in paraffin-embedded organs from healthy turbot (. Scophthalmus maximus), an economically-important marine fish species. A commercial anti-human TNFÎ± antibody, whose specificity was confirmed by western blot analysis, was used. Immunoreactive cells were observed in higher numbers in the lymphohematopoietic organs, kidney, spleen and thymus, although TNFÎ±-positive cells were also present in the digestive tract, liver, heart, gills and skin. Similarly to non-fish species, monocytes/macrophages appeared to be the main producers of this cytokine; nevertheless, the presence of immunoreactive rodlet cells in different tissues was also reported. The nature and distribution of the labeled cells appeared to be related with a strategic localization for defense response to antigenic challenge. The relative abundance of TNFÎ±-positive cells in the lymphohematopoietic organs also suggests that this cytokine may have a broader role in the normal physiology of those organs. The immunohistochemical technique allowed the in-situ characterization of TNFÎ± expression, representing a valid tool to investigate the immune response of turbot.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028419</affiliation-url><afid>60028419</afid><affilname>Universidad de Santiago de Compostela</affilname><name-variant>Universidade de Santiago de Compostela</name-variant><affiliation-city>Santiago de Compostela</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028419</affiliation-url><afid>60028419</afid><affilname>Universidad de Santiago de Compostela</affilname><name-variant>Universidade de Santiago de Compostela</name-variant><affiliation-city>Santiago de Compostela</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028419</affiliation-url><afid>60028419</afid><affilname>Universidad de Santiago de Compostela</affilname><name-variant>Universidade de Santiago de Compostela</name-variant><affiliation-city>Santiago de Compostela</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:49962416000</author-url><authid>49962416000</authid><authname>Ronza P.</authname><surname>Ronza</surname><given-name>Paolo</given-name><initials>P.</initials><afid>60028419</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56654339300</author-url><authid>56654339300</authid><authname>Losada A.</authname><surname>Losada</surname><given-name>Ana Paula</given-name><initials>A.P.</initials><afid>60028419</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35119791000</author-url><authid>35119791000</authid><authname>VillamarÃ­n A.</authname><surname>VillamarÃ­n</surname><given-name>Antonio</given-name><initials>A.</initials><afid>60028419</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:13407966200</author-url><authid>13407966200</authid><authname>BermÃºdez R.</authname><surname>BermÃºdez</surname><given-name>Roberto</given-name><initials>R.</initials><afid>60028419</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7005283272</author-url><authid>7005283272</authid><authname>Quiroga M.</authname><surname>Quiroga</surname><given-name>MarÃ­a Isabel</given-name><initials>M.I.</initials><afid>60028419</afid></author><authkeywords>Cytokine | Immune system | Immunohistochemistry | Monocyte/macrophage | Rodlet cell | Tumor necrosis factor alpha | Turbot</authkeywords><intid>1035977689</intid><source-id>15066</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929298196"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929298196?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929298196&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929298196&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006816"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929298196</prism:url><dc:identifier>SCOPUS_ID:84929298196</dc:identifier><eid>2-s2.0-84929298196</eid><dc:title>Left anterior descending coronary artery fistula to left ventricle: The revenge of a well treated myocardial infarction in the era of primary percutaneous angioplasty</dc:title><dc:creator>Barbero U.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>508-510</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.418</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113157954</affiliation-url><afid>113157954</afid><affilname>CittÃ  della Salute e della Scienza Hospital</affilname><name-variant>CittÃ  della Salute e della Scienza Hospital</name-variant><affiliation-city>Torino</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55388723500</author-url><authid>55388723500</authid><authname>Barbero U.</authname><surname>Barbero</surname><given-name>Umberto</given-name><initials>U.</initials><afid>113157954</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36885744200</author-url><authid>36885744200</authid><authname>Ferraris F.</authname><surname>Ferraris</surname><given-name>Federico</given-name><initials>F.</initials><afid>113157954</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7004664351</author-url><authid>7004664351</authid><authname>Bergerone S.</authname><surname>Bergerone</surname><given-name>Serena</given-name><initials>S.</initials><afid>113157954</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6701602705</author-url><authid>6701602705</authid><authname>Montefusco A.</authname><surname>Montefusco</surname><given-name>Antonio</given-name><initials>A.</initials><afid>113157954</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:37110862100</author-url><authid>37110862100</authid><authname>Meynet I.</authname><surname>Meynet</surname><given-name>Ilaria</given-name><initials>I.</initials><afid>113157954</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:36604133600</author-url><authid>36604133600</authid><authname>D'Ascenzo F.</authname><surname>D'Ascenzo</surname><given-name>Fabrizio</given-name><initials>F.</initials><afid>113157954</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7006090821</author-url><authid>7006090821</authid><authname>Gaita F.</authname><surname>Gaita</surname><given-name>Fiorenzo</given-name><initials>F.</initials><afid>113157954</afid></author><authkeywords>Coronary artery fistula | Echocardiography | Magnetic resonance | Myocardial infarction</authkeywords><intid>1785946029</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929352997"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929352997?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929352997&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929352997&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008402"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929352997</prism:url><dc:identifier>SCOPUS_ID:84929352997</dc:identifier><eid>2-s2.0-84929352997</eid><dc:title>Myocardial bridging of the left circumflex artery: An extremely rare entity</dc:title><dc:creator>Duygu H.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>231</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.117</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006471</affiliation-url><afid>60006471</afid><affilname>Near East University</affilname><name-variant>Near East University</name-variant><affiliation-city>Nicosia</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:10439166000</author-url><authid>10439166000</authid><authname>Duygu H.</authname><surname>Duygu</surname><given-name>Hamza</given-name><initials>H.</initials><afid>60006471</afid></author><authkeywords>Atherosclerosis | Left circumflex artery | Myocardial bridging | Vasospasm</authkeywords><intid>1035941217</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84921442608"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84921442608?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84921442608&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84921442608&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915014011691"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84921442608</prism:url><dc:identifier>SCOPUS_ID:84921442608</dc:identifier><eid>2-s2.0-84921442608</eid><dc:title>Stent thrombosis is not increased following percutaneous coronary intervention in patients with non-insulin dependent diabetes mellitus taking metformin</dc:title><dc:creator>Lipinski M.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>235</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>295-298</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2014.05.919</prism:doi><pii>S0021915014011691</pii><dc:description>Â© 2014 Elsevier Ireland Ltd. Objective: Recent studies have suggested that metformin may inhibit endothelialization following limus-eluting stent (LES) placement and may increase the risk of stent thrombosis. Therefore, we assessed the impact of metformin on stent thrombosis and major adverse cardiovascular events (MACE) in non-insulin-dependent diabetes mellitus (NIDDM) patients who receive drug-eluting stents (DES). Methods: We assessed the impact of metformin and stent type on stent thrombosis, MACE, and death in NIDDM patients following DES placement. Of the 1201 patients included, 74.8% received LES, 25.2% received paclitaxel-eluting stents (PES), and 55% were taking metformin. Results: There was no difference in stent thrombosis, regardless of stent type or metformin use. While Kaplan-Meier curves demonstrated reduced MACE (. p=0.007) and death (. p=0.006) with metformin use, multivariate analysis demonstrated that stent type and metformin use were not associated with outcome. Conclusion: In NIDDM patients, metformin use or stent type following DES placement did not increase stent thrombosis and MACE rates.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026876</affiliation-url><afid>60026876</afid><affilname>Washington Hospital Center</affilname><name-variant>Washington Hospital Center</name-variant><affiliation-city>Washington</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><pubmed-id>24908239</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:9842449400</author-url><authid>9842449400</authid><authname>Lipinski M.</authname><surname>Lipinski</surname><given-name>Michael J.</given-name><initials>M.J.</initials><afid>60026876</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:24460476100</author-url><authid>24460476100</authid><authname>Pendyala L.</authname><surname>Pendyala</surname><given-name>Lakshmana K.</given-name><initials>L.K.</initials><afid>60026876</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6506677099</author-url><authid>6506677099</authid><authname>Torguson R.</authname><surname>Torguson</surname><given-name>Rebecca</given-name><initials>R.</initials><afid>60026876</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56189201800</author-url><authid>56189201800</authid><authname>Chen F.</authname><surname>Chen</surname><given-name>Fang</given-name><initials>F.</initials><afid>60026876</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35375717700</author-url><authid>35375717700</authid><authname>Waksman R.</authname><surname>Waksman</surname><given-name>Ron</given-name><initials>R.</initials><afid>60026876</afid></author><authkeywords>Diabetes mellitus | Drug-eluting stents | Metformin | Outcomes | Percutaneous coronary intervention</authkeywords><intid>1534650163</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929377992"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929377992?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929377992&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929377992&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006233"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929377992</prism:url><dc:identifier>SCOPUS_ID:84929377992</dc:identifier><eid>2-s2.0-84929377992</eid><dc:title>Impact of glycemic variability in patients with ST-elevated myocardial infarction</dc:title><dc:creator>Tokue M.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>660-662</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.365</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018642</affiliation-url><afid>60018642</afid><affilname>Toho University</affilname><name-variant>Toho University</name-variant><affiliation-city>Tokyo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54391658000</author-url><authid>54391658000</authid><authname>Tokue M.</authname><surname>Tokue</surname><given-name>Masahide</given-name><initials>M.</initials><afid>60018642</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004250349</author-url><authid>7004250349</authid><authname>Iijima R.</authname><surname>Iijima</surname><given-name>Raisuke</given-name><initials>R.</initials><afid>60018642</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:53865176800</author-url><authid>53865176800</authid><authname>Imamura T.</authname><surname>Imamura</surname><given-name>Takaaki</given-name><initials>T.</initials><afid>60018642</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:54391417800</author-url><authid>54391417800</authid><authname>Niikura H.</authname><surname>Niikura</surname><given-name>Hiroki</given-name><initials>H.</initials><afid>60018642</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36463488400</author-url><authid>36463488400</authid><authname>Hayashi F.</authname><surname>Hayashi</surname><given-name>Fumiyuki</given-name><initials>F.</initials><afid>60018642</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:36633577500</author-url><authid>36633577500</authid><authname>Yazaki Y.</authname><surname>Yazaki</surname><given-name>Yoshiyuki</given-name><initials>Y.</initials><afid>60018642</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55642003800</author-url><authid>55642003800</authid><authname>Nagashima Y.</authname><surname>Nagashima</surname><given-name>Yoshinori</given-name><initials>Y.</initials><afid>60018642</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:16685944900</author-url><authid>16685944900</authid><authname>Yamazaki K.</authname><surname>Yamazaki</surname><given-name>Kenji</given-name><initials>K.</initials><afid>60018642</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56643736500</author-url><authid>56643736500</authid><authname>Ono T.</authname><surname>Ono</surname><given-name>Tsuyoshi</given-name><initials>T.</initials><afid>60018642</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56472271400</author-url><authid>56472271400</authid><authname>Hara H.</authname><surname>Hara</surname><given-name>Hidehiko</given-name><initials>H.</initials><afid>60018642</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56263794700</author-url><authid>56263794700</authid><authname>Nakamura M.</authname><surname>Nakamura</surname><given-name>Masato</given-name><initials>M.</initials><afid>60018642</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7005143291</author-url><authid>7005143291</authid><authname>Sugi K.</authname><surname>Sugi</surname><given-name>Kaoru</given-name><initials>K.</initials><afid>60018642</afid></author><authkeywords>Continuous glucose monitoring (cgm) system | Glucose variability | Hyperglycemia | St elevation myocardial infarction</authkeywords><intid>2035938727</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929311689"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929311689?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929311689&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929311689&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006828"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929311689</prism:url><dc:identifier>SCOPUS_ID:84929311689</dc:identifier><eid>2-s2.0-84929311689</eid><dc:title>Risperidone unmasking an accessory pathway</dc:title><dc:creator>Imran T.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>488-490</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.419</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030623</affiliation-url><afid>60030623</afid><affilname>Rutgers, The State University of New Jersey</affilname><name-variant>Rutgers University</name-variant><affiliation-city>New Brunswick</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030623</affiliation-url><afid>60030623</afid><affilname>Rutgers, The State University of New Jersey</affilname><name-variant>Rutgers University</name-variant><affiliation-city>New Brunswick</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030623</affiliation-url><afid>60030623</afid><affilname>Rutgers, The State University of New Jersey</affilname><name-variant>Rutgers University</name-variant><affiliation-city>New Brunswick</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56454379600</author-url><authid>56454379600</authid><authname>Imran T.</authname><surname>Imran</surname><given-name>Tasnim F.</given-name><initials>T.F.</initials><afid>60030623</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644663700</author-url><authid>56644663700</authid><authname>Niazi O.</authname><surname>Niazi</surname><given-name>Osama T.</given-name><initials>O.T.</initials><afid>60030623</afid><afid>60030623</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644663700</author-url><authid>56644663700</authid><authname>Niazi O.</authname><surname>Niazi</surname><given-name>Osama T.</given-name><initials>O.T.</initials><afid>60030623</afid><afid>60030623</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56644781800</author-url><authid>56644781800</authid><authname>Aminc R.</authname><surname>Aminc</surname><given-name>Ritesh</given-name><initials>R.</initials><afid>60030623</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8285734800</author-url><authid>8285734800</authid><authname>Mazza V.</authname><surname>Mazza</surname><given-name>Victor</given-name><initials>V.</initials><afid>60030623</afid><afid>60030623</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8285734800</author-url><authid>8285734800</authid><authname>Mazza V.</authname><surname>Mazza</surname><given-name>Victor</given-name><initials>V.</initials><afid>60030623</afid><afid>60030623</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6602361694</author-url><authid>6602361694</authid><authname>Klapholz M.</authname><surname>Klapholz</surname><given-name>Marc</given-name><initials>M.</initials><afid>60030623</afid><afid>60030623</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6602361694</author-url><authid>6602361694</authid><authname>Klapholz M.</authname><surname>Klapholz</surname><given-name>Marc</given-name><initials>M.</initials><afid>60030623</afid><afid>60030623</afid></author><authkeywords>Accessory pathway | Atrioventricular node blockade | Risperidone | WPWpattern</authkeywords><intid>1035941176</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929379109"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929379109?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929379109&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929379109&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006269"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929379109</prism:url><dc:identifier>SCOPUS_ID:84929379109</dc:identifier><eid>2-s2.0-84929379109</eid><dc:title>Current profile of infective endocarditis in intravenous drug users: Prognostic relevance of the valves involved</dc:title><dc:creator>Ortiz-Bautista C.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>472-474</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.368</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020340</affiliation-url><afid>60020340</afid><affilname>Hospital Universitario de Valladolid</affilname><name-variant>Hospital Universitario</name-variant><affiliation-city>Valladolid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032461</affiliation-url><afid>60032461</afid><affilname>Hospital Clinico San Carlos de Madrid</affilname><name-variant>Hospital Universitario San Carlos</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024257</affiliation-url><afid>60024257</afid><affilname>Hospital Universitario de la Princesa</affilname><name-variant>Hospital Universitario de la Princesa</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644706500</author-url><authid>56644706500</authid><authname>Ortiz-Bautista C.</authname><surname>Ortiz-Bautista</surname><given-name>Carlos</given-name><initials>C.</initials><afid>60020340</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56440653800</author-url><authid>56440653800</authid><authname>LÃ³pez J.</authname><surname>LÃ³pez</surname><given-name>Javier</given-name><initials>J.</initials><afid>60020340</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56644870200</author-url><authid>56644870200</authid><authname>GarcÃ­a-Granja P.</authname><surname>GarcÃ­a-Granja</surname><given-name>Pablo Elpidio</given-name><initials>P.E.</initials><afid>60020340</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6603926160</author-url><authid>6603926160</authid><authname>Sevilla T.</authname><surname>Sevilla</surname><given-name>Teresa</given-name><initials>T.</initials><afid>60020340</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7006631528</author-url><authid>7006631528</authid><authname>Vilacosta I.</authname><surname>Vilacosta</surname><given-name>Isidre</given-name><initials>I.</initials><afid>60032461</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6601973618</author-url><authid>6601973618</authid><authname>SarriÃ¡ C.</authname><surname>SarriÃ¡</surname><given-name>Cristina</given-name><initials>C.</initials><afid>60024257</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:51764196800</author-url><authid>51764196800</authid><authname>Olmos C.</authname><surname>Olmos</surname><given-name>Carmen</given-name><initials>C.</initials><afid>60032461</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:54913336500</author-url><authid>54913336500</authid><authname>Ferrera C.</authname><surname>Ferrera</surname><given-name>Carlos</given-name><initials>C.</initials><afid>60032461</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7003572486</author-url><authid>7003572486</authid><authname>SÃ¡ez C.</authname><surname>SÃ¡ez</surname><given-name>Carmen</given-name><initials>C.</initials><afid>60024257</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:16047881100</author-url><authid>16047881100</authid><authname>GÃ³mez I.</authname><surname>GÃ³mez</surname><given-name>Itziar</given-name><initials>I.</initials><afid>60020340</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56441047800</author-url><authid>56441047800</authid><authname>San RomÃ¡n J.</authname><surname>San RomÃ¡n</surname><given-name>JosÃ© Alberto</given-name><initials>J.A.</initials><afid>60020340</afid></author><authkeywords>Infective endocarditis | Intravenous drug use | Right-sided infective endocarditis</authkeywords><intid>1035939212</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929353345"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929353345?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929353345&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929353345&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008128"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929353345</prism:url><dc:identifier>SCOPUS_ID:84929353345</dc:identifier><eid>2-s2.0-84929353345</eid><dc:title>Ruptured tricuspid septal leaflet aneurysm in a patient with aortic and mitral valve replacement</dc:title><dc:creator>Aksu U.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>40-41</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.089</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015566</affiliation-url><afid>60015566</afid><affilname>Ataturk University, Faculty of Medicine</affilname><name-variant>AtatÃ¼rk University</name-variant><affiliation-city>Erzurum</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56641508900</author-url><authid>56641508900</authid><authname>Aksu U.</authname><surname>Aksu</surname><given-name>UÊur</given-name><initials>U.</initials><afid>60015566</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55324376200</author-url><authid>55324376200</authid><authname>Topcu S.</authname><surname>Topcu</surname><given-name>Selim</given-name><initials>S.</initials><afid>60015566</afid></author><authkeywords>Infective endocarditis | Tricuspid septal leaflet aneurysm</authkeywords><intid>35943117</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929377515"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929377515?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929377515&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929377515&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007615"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929377515</prism:url><dc:identifier>SCOPUS_ID:84929377515</dc:identifier><eid>2-s2.0-84929377515</eid><dc:title>Left ventricular outflow tract obstruction and Takotsubo syndrome: A heretofore unsettled pathophysiologic association</dc:title><dc:creator>Madias J.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>58-59</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.042</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012981</affiliation-url><afid>60012981</afid><affilname>Icahn School of Medicine at Mount Sinai</affilname><name-variant>Mount Sinai School of Medicine</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016846</affiliation-url><afid>60016846</afid><affilname>Elmhurst Hospital Center</affilname><name-variant>City Hospital Center at Elmhurst</name-variant><affiliation-city>Elmhurst</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7006186911</author-url><authid>7006186911</authid><authname>Madias J.</authname><surname>Madias</surname><given-name>John E.</given-name><initials>J.E.</initials><afid>60012981</afid><afid>60016846</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7006186911</author-url><authid>7006186911</authid><authname>Madias J.</authname><surname>Madias</surname><given-name>John E.</given-name><initials>J.E.</initials><afid>60012981</afid><afid>60016846</afid></author><authkeywords>Basal hyperkineis in Takotsubo syndrome | Catecholamines | Hyperacute phase of Takotsubo syndrome | Left ventricular tract outflow tract obstriction and Takotsubo syndrome | Pathophysiology of Takotsubo syndrome | Takotsubo syndrome</authkeywords><intid>1785945619</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929299857"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929299857?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929299857&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929299857&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315005434"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929299857</prism:url><dc:identifier>SCOPUS_ID:84929299857</dc:identifier><eid>2-s2.0-84929299857</eid><dc:title>Lack of mitral valve leaflet coaptation in a case of non-compaction cardiomyopathy</dc:title><dc:creator>Nikolaos K.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>272</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.303</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031155</affiliation-url><afid>60031155</afid><affilname>Panepistimion Patron</affilname><name-variant>University of Patras</name-variant><affiliation-city>Patra</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644599600</author-url><authid>56644599600</authid><authname>Nikolaos K.</authname><surname>Nikolaos</surname><given-name>Koutsogiannis</given-name><initials>K.</initials><afid>60031155</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644888700</author-url><authid>56644888700</authid><authname>Ioanna K.</authname><surname>Ioanna</surname><given-name>Koniari</given-name><initials>K.</initials><afid>60031155</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56644763500</author-url><authid>56644763500</authid><authname>Ioanna X.</authname><surname>Ioanna</surname><given-name>Xanthopoulou</given-name><initials>X.</initials><afid>60031155</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56644309800</author-url><authid>56644309800</authid><authname>George H.</authname><surname>George</surname><given-name>Hahalis</given-name><initials>H.</initials><afid>60031155</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56644656100</author-url><authid>56644656100</authid><authname>Dimitrios A.</authname><surname>Dimitrios</surname><given-name>Alexopoulos</given-name><initials>A.</initials><afid>60031155</afid></author><authkeywords>Leaflet coaptation | Mitral regurgitation | Non-compaction cardiomyopathy</authkeywords><intid>1535944328</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84921510478"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84921510478?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84921510478&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84921510478&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915014011794"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84921510478</prism:url><dc:identifier>SCOPUS_ID:84921510478</dc:identifier><eid>2-s2.0-84921510478</eid><dc:title>Time course of atherosclerosis regression</dc:title><dc:creator>Spence J.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>235</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>347-348</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2014.05.929</prism:doi><pii>S0021915014011794</pii><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029991</affiliation-url><afid>60029991</afid><affilname>Robarts Research Institute</affilname><name-variant>John P. Robarts Research Institute</name-variant><affiliation-city>London</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><pubmed-id>24911639</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56076126900</author-url><authid>56076126900</authid><authname>Spence J.</authname><surname>Spence</surname><given-name>J. David</given-name><initials>J.D.</initials><afid>60029991</afid></author><authkeywords>Atherosclerosis | IMT | IVUS | Measurement | Plaque burden | Regression | Statin</authkeywords><intid>1534651547</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929314927"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929314927?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929314927&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929314927&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007299"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929314927</prism:url><dc:identifier>SCOPUS_ID:84929314927</dc:identifier><eid>2-s2.0-84929314927</eid><dc:title>Acinetobacter baumannii and endocarditis, rare complication but important clinical relevance</dc:title><dc:creator>LaganÃ  P.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>678-679</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.019</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011576</affiliation-url><afid>60011576</afid><affilname>Universita degli Studi di Messina</affilname><name-variant>UniversitÃ  di Messina</name-variant><affiliation-city>Messina</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603185635</author-url><authid>6603185635</authid><authname>LaganÃ  P.</authname><surname>LaganÃ </surname><given-name>P.</given-name><initials>P.</initials><afid>60011576</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644826400</author-url><authid>56644826400</authid><authname>Melcarne L.</authname><surname>Melcarne</surname><given-name>L.</given-name><initials>L.</initials><afid>60011576</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:8411250800</author-url><authid>8411250800</authid><authname>Delia S.</authname><surname>Delia</surname><given-name>S.</given-name><initials>S.</initials><afid>60011576</afid></author><authkeywords>Acinetobacter baumannii | Cardiac valve prosthesis | Infective endocarditis | Leak paravalvular</authkeywords><intid>1785946939</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929324705"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929324705?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929324705&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929324705&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007445"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929324705</prism:url><dc:identifier>SCOPUS_ID:84929324705</dc:identifier><eid>2-s2.0-84929324705</eid><dc:title>Negative acute hemodynamic response to balloon pulmonary angioplasty does not predicate the long-term outcome in patients with chronic thromboembolic pulmonary hypertension</dc:title><dc:creator>Hosokawa K.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>81-83</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.025</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021786</affiliation-url><afid>60021786</afid><affilname>Kyushu University Hospital</affilname><name-variant>Kyushu University Hospital</name-variant><affiliation-city>Fukuoka</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011047</affiliation-url><afid>60011047</afid><affilname>Kyushu University</affilname><name-variant>Kyushu University</name-variant><affiliation-city>Fukuoka</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56577478300</author-url><authid>56577478300</authid><authname>Hosokawa K.</authname><surname>Hosokawa</surname><given-name>Kazuya</given-name><initials>K.</initials><afid>60021786</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56643640100</author-url><authid>56643640100</authid><authname>Abe K.</authname><surname>Abe</surname><given-name>Kohtaro</given-name><initials>K.</initials><afid>60011047</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56644377700</author-url><authid>56644377700</authid><authname>Oi K.</authname><surname>Oi</surname><given-name>Keiji</given-name><initials>K.</initials><afid>60021786</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56079656800</author-url><authid>56079656800</authid><authname>Mukai Y.</authname><surname>Mukai</surname><given-name>Yasushi</given-name><initials>Y.</initials><afid>60021786</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7102226026</author-url><authid>7102226026</authid><authname>Hirooka Y.</authname><surname>Hirooka</surname><given-name>Yoshitaka</given-name><initials>Y.</initials><afid>60011047</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7102423451</author-url><authid>7102423451</authid><authname>Sunagawa K.</authname><surname>Sunagawa</surname><given-name>Kenji</given-name><initials>K.</initials><afid>60021786</afid></author><authkeywords>Balloon pulmonary angioplasty | Chronic thromboembolic pulmonary hypertension | Endovascular treatment | Pulmonary hypertension</authkeywords><intid>1785945991</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929379117"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929379117?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929379117&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929379117&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008517"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929379117</prism:url><dc:identifier>SCOPUS_ID:84929379117</dc:identifier><eid>2-s2.0-84929379117</eid><dc:title>Hyperkalemia induced sinoatrial block or atrial fibrillation?</dc:title><dc:creator>Kirat T.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>102</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.128</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112985623</affiliation-url><afid>112985623</afid><affilname>YÃ¼celen Hospital</affilname><name-variant>YÃ¼celen Hospital</name-variant><affiliation-city/><affiliation-country>Turkey</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114686357</affiliation-url><afid>114686357</afid><affilname>Sitki KoÃ§man University</affilname><name-variant>Sitki KoÃ§man University</name-variant><affiliation-city/><affiliation-country>Turkey</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55262961900</author-url><authid>55262961900</authid><authname>Kirat T.</authname><surname>Kirat</surname><given-name>Tamer</given-name><initials>T.</initials><afid>112985623</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7003978185</author-url><authid>7003978185</authid><authname>KÃ¶se N.</authname><surname>KÃ¶se</surname><given-name>Nuri</given-name><initials>N.</initials><afid>114686357</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56374644600</author-url><authid>56374644600</authid><authname>Altun I.</authname><surname>Altun</surname><given-name>Ibrahim</given-name><initials>I.</initials><afid>114686357</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:23484385000</author-url><authid>23484385000</authid><authname>Akin F.</authname><surname>Akin</surname><given-name>Fatih</given-name><initials>F.</initials><afid>114686357</afid></author><authkeywords>Atrial fibrillation | Bicarbonate | Furosemide | Hyperkalemia</authkeywords><intid>2035939416</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929318540"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929318540?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929318540&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929318540&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008268"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929318540</prism:url><dc:identifier>SCOPUS_ID:84929318540</dc:identifier><eid>2-s2.0-84929318540</eid><dc:title>Coronary artery disease/Takotsubo syndrome vs. acute coronary syndromes/Takotsubo syndrome, and their physical/emotional triggers</dc:title><dc:creator>Madias J.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>279-280</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.103</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012981</affiliation-url><afid>60012981</afid><affilname>Icahn School of Medicine at Mount Sinai</affilname><name-variant>Mount Sinai School of Medicine</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016846</affiliation-url><afid>60016846</afid><affilname>Elmhurst Hospital Center</affilname><name-variant>City Hospital Center at Elmhurst</name-variant><affiliation-city>Elmhurst</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7006186911</author-url><authid>7006186911</authid><authname>Madias J.</authname><surname>Madias</surname><given-name>John E.</given-name><initials>J.E.</initials><afid>60012981</afid><afid>60016846</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7006186911</author-url><authid>7006186911</authid><authname>Madias J.</authname><surname>Madias</surname><given-name>John E.</given-name><initials>J.E.</initials><afid>60012981</afid><afid>60016846</afid></author><authkeywords>Acute coronary syndrome | Contrast ventriculography | Coronary artery disease | Echocardiography in takotsubo syndrome | Takotsubo syndrome</authkeywords><intid>35945076</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929333238"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929333238?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929333238&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929333238&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008979"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929333238</prism:url><dc:identifier>SCOPUS_ID:84929333238</dc:identifier><eid>2-s2.0-84929333238</eid><dc:title>Predictors of return of spontaneous circulation in patients resuscitated from out-of-hospital cardiac arrest</dc:title><dc:creator>Tang P.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>181-182</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.173</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012256</affiliation-url><afid>60012256</afid><affilname>Kaohsiung Medical University</affilname><name-variant>Kaohsiung Medical University</name-variant><affiliation-city>Kaohsiung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073387</affiliation-url><afid>60073387</afid><affilname>Kaohsiung Medical University Chung-Ho Memorial Hospital</affilname><name-variant>Kaohsiung Medical University Hospital</name-variant><affiliation-city>Kaohsiung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073387</affiliation-url><afid>60073387</afid><affilname>Kaohsiung Medical University Chung-Ho Memorial Hospital</affilname><name-variant>Kaohsiung Medical University Hospital</name-variant><affiliation-city>Kaohsiung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55260959000</author-url><authid>55260959000</authid><authname>Tang P.</authname><surname>Tang</surname><given-name>Paul Wei Hua</given-name><initials>P.W.H.</initials><afid>60073387</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56643442900</author-url><authid>56643442900</authid><authname>Chen C.</authname><surname>Chen</surname><given-name>Chao Wen</given-name><initials>C.W.</initials><afid>60073387</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56643801300</author-url><authid>56643801300</authid><authname>Lai W.</authname><surname>Lai</surname><given-name>Wen Ter</given-name><initials>W.T.</initials><afid>60012256</afid><afid>60073387</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56643801300</author-url><authid>56643801300</authid><authname>Lai W.</authname><surname>Lai</surname><given-name>Wen Ter</given-name><initials>W.T.</initials><afid>60012256</afid><afid>60073387</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56606501600</author-url><authid>56606501600</authid><authname>Lee K.</authname><surname>Lee</surname><given-name>Kun Tai</given-name><initials>K.T.</initials><afid>60012256</afid><afid>60073387</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56606501600</author-url><authid>56606501600</authid><authname>Lee K.</authname><surname>Lee</surname><given-name>Kun Tai</given-name><initials>K.T.</initials><afid>60012256</afid><afid>60073387</afid></author><authkeywords>Cardiopulmonary resuscitation | Out-of-hospital cardiac arrest | Return of spontaneous circulation</authkeywords><intid>2035938927</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929315894"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929315894?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929315894&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929315894&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008256"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929315894</prism:url><dc:identifier>SCOPUS_ID:84929315894</dc:identifier><eid>2-s2.0-84929315894</eid><dc:title>Drug-coated balloon angioplasty for coronary chronic total occlusions. An OCT analysis for a "new" intriguing strategy</dc:title><dc:creator>Cortese B.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>257-258</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.102</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:101935531</affiliation-url><afid>101935531</afid><affilname>Interventional Cardiology</affilname><name-variant>Interventional Cardiology</name-variant><affiliation-city>Milan</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115238975</affiliation-url><afid>115238975</afid><affilname>Interventional Cardiology</affilname><name-variant>Interventional Cardiology</name-variant><affiliation-city>Palermo</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:22984973300</author-url><authid>22984973300</authid><authname>Cortese B.</authname><surname>Cortese</surname><given-name>Bernardo</given-name><initials>B.</initials><afid>101935531</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56638651500</author-url><authid>56638651500</authid><authname>Buccheri D.</authname><surname>Buccheri</surname><given-name>Dario</given-name><initials>D.</initials><afid>101935531</afid><afid>115238975</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56638651500</author-url><authid>56638651500</authid><authname>Buccheri D.</authname><surname>Buccheri</surname><given-name>Dario</given-name><initials>D.</initials><afid>101935531</afid><afid>115238975</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36895925900</author-url><authid>36895925900</authid><authname>Piraino D.</authname><surname>Piraino</surname><given-name>Davide</given-name><initials>D.</initials><afid>101935531</afid><afid>115238975</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36895925900</author-url><authid>36895925900</authid><authname>Piraino D.</authname><surname>Piraino</surname><given-name>Davide</given-name><initials>D.</initials><afid>101935531</afid><afid>115238975</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6602504546</author-url><authid>6602504546</authid><authname>Silva-Orrego P.</authname><surname>Silva-Orrego</surname><given-name>Pedro</given-name><initials>P.</initials><afid>101935531</afid></author><authkeywords>Chronic total occlusion (CTO) | Drug-coated balloon (DCB) | Drug-eluting stent (DES) | Dual-antiplatelet therapy (DAPT) | Optical coherence tomography (OCT) | Percutaneous coronary intervention (PCI)</authkeywords><intid>1035939771</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929580549"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929580549?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929580549&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929580549&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1053811915003936"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929580549</prism:url><dc:identifier>SCOPUS_ID:84929580549</dc:identifier><eid>2-s2.0-84929580549</eid><dc:title>The hemodynamic response to somatosensory stimulation in mice depends on the anesthetic used: Implications on analysis of mouse fMRI data</dc:title><dc:creator>Schlegel F.</dc:creator><prism:publicationName>NeuroImage</prism:publicationName><prism:issn>10538119</prism:issn><prism:eIssn>10959572</prism:eIssn><prism:volume>116</prism:volume><prism:pageRange>40-49</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.neuroimage.2015.05.013</prism:doi><pii>S1053811915003936</pii><dc:description>Â© 2015 Elsevier Inc. In recent years, the number of functional MRI (fMRI) studies in mice has been rapidly increasing. Technological improvements provide the sensitivity required to match the high demands on spatial and temporal resolution and to analyze fast and small signal components of the fMRI response. Yet, the interpretation of mouse fMRI data largely relies on assumptions that were uncritically adopted from previous research in humans or rats. Here, we show based on a large dataset employing an innocuous electrical stimulation paradigm, that (1) the shape of the HRF shapes comprises significant transient signal components; correspondingly analysis procedures have to account for this dynamic nature and allow for variable response functions. (2) The effects of the anesthetics are crucial in determining the shape of the hemodynamic response function (HRF) and also influence the spatial specificity of BOLD signal. (3) The dominant systemic confounding contributions elicited by stimulus-evoked cardiovascular responses observed in mouse fMRI when applying block stimuli may be largely avoided by a milder event-related design applying a randomly spaced single pulse train (RSSPT). Thereby the spatial specificity of the fMRI response is largely retained. We conclude that the sensitivity, specificity and interpretability of stimulus-evoked BOLD signals in mice can be improved by combining appropriate stimulation paradigms with analysis procedures that include adapted HRFs.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025858</affiliation-url><afid>60025858</afid><affilname>Eidgenossische Technische Hochschule Zurich</affilname><name-variant>ETH Zurich</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025858</affiliation-url><afid>60025858</afid><affilname>Eidgenossische Technische Hochschule Zurich</affilname><name-variant>ETH Zurich</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012614</affiliation-url><afid>60012614</afid><affilname>Universitat Zurich</affilname><name-variant>University of Zurich</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55206749100</author-url><authid>55206749100</authid><authname>Schlegel F.</authname><surname>Schlegel</surname><given-name>Felix</given-name><initials>F.</initials><afid>60025858</afid><afid>60025858</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55206749100</author-url><authid>55206749100</authid><authname>Schlegel F.</authname><surname>Schlegel</surname><given-name>Felix</given-name><initials>F.</initials><afid>60025858</afid><afid>60025858</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36097417500</author-url><authid>36097417500</authid><authname>Schroeter A.</authname><surname>Schroeter</surname><given-name>Aileen</given-name><initials>A.</initials><afid>60025858</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7006483407</author-url><authid>7006483407</authid><authname>Rudin M.</authname><surname>Rudin</surname><given-name>Markus</given-name><initials>M.</initials><afid>60025858</afid><afid>60025858</afid><afid>60012614</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7006483407</author-url><authid>7006483407</authid><authname>Rudin M.</authname><surname>Rudin</surname><given-name>Markus</given-name><initials>M.</initials><afid>60025858</afid><afid>60025858</afid><afid>60012614</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7006483407</author-url><authid>7006483407</authid><authname>Rudin M.</authname><surname>Rudin</surname><given-name>Markus</given-name><initials>M.</initials><afid>60025858</afid><afid>60025858</afid><afid>60012614</afid></author><authkeywords>Anesthesia | BOLD fMRI | Electrical stimulation | Event-related design | Hemodynamic response function | Non-linear regression</authkeywords><intid>535983163</intid><source-id>17495</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929603351"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929603351?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929603351&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929603351&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022282815001546"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929603351</prism:url><dc:identifier>SCOPUS_ID:84929603351</dc:identifier><eid>2-s2.0-84929603351</eid><dc:title>Mechanical stretch enhances the expression and activity of osteopontin and MMP-2 via the Akt1/AP-1 pathways in VSMC</dc:title><dc:creator>Seo K.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>85</prism:volume><prism:pageRange>13-24</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.05.006</prism:doi><pii>S0022282815001546</pii><dc:description>Â© 2015 Elsevier Ltd. Hemodynamic forces causing mechanical stretch (MS) of vascular smooth muscle cells (VSMC) play an important role in vascular remodeling, but the underlying mechanism involved is not fully understood. Thus, this study investigated whether osteopontin (OPN) expression in VSMC was induced by MS, and identified the intracellular signaling pathways involved in OPN production. The plasma level of OPN and its expression in aortic tissue were increased in various animal models of hypertension including spontaneous hypertensive rats and hypertensive mice induced by angiotensin II or L-NAME. When aortic VSMC was stimulated with MS, OPN production was increased, which was markedly attenuated in VSMC treated with PI3K/Akt inhibitor as well as in Akt1-depleted cells, but not in Akt2-depleted cells, suggesting a pivotal role of Akt1 isoform in OPN expression in VSMC. In the promoter assay, MS increased OPN promoter activity, which was attenuated when the region harboring AP-1 binding sites was mutated. The MS-enhanced promoter activity and OPN expression were also decreased in cells treated with AP-1 siRNA or inhibitor. Moreover, MS-induced MMP-2 production was attenuated in cells treated with OPN siRNA or anti-OPN antibody as well as in OPN-deficient VSMC cultured from aorta of OPN deficient mice. In in vivo experiments, the expressions of OPN and MMP-2 were increased in the aortic tissues from hypertensive mice, but these increases were markedly attenuated in OPN-deficient mice with hypertension. In conclusion, these results suggested that OPN expression in the hypertensive vasculature was increased via signaling pathways that involve Akt1/AP-1, leading to vascular remodeling by increasing the production of MMP-2.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008783</affiliation-url><afid>60008783</afid><affilname>Pusan National University</affilname><name-variant>Pusan National University</name-variant><affiliation-city>Busan</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:25822858000</author-url><authid>25822858000</authid><authname>Seo K.</authname><surname>Seo</surname><given-name>Kyo Won</given-name><initials>K.W.</initials><afid>60008783</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55653045000</author-url><authid>55653045000</authid><authname>Lee S.</authname><surname>Lee</surname><given-name>Seung Jin</given-name><initials>S.J.</initials><afid>60008783</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56542562200</author-url><authid>56542562200</authid><authname>Ye B.</authname><surname>Ye</surname><given-name>Byeong Hyeok</given-name><initials>B.H.</initials><afid>60008783</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56198005800</author-url><authid>56198005800</authid><authname>Kim Y.</authname><surname>Kim</surname><given-name>Young Whan</given-name><initials>Y.W.</initials><afid>60008783</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7202714266</author-url><authid>7202714266</authid><authname>Bae S.</authname><surname>Bae</surname><given-name>Sun Sik</given-name><initials>S.S.</initials><afid>60008783</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7409872890</author-url><authid>7409872890</authid><authname>Kim C.</authname><surname>Kim</surname><given-name>Chi Dae</given-name><initials>C.D.</initials><afid>60008783</afid></author><authkeywords>Hypertension | Mechanical stretch | MMP | OPN | VSMC</authkeywords><intid>1535981590</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928991640"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928991640?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928991640&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928991640&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0031938415002553"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928991640</prism:url><dc:identifier>SCOPUS_ID:84928991640</dc:identifier><eid>2-s2.0-84928991640</eid><dc:title>Effect of food restriction on energy budget in warm-acclimated striped hamsters</dc:title><dc:creator>Zhao Z.</dc:creator><prism:publicationName>Physiology and Behavior</prism:publicationName><prism:issn>00319384</prism:issn><prism:eIssn>1873507X</prism:eIssn><prism:volume>147</prism:volume><prism:pageRange>220-226</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.physbeh.2015.04.048</prism:doi><pii>S0031938415002553</pii><dc:description>Â© 2015 Elsevier Inc. The capacity of small mammals to sustain periods of food shortage largely depends on the adaptive regulation of energy budget in response to the decrease in food supply. In addition to food availability, ambient temperature (T&lt;inf&gt;a&lt;/inf&gt;) is an important factor affecting the rates of both energy intake and expenditure. To examine the effect of T&lt;inf&gt;a&lt;/inf&gt; on energy strategy and the capacity to sustain food shortage, striped hamsters were exposed to a warm condition (30Â°C) and were then restricted to 70% of ad libitum food intake. Body mass, energy intake and expenditure and physiological markers indicative of thermogenesis were measured. Warm exposure had no effect on body mass and digestibility, but decreased energy intake, basal metabolic rate and maximum nonshivering thermogenesis. The mitochondria protein content, cytochrome c oxidase activity and uncoupling protein 1 level of brown adipose tissue were significantly lower in hamsters at 30Â°C than at 21Â°C. Food restriction induced a significant decrease in body mass, but the decreased body mass was attenuated at 30Â°C relative to 21Â°C. This suggests that striped hamsters could not compensate for the limited food supply by decreasing daily energy expenditure at 21Â°C, whereas they could at 30Â°C. The significant reductions in the rates of metabolism and thermogenesis in warm-acclimated hamsters increase the capacity to cope with food shortage. Although, it remains uncertain whether this response represents some generalized evolutionary adaptation, the T&lt;inf&gt;a&lt;/inf&gt;-dependent adjustment in the capacity to survive food restriction may reflect that warm acclimation plays an important role in adaptive regulation of both physiology and behavior in response to the variations of food availability.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020224</affiliation-url><afid>60020224</afid><affilname>Wenzhou University</affilname><name-variant>Wenzhou University</name-variant><affiliation-city>Wenzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019499</affiliation-url><afid>60019499</afid><affilname>Chinese Academy of Sciences</affilname><name-variant>Chinese Academy of Sciences</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030274</affiliation-url><afid>60030274</afid><affilname>Liaocheng University</affilname><name-variant>Liaocheng University</name-variant><affiliation-city>Liaocheng</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7404148775</author-url><authid>7404148775</authid><authname>Zhao Z.</authname><surname>Zhao</surname><given-name>Zhi Jun</given-name><initials>Z.J.</initials><afid>60020224</afid><afid>60019499</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7404148775</author-url><authid>7404148775</authid><authname>Zhao Z.</authname><surname>Zhao</surname><given-name>Zhi Jun</given-name><initials>Z.J.</initials><afid>60020224</afid><afid>60019499</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:15030037900</author-url><authid>15030037900</authid><authname>Chi Q.</authname><surname>Chi</surname><given-name>Qing Sheng</given-name><initials>Q.S.</initials><afid>60019499</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56625358600</author-url><authid>56625358600</authid><authname>Zhao L.</authname><surname>Zhao</surname><given-name>Liang</given-name><initials>L.</initials><afid>60030274</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55596358300</author-url><authid>55596358300</authid><authname>Zhu Q.</authname><surname>Zhu</surname><given-name>Qiao Xia</given-name><initials>Q.X.</initials><afid>60030274</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36983493100</author-url><authid>36983493100</authid><authname>Cao J.</authname><surname>Cao</surname><given-name>Jing</given-name><initials>J.</initials><afid>60020224</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55672306900</author-url><authid>55672306900</authid><authname>Wang D.</authname><surname>Wang</surname><given-name>De Hua</given-name><initials>D.H.</initials><afid>60019499</afid></author><authkeywords>Basal metabolic rate | Energy budget | Food shortage | Striped hamster | Thermogenesis</authkeywords><intid>1785884838</intid><source-id>24007</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926322789"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926322789?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926322789&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926322789&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0958166915000592"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926322789</prism:url><dc:identifier>SCOPUS_ID:84926322789</dc:identifier><eid>2-s2.0-84926322789</eid><dc:title>Exometabolomics and MSI: Deconstructing how cells interact to transform their small molecule environment</dc:title><dc:creator>Silva L.</dc:creator><prism:publicationName>Current Opinion in Biotechnology</prism:publicationName><prism:issn>09581669</prism:issn><prism:eIssn>18790429</prism:eIssn><prism:volume>34</prism:volume><prism:pageRange>209-216</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.copbio.2015.03.015</prism:doi><pii>S0958166915000592</pii><dc:description>Â© 2015 . Metabolism is at the heart of many biotechnologies from biofuels to medical diagnostics. Metabolomic methods that provide glimpses into cellular metabolism have rapidly developed into a critical component of the biotechnological development process. Most metabolomics methods have focused on what is happening inside the cell. Equally important are the biochemical transformations of the cell, and their effect on other cells and their environment; the exometabolome. Exometabolomics is therefore gaining popularity as a robust approach for obtaining rich phenotypic data, and being used in bioprocessing and biofuel development. Mass spectrometry imaging approaches, including several nanotechnologies, provide complimentary information by localizing metabolic processes within complex biological matrices. Together, the two technologies can provide new insights into the metabolism and interactions of cells.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007174</affiliation-url><afid>60007174</afid><affilname>Lawrence Berkeley National Laboratory</affilname><name-variant>Lawrence Berkeley Laboratory</name-variant><affiliation-city>Berkeley</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Department of Energy</affilname><name-variant>Joint Genome Institute</name-variant><affiliation-city>Walnut Creek</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:37110133500</author-url><authid>37110133500</authid><authname>Silva L.</authname><surname>Silva</surname><given-name>Leslie P.</given-name><initials>L.P.</initials><afid>60007174</afid><afid/></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:37110133500</author-url><authid>37110133500</authid><authname>Silva L.</authname><surname>Silva</surname><given-name>Leslie P.</given-name><initials>L.P.</initials><afid>60007174</afid><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8578463900</author-url><authid>8578463900</authid><authname>Northen T.</authname><surname>Northen</surname><given-name>Trent R.</given-name><initials>T.R.</initials><afid>60007174</afid><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8578463900</author-url><authid>8578463900</authid><authname>Northen T.</authname><surname>Northen</surname><given-name>Trent R.</given-name><initials>T.R.</initials><afid>60007174</afid><afid/></author><intid>1535430669</intid><source-id>15579</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929573023"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929573023?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929573023&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929573023&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1050464815001576"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929573023</prism:url><dc:identifier>SCOPUS_ID:84929573023</dc:identifier><eid>2-s2.0-84929573023</eid><dc:title>First description and expression analysis of tumor necrosis factor receptor-associated factor 6 (TRAF6) from the swimming crab, Portunus trituberculatus</dc:title><dc:creator>Zhou S.</dc:creator><prism:publicationName>Fish and Shellfish Immunology</prism:publicationName><prism:issn>10504648</prism:issn><prism:eIssn>10959947</prism:eIssn><prism:volume>45</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>205-210</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.fsi.2015.04.005</prism:doi><pii>S1050464815001576</pii><dc:description>Â© 2015 Elsevier Ltd. Tumor necrosis factor receptor-associated factor 6 (TRAF6) is a cytoplasmic adapter protein that mediates signals induced by the tumor necrosis factor receptor (TNFR) superfamily and the interleukin-1 receptor (IL-1R). In the present study, the full-length cDNA of TRAF6 (Pt-TRAF6) was identified in a marine crab, Portunus trituberculatus. Pt-TRAF6 ORF is predicted to encode a 599-amino acid protein, including a RING type zinc finger, two TRAF-type zinc fingers, and a meprin and TRAF homology (MATH) domain. The overall amino acid sequence identity between Pt-TRAF6 and other TRAF6s ranged from 50.9 to 51.3% for shrimp and from 16.1 to 19.4% for insects. The Pt-TRAF6 gene contains six exons and five introns, which is different from the organization of the insect TRAF6 gene. Pt-TRAF6 transcripts were broadly expressed in all tissues tested, and their expression was higher in hemocytes, gills, the intestine, and heart than in muscle. Interestingly, the level of Pt-TRAF6 transcript differed between male and female crabs. After Vibrio alginolyticus or lipopolysaccharide (LPS) challenge, the Pt-TRAF6 transcript was down-regulated in hemocytes and up-regulated in gills. Moreover, Pt-TRAF6 expression was altered sooner in the LPS challenge group than in the V.alginolyticus challenge group. These results indicate that Pt-TRAF6 may respond to Gram-negative bacterial infections.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031419</affiliation-url><afid>60031419</afid><affilname>Ningbo University</affilname><name-variant>Ningbo University</name-variant><affiliation-city>Ningbo</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:24777781900</author-url><authid>24777781900</authid><authname>Zhou S.</authname><surname>Zhou</surname><given-name>Su Ming</given-name><initials>S.M.</initials><afid>60031419</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56500848200</author-url><authid>56500848200</authid><authname>Li M.</authname><surname>Li</surname><given-name>Meng</given-name><initials>M.</initials><afid>60031419</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56650507800</author-url><authid>56650507800</authid><authname>Yang N.</authname><surname>Yang</surname><given-name>Ning</given-name><initials>N.</initials><afid>60031419</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56650284800</author-url><authid>56650284800</authid><authname>Liu S.</authname><surname>Liu</surname><given-name>Shun</given-name><initials>S.</initials><afid>60031419</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56650419300</author-url><authid>56650419300</authid><authname>Yuan X.</authname><surname>Yuan</surname><given-name>Xue Mei</given-name><initials>X.M.</initials><afid>60031419</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56650529600</author-url><authid>56650529600</authid><authname>Tao Z.</authname><surname>Tao</surname><given-name>Zhen</given-name><initials>Z.</initials><afid>60031419</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:36513857400</author-url><authid>36513857400</authid><authname>Wang G.</authname><surname>Wang</surname><given-name>Guo Liang</given-name><initials>G.L.</initials><afid>60031419</afid></author><authkeywords>Gene structure | LPS | Portunus trituberculatus | TRAF6 | Vibrio alginolyticus</authkeywords><intid>1535981160</intid><source-id>15066</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929501485"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929501485?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929501485&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929501485&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1464343X15000977"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929501485</prism:url><dc:identifier>SCOPUS_ID:84929501485</dc:identifier><eid>2-s2.0-84929501485</eid><dc:title>Geology, geomorphology, geodiversity and geoconservation of the Sof Omar Cave System, Southeastern Ethiopia</dc:title><dc:creator>Asrat A.</dc:creator><prism:publicationName>Journal of African Earth Sciences</prism:publicationName><prism:issn>1464343X</prism:issn><prism:eIssn>18791956</prism:eIssn><prism:volume>108</prism:volume><prism:pageRange>47-63</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jafrearsci.2015.04.015</prism:doi><pii>S1464343X15000977</pii><dc:description>Â© 2015 Elsevier Ltd. The Sof Omar Cave System, a spectacular and extensive cave system in Southeastern Ethiopia represents a maze of dry cave passages, which subsequently were crossed by a subterranean watercourse formed by the Weib River, forming combined underground passages of a total length of 15.1. km, the longest and most extensive in Ethiopia. The Sof Omar cave and subterranean river system developed on Jurassic limestone beds particularly on the Gebredarie Series (massive, crystalline limestone beds intercalated with thin marl and mudstone beds). The cave system and the subterranean River developed along a generally horizontal outline within a 20. m thick layer. The Sof Omar gorge is a wide but shallow doline, whose central section is incised by the ancient surface route of the Weib River. Prominent half dolines opening toward the sink and resurgence areas, as well as consistently inward dipping limestone beds at these localities imply collapse phenomenon. Karstification triggered by rift-related uplifting and extension during the mid-Miocene East African rifting, accompanied by extensive collapse along bedding planes likely initiated the caving process. The rifted and collapsed chambers were later widened by slow but persistent dissolution. The dry cave passages were formed earlier than the subterranean river course, though the latter might have partly followed the pre-existing cave passages and enlarged them to form the current subterranean river course. The Sof Omar caves are still at the heart of the cultural and religious life of the local population, where the dry cave passages, domes, and chambers are considered as important religious and cultural locales. With its subterranean river, large chambers connected by narrow and long rift passages, a unique and prominent sinkhole above the caves, wooded gorge teeming with numerous and unique tropical plant and bird species, the Sof Omar Cave System and adjoining gorge has outstanding scenic values. Apart from these naturally outstanding values, what makes the Sof Omar Cave System unique and unsurpassed in the world is its cultural significance. The caves form part of the cultural and religious life of the local population leading to the unique harmony between nature and culture. The cave system and its adjoining forested gorge is a natural-cultural heritage site that requires an active geoconservation.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60071181</affiliation-url><afid>60071181</afid><affilname>Addis Ababa University</affilname><name-variant>Addis Ababa University</name-variant><affiliation-city>Addis Ababa</affiliation-city><affiliation-country>Ethiopia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:15768619100</author-url><authid>15768619100</authid><authname>Asrat A.</authname><surname>Asrat</surname><given-name>Asfawossen</given-name><initials>A.</initials><afid>60071181</afid></author><authkeywords>Cave geomorphology | Cave system | Ethiopia | Geoconservation | Sof Omar</authkeywords><intid>2035958851</intid><source-id>31815</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929465638"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929465638?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929465638&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929465638&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006865"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929465638</prism:url><dc:identifier>SCOPUS_ID:84929465638</dc:identifier><eid>2-s2.0-84929465638</eid><dc:title>Molecular pathogenesis of Marfan syndrome</dc:title><dc:creator>Ramachandra C.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>585-591</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.423</prism:doi><dc:description>Â© 2015 Elsevier Ireland Ltd. All rights reserved. Marfan syndrome (MFS) is a genetic disorder that affects multiple organs. Mortality imposed by aortic aneurysm and dissections represent the most serious clinical manifestation of MFS. Progressive pathological aortic root enlargement as the result of degeneration of microfibril architecture and consequential loss of extracellular matrix integrity due to fibrillin-1 (FBN1) mutations are commonly diagnosed clinical manifestations of MFS. However, overlapping clinical manifestations with other aneurysmal disorders present a significant challenge in early and accurate diagnosis of MFS. While FBN1 mutations, abnormal transforming growth factor-Î² signaling and dysregulated matrix metalloproteinases have been implicated in MFS, clinically accepted risk-stratifying biomarkers have yet to be reliably identified. In this review, we summarize current consensus and recent insights in the understanding of MFS pathogenesis. Finally, we introduce the application of induced pluripotent stem cells (iPSCs) as cellular models for MFS and its potential as a novel platform into providing better appreciation of mechanisms underlying MFS diverse manifestations in the cardiovascular system.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114420872</affiliation-url><afid>114420872</afid><affilname>National Heart Research Institute Singapore</affilname><name-variant>National Heart Research Institute Singapore (NHRIS)</name-variant><affiliation-city>Singapore City</affiliation-city><affiliation-country>Singapore</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004409</affiliation-url><afid>60004409</afid><affilname>National Heart Centre, Singapore</affilname><name-variant>National Heart Centre Singapore</name-variant><affiliation-city>Singapore City</affiliation-city><affiliation-country>Singapore</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60095034</affiliation-url><afid>60095034</afid><affilname>Duke-NUS Graduate Medical School Singapore</affilname><name-variant>Duke-NUS Graduate Medical School Singapore</name-variant><affiliation-city>Singapore City</affiliation-city><affiliation-country>Singapore</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:51663742400</author-url><authid>51663742400</authid><authname>Ramachandra C.</authname><surname>Ramachandra</surname><given-name>Chrishan J A</given-name><initials>C.J.A.</initials><afid>114420872</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7402756324</author-url><authid>7402756324</authid><authname>Mehta A.</authname><surname>Mehta</surname><given-name>Ashish</given-name><initials>A.</initials><afid>114420872</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56647491100</author-url><authid>56647491100</authid><authname>Guo K.</authname><surname>Guo</surname><given-name>Kenneth Wei Qiang</given-name><initials>K.W.Q.</initials><afid>60004409</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56457229800</author-url><authid>56457229800</authid><authname>Wong P.</authname><surname>Wong</surname><given-name>Philip</given-name><initials>P.</initials><afid>114420872</afid><afid>60004409</afid><afid>60095034</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56457229800</author-url><authid>56457229800</authid><authname>Wong P.</authname><surname>Wong</surname><given-name>Philip</given-name><initials>P.</initials><afid>114420872</afid><afid>60004409</afid><afid>60095034</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56457229800</author-url><authid>56457229800</authid><authname>Wong P.</authname><surname>Wong</surname><given-name>Philip</given-name><initials>P.</initials><afid>114420872</afid><afid>60004409</afid><afid>60095034</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56647288000</author-url><authid>56647288000</authid><authname>Tan J.</authname><surname>Tan</surname><given-name>Ju Le</given-name><initials>J.L.</initials><afid>60004409</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:8773017000</author-url><authid>8773017000</authid><authname>Shim W.</authname><surname>Shim</surname><given-name>Winston</given-name><initials>W.</initials><afid>114420872</afid><afid>60095034</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:8773017000</author-url><authid>8773017000</authid><authname>Shim W.</authname><surname>Shim</surname><given-name>Winston</given-name><initials>W.</initials><afid>114420872</afid><afid>60095034</afid></author><authkeywords>Aortic aneurysms | Fibrillin-1 | Induced pluripotent stem cells | Marfan syndrome | TGF-Î²</authkeywords><intid>35962411</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929459491"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929459491?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929459491&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929459491&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006786"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929459491</prism:url><dc:identifier>SCOPUS_ID:84929459491</dc:identifier><eid>2-s2.0-84929459491</eid><dc:title>Plasma mid-regional pro-atrial natriuretic peptide and N-terminal pro-brain natriuretic peptide improve discrimination of lone atrial fibrillation</dc:title><dc:creator>Chang I.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>10-12</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.415</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029445</affiliation-url><afid>60029445</afid><affilname>University of Minnesota Twin Cities</affilname><name-variant>University of Minnesota</name-variant><affiliation-city>Minneapolis</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026680</affiliation-url><afid>60026680</afid><affilname>Yong Loo Lin School of Medicine</affilname><name-variant>National University of</name-variant><affiliation-city>Singapore City</affiliation-city><affiliation-country>Singapore</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013223</affiliation-url><afid>60013223</afid><affilname>University of Minnesota School of Public Health</affilname><name-variant>University of Minnesota</name-variant><affiliation-city>Minneapolis</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017311</affiliation-url><afid>60017311</afid><affilname>University of Otago</affilname><name-variant>University of Otago</name-variant><affiliation-city>Dunedin</affiliation-city><affiliation-country>New Zealand</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113956463</affiliation-url><afid>113956463</afid><affilname>National University Heart Centre</affilname><name-variant>National University Heart Centre</name-variant><affiliation-city/><affiliation-country>Singapore</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55882520500</author-url><authid>55882520500</authid><authname>Chang I.</authname><surname>Chang</surname><given-name>Ian C Y</given-name><initials>I.C.Y.</initials><afid>60029445</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:10340284900</author-url><authid>10340284900</authid><authname>Chen L.</authname><surname>Chen</surname><given-name>Lin Y.</given-name><initials>L.Y.</initials><afid>60029445</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56647636400</author-url><authid>56647636400</authid><authname>Chong J.</authname><surname>Chong</surname><given-name>Jenny P C</given-name><initials>J.P.C.</initials><afid>60026680</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55430228600</author-url><authid>55430228600</authid><authname>Austin E.</authname><surname>Austin</surname><given-name>Erin</given-name><initials>E.</initials><afid>60013223</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:26644438300</author-url><authid>26644438300</authid><authname>Quay C.</authname><surname>Quay</surname><given-name>Chwee N.</given-name><initials>C.N.</initials><afid>60026680</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55657014200</author-url><authid>55657014200</authid><authname>Gong L.</authname><surname>Gong</surname><given-name>Lingli</given-name><initials>L.</initials><afid>60026680</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56260590000</author-url><authid>56260590000</authid><authname>Richards A.</authname><surname>Richards</surname><given-name>A. Mark</given-name><initials>A.M.</initials><afid>60026680</afid><afid>60017311</afid><afid>113956463</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56260590000</author-url><authid>56260590000</authid><authname>Richards A.</authname><surname>Richards</surname><given-name>A. Mark</given-name><initials>A.M.</initials><afid>60026680</afid><afid>60017311</afid><afid>113956463</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56260590000</author-url><authid>56260590000</authid><authname>Richards A.</authname><surname>Richards</surname><given-name>A. Mark</given-name><initials>A.M.</initials><afid>60026680</afid><afid>60017311</afid><afid>113956463</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56499922500</author-url><authid>56499922500</authid><authname>Ling L.</authname><surname>Ling</surname><given-name>Lieng H.</given-name><initials>L.H.</initials><afid>60026680</afid><afid>113956463</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56499922500</author-url><authid>56499922500</authid><authname>Ling L.</authname><surname>Ling</surname><given-name>Lieng H.</given-name><initials>L.H.</initials><afid>60026680</afid><afid>113956463</afid></author><authkeywords>Atrial fibrillation | Biomarkers | Case-control study | Mid-regional pro-atrial natriuretic peptide | N-terminal pro-brain natriuretic peptide</authkeywords><intid>1035958434</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929192751"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929192751?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929192751&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929192751&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0091743515001437"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929192751</prism:url><dc:identifier>SCOPUS_ID:84929192751</dc:identifier><eid>2-s2.0-84929192751</eid><dc:title>Trends in prolonged sitting time among European adults: 27 country analysis</dc:title><dc:creator>Milton K.</dc:creator><prism:publicationName>Preventive Medicine</prism:publicationName><prism:issn>00917435</prism:issn><prism:eIssn>10960260</prism:eIssn><prism:volume>77</prism:volume><prism:pageRange>11-16</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ypmed.2015.04.016</prism:doi><pii>S0091743515001437</pii><dc:description>Â© 2015. Objective: To examine trends in adult sitting time across 27 European countries. Method: Data were from the Eurobarometer surveys collected in 2002, 2005, and 2013. Sitting time data were used to categorise respondents into 'low' (0 to 4h30min), 'middle' (4h31min to 7h30min), and 'high' levels of sitting (&gt;7h30min). We modelled the likelihood of being in the high sitting group within a given country and overall across the three time points, controlling for age, gender, education, employment status, and physical activity. Results: In total 17 countries had sitting data at all three time points; among these countries the prevalence of 'high sitting' decreased steadily from 23.1% (95% CI. = 22.2-24.1) in 2002 to 21.8% (95% CI. = 20.8-22.8) in 2005, and 17.8% (95% CI. = 16.9-18.7) in 2013. A further 10 countries had data only over the latter two time points; among these countries the prevalence of high sitting decreased from 27.7% (95% CI. = 26.0-29.4) in 2005 to 19.0% (95% CI. = 17.6-20.5) in 2013. Conclusion: Time spent in sedentary behaviour may not be increasing in the European region, and prolonged sitting may, in fact, be decreasing. This finding has important implications for the sedentary behaviour debate and the policy response.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026851</affiliation-url><afid>60026851</afid><affilname>University of Oxford</affilname><name-variant>Oxford University</name-variant><affiliation-city>Oxford</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025709</affiliation-url><afid>60025709</afid><affilname>University of Sydney</affilname><name-variant>University of Sydney</name-variant><affiliation-city>Sydney</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025709</affiliation-url><afid>60025709</afid><affilname>University of Sydney</affilname><name-variant>University of Sydney</name-variant><affiliation-city>Sydney</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36464001500</author-url><authid>36464001500</authid><authname>Milton K.</authname><surname>Milton</surname><given-name>Karen</given-name><initials>K.</initials><afid>60026851</afid><afid>60025709</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36464001500</author-url><authid>36464001500</authid><authname>Milton K.</authname><surname>Milton</surname><given-name>Karen</given-name><initials>K.</initials><afid>60026851</afid><afid>60025709</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56462191800</author-url><authid>56462191800</authid><authname>Gale J.</authname><surname>Gale</surname><given-name>Joanne</given-name><initials>J.</initials><afid>60025709</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55847987800</author-url><authid>55847987800</authid><authname>Stamatakis E.</authname><surname>Stamatakis</surname><given-name>Emmanuel</given-name><initials>E.</initials><afid>60025709</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:25421265100</author-url><authid>25421265100</authid><authname>Bauman A.</authname><surname>Bauman</surname><given-name>Adrian</given-name><initials>A.</initials><afid>60025709</afid></author><authkeywords>Eurobarometer | Europe | Sedentary behaviour | Sitting time | Trends</authkeywords><intid>535917694</intid><source-id>17665</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928945084"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928945084?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928945084&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928945084&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S092849311530045X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928945084</prism:url><dc:identifier>SCOPUS_ID:84928945084</dc:identifier><eid>2-s2.0-84928945084</eid><dc:title>Thrombogenicity and biocompatibility studies of reduced graphene oxide modified acellular pulmonary valve tissue</dc:title><dc:creator>Wilczek P.</dc:creator><prism:publicationName>Materials Science and Engineering C</prism:publicationName><prism:issn>09284931</prism:issn><prism:volume>53</prism:volume><prism:pageRange>310-321</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.msec.2015.04.044</prism:doi><pii>S092849311530045X</pii><dc:description>Â© 2015 Elsevier B.V. All rights reserved. Current strategies in tissue engineering seek to obtain a functional tissue analogue by either seeding acellular scaffolds with cells ex vivo or repopulating them with cells in vivo, after implantation in patients. To function properly, the scaffold should be non-thrombogenic and biocompatible. Especially for the case of in vivo cell repopulation, the scaffold should be prepared in a manner that protects the tissue against platelet activation and adhesion. Anti-thrombogenicity can be achieved by chemical or physical surface modification. The aim of our study was to evaluate the platelet activation and thrombogenic properties of an acellular tissue scaffold that was surface modified with reduced graphene oxide (rGO). Graphene oxide was prepared by a modified Hummers method. For the study, an acellular pulmonary valve conduit modified with rGO was used. The rGO modified tissue samples were subjected to in vitro testing through interaction with whole blood under simulated laminar flow conditions. The following cellular receptors were then analysed: CD42a, CD42b, CD41a, CD40, CD65P and PAC-1. In parallel, the adhesion of platelets (CD62P positive), leukocytes (CD45 positive) and platelet-leukocyte aggregates (CD62P/CD45 positive) on the modified surface was evaluated. As a reference, non-coated acellular tissue, Poly-l lysine and fibronectin coated tissue were also tested. The rGO surface was also analysed for biocompatibility by performing a cytotoxicity test, TUNEL assay and Cell Cycle analysis. There was no significant difference in platelet activation and adhesion between the study groups. The only significant difference was observed for the PAC-1 receptor between Poly-l lysine group and rGO and the percentage of PAC-1 positive cells was 6% and 18% respectively. The average number of activated platelets (CD62P) in the field of view was 1, while the average number of leukocytes in the field of view was 3. No adherent platelet-leukocyte aggregates were observed. There were no significant differences in the DNA fragmentation. No significant effect of rGO on the amount of cells in different phases of the cell cycle was observed. Cytotoxicity indicates that the rGO can damage cells in direct contact but have no effect on the viability of fibroblasts in indirect contact.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114721005</affiliation-url><afid>114721005</afid><affilname>Heart Prosthesis Institute</affilname><name-variant>Heart Prosthesis Institute</name-variant><affiliation-city/><affiliation-country>Poland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024943</affiliation-url><afid>60024943</afid><affilname>Instytut Metalurgii i Inzynierii Materialowej Polskiej Akademii Nauk</affilname><name-variant>Academy of Mining and Metallurgy</name-variant><affiliation-city>Krakow</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60085353</affiliation-url><afid>60085353</afid><affilname>Instytutu Technologii Materialow Elektronicznych w Warszawie</affilname><name-variant>Institute of Electronic Materials Technology</name-variant><affiliation-city>Warsaw</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027742</affiliation-url><afid>60027742</afid><affilname>Joanneum Research Forschungsgesellschaft mbH</affilname><name-variant>Joanneum Research</name-variant><affiliation-city>Graz</affiliation-city><affiliation-country>Austria</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:28268133000</author-url><authid>28268133000</authid><authname>Wilczek P.</authname><surname>Wilczek</surname><given-name>Piotr</given-name><initials>P.</initials><afid>114721005</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004446625</author-url><authid>7004446625</authid><authname>Major R.</authname><surname>Major</surname><given-name>Roman</given-name><initials>R.</initials><afid>60024943</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6603262516</author-url><authid>6603262516</authid><authname>Lipinska L.</authname><surname>Lipinska</surname><given-name>Ludwika</given-name><initials>L.</initials><afid>60085353</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7102362061</author-url><authid>7102362061</authid><authname>Lackner J.</authname><surname>Lackner</surname><given-name>Juergen</given-name><initials>J.</initials><afid>60027742</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55669913300</author-url><authid>55669913300</authid><authname>Mzyk A.</authname><surname>Mzyk</surname><given-name>Aldona</given-name><initials>A.</initials><afid>60024943</afid></author><authkeywords>Platelet activation | Reduced graphene oxide | Scaffold | Tissue engineering</authkeywords><intid>1035873021</intid><source-id>17813</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929339887"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929339887?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929339887&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929339887&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007603"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929339887</prism:url><dc:identifier>SCOPUS_ID:84929339887</dc:identifier><eid>2-s2.0-84929339887</eid><dc:title>The effect of renal denervation on endothelial function and inflammatory markers in patients with resistant hypertension</dc:title><dc:creator>Eikelis N.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>96-98</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.041</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033409</affiliation-url><afid>60033409</afid><affilname>Baker IDI Heart and Diabetes Institute</affilname><name-variant>Baker Heart Research Institute</name-variant><affiliation-city>Melbourne</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008014</affiliation-url><afid>60008014</afid><affilname>Alfred Hospital</affilname><name-variant>Alfred Hospital</name-variant><affiliation-city>Melbourne</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019578</affiliation-url><afid>60019578</afid><affilname>Monash University</affilname><name-variant>Monash University</name-variant><affiliation-city>Melbourne</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">14</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6506084933</author-url><authid>6506084933</authid><authname>Eikelis N.</authname><surname>Eikelis</surname><given-name>N.</given-name><initials>N.</initials><afid>60033409</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8258233700</author-url><authid>8258233700</authid><authname>Hering D.</authname><surname>Hering</surname><given-name>D.</given-name><initials>D.</initials><afid>60033409</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55387745600</author-url><authid>55387745600</authid><authname>Marusic P.</authname><surname>Marusic</surname><given-name>P.</given-name><initials>P.</initials><afid>60033409</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35559807900</author-url><authid>35559807900</authid><authname>Sari C.</authname><surname>Sari</surname><given-name>C.</given-name><initials>C.</initials><afid>60033409</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7102793324</author-url><authid>7102793324</authid><authname>Walton A.</authname><surname>Walton</surname><given-name>A.</given-name><initials>A.</initials><afid>60008014</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56591413700</author-url><authid>56591413700</authid><authname>Phillips S.</authname><surname>Phillips</surname><given-name>S.</given-name><initials>S.</initials><afid>60033409</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7103399077</author-url><authid>7103399077</authid><authname>Lambert E.</authname><surname>Lambert</surname><given-name>E.</given-name><initials>E.</initials><afid>60033409</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56605904200</author-url><authid>56605904200</authid><authname>Duval J.</authname><surname>Duval</surname><given-name>J.</given-name><initials>J.</initials><afid>60033409</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:26643264600</author-url><authid>26643264600</authid><authname>Krum H.</authname><surname>Krum</surname><given-name>H.</given-name><initials>H.</initials><afid>60019578</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7201789930</author-url><authid>7201789930</authid><authname>Lambert G.</authname><surname>Lambert</surname><given-name>G.</given-name><initials>G.</initials><afid>60033409</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7102382207</author-url><authid>7102382207</authid><authname>Esler M.</authname><surname>Esler</surname><given-name>M.</given-name><initials>M.</initials><afid>60033409</afid><afid>60008014</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7102382207</author-url><authid>7102382207</authid><authname>Esler M.</authname><surname>Esler</surname><given-name>M.</given-name><initials>M.</initials><afid>60033409</afid><afid>60008014</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7003349164</author-url><authid>7003349164</authid><authname>Schlaich M.</authname><surname>Schlaich</surname><given-name>M.</given-name><initials>M.</initials><afid>60033409</afid><afid>60008014</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7003349164</author-url><authid>7003349164</authid><authname>Schlaich M.</authname><surname>Schlaich</surname><given-name>M.</given-name><initials>M.</initials><afid>60033409</afid><afid>60008014</afid></author><authkeywords>Endothelial function | Inflammatory cytokines | Renal denervation | Resistant hypertension</authkeywords><intid>1035941648</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929346664"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929346664?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929346664&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929346664&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007597"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929346664</prism:url><dc:identifier>SCOPUS_ID:84929346664</dc:identifier><eid>2-s2.0-84929346664</eid><dc:title>Massive coronary air embolism successfully treated with intracoronary catheter aspiration and intracoronary adenosine</dc:title><dc:creator>Yew K.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>56-57</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.040</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009426</affiliation-url><afid>60009426</afid><affilname>Sarawak General Hospital</affilname><name-variant>Sarawak General Hospital</name-variant><affiliation-city>Kuching</affiliation-city><affiliation-country>Malaysia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009426</affiliation-url><afid>60009426</afid><affilname>Sarawak General Hospital</affilname><name-variant>Sarawak General Hospital</name-variant><affiliation-city>Kuching</affiliation-city><affiliation-country>Malaysia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:42762568900</author-url><authid>42762568900</authid><authname>Yew K.</authname><surname>Yew</surname><given-name>Kuan Leong</given-name><initials>K.L.</initials><afid>60009426</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55785924400</author-url><authid>55785924400</authid><authname>Razali F.</authname><surname>Razali</surname><given-name>Farah</given-name><initials>F.</initials><afid>60009426</afid></author><authkeywords>Complete atrioventricular block | Contralateral coronary air embolism | Coronary air embolism | Intracoronary adenosine | Intracoronary catheter aspiration | Microvascular dysfunction</authkeywords><intid>35945078</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84921442396"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84921442396?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84921442396&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84921442396&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915014011848"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84921442396</prism:url><dc:identifier>SCOPUS_ID:84921442396</dc:identifier><eid>2-s2.0-84921442396</eid><dc:title>Vulnerable plaques in the contralateral carotid arteries in symptomatic patients: A detailed ultrasound analysis</dc:title><dc:creator>Ibrahimi P.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>235</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>526-531</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2014.05.934</prism:doi><pii>S0021915014011848</pii><dc:description>Â© 2014 Elsevier Ireland Ltd. Background and aim: Carotid plaques may represent a generalized atherosclerotic syndrome or a localized disease. The aim of this study was to assess the morphological and textural features of carotid plaques located contralateral to the symptomatic side and compare them with the symptomatic side and with plaques from asymptomatic patients. Methods: We studied 66 arteries in 39 patients (mean age 70Â±7 year, 33% females). Arterial plaques were classified as either symptomatic (. n=30), contralateral to symptomatic (. n=25) or asymptomatic (. n=11). We compared several plaque features between these groups including the mean values of the grey scale median (GSM), entropy, juxtaluminal black area (JBA) without visible echogenic cap, GSM of the JBA and surface irregularity. Results: The plaques contralateral to symptomatic arteries had similar morphological and textural features to those in the symptomatic arteries. In contrast, they had more vulnerable morphological and textural features than those in asymptomatic arteries: less smooth plaques (12% vs. 55%) and instead more often mildly irregular (60% vs 36%) or markedly irregular (28% vs. 9%; p=0.03), lower GSM (26.2Â±8 vs. 49.4Â±14, p&lt;0.001) and lower GSM of the JBA (5.0Â±3.6 vs. 11.4Â±2.1, p=0.008). The frequency of entropy and plaque calcification was similar in all groups. Conclusion: Symptomatic patients with carotid artery disease seem to have similar morphological and textural features of vulnerability in the symptomatic and the contralateral carotid arteries, which are profound compared with asymptomatic carotid arteries. These findings support the concept of generalized carotid atherosclerotic pathology rather than incidental unilateral disease, and also emphasize a need for aggressive measures for plaque stabilization, particularly in symptomatic patients.</dc:description><citedby-count>2</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031040</affiliation-url><afid>60031040</afid><affilname>Umea universitet</affilname><name-variant>UmeÃ¥ University</name-variant><affiliation-city>Umea</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031040</affiliation-url><afid>60031040</afid><affilname>Umea universitet</affilname><name-variant>UmeÃ¥ University</name-variant><affiliation-city>Umea</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031040</affiliation-url><afid>60031040</afid><affilname>Umea universitet</affilname><name-variant>UmeÃ¥ University</name-variant><affiliation-city>Umea</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><pubmed-id>24953493</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55486226500</author-url><authid>55486226500</authid><authname>Ibrahimi P.</authname><surname>Ibrahimi</surname><given-name>Pranvera</given-name><initials>P.</initials><afid>60031040</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55485647800</author-url><authid>55485647800</authid><authname>Jashari F.</authname><surname>Jashari</surname><given-name>Fisnik</given-name><initials>F.</initials><afid>60031040</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55816083400</author-url><authid>55816083400</authid><authname>Johansson E.</authname><surname>Johansson</surname><given-name>Elias</given-name><initials>E.</initials><afid>60031040</afid><afid>60031040</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55816083400</author-url><authid>55816083400</authid><authname>Johansson E.</authname><surname>Johansson</surname><given-name>Elias</given-name><initials>E.</initials><afid>60031040</afid><afid>60031040</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:24767723600</author-url><authid>24767723600</authid><authname>Gronlund C.</authname><surname>Gronlund</surname><given-name>Christer</given-name><initials>C.</initials><afid>60031040</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:12764374400</author-url><authid>12764374400</authid><authname>Bajraktari G.</authname><surname>Bajraktari</surname><given-name>Gani</given-name><initials>G.</initials><afid>60031040</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:24558407300</author-url><authid>24558407300</authid><authname>Wester P.</authname><surname>Wester</surname><given-name>Per</given-name><initials>P.</initials><afid>60031040</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7006300845</author-url><authid>7006300845</authid><authname>Henein M.</authname><surname>Henein</surname><given-name>Michael Y.</given-name><initials>M.Y.</initials><afid>60031040</afid></author><authkeywords>Carotid artery disease | Gray scale median | Juxtaluminal black area | Plaque vulnerability</authkeywords><intid>1534651651</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929328341"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929328341?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929328341&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929328341&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315005999"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929328341</prism:url><dc:identifier>SCOPUS_ID:84929328341</dc:identifier><eid>2-s2.0-84929328341</eid><dc:title>Impact of gender on outcomes after atrial fibrillation ablation</dc:title><dc:creator>Vallakati A.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>12-16</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.341</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000305</affiliation-url><afid>60000305</afid><affilname>Case Western Reserve University</affilname><name-variant>Case Western Reserve University</name-variant><affiliation-city>Cleveland</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023246</affiliation-url><afid>60023246</afid><affilname>University of Kansas Hospital</affilname><name-variant>University of Kansas Hospital ^</name-variant><affiliation-city>Kansas City</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002337</affiliation-url><afid>60002337</afid><affilname>State University of New York System</affilname><name-variant>State University of New York</name-variant><affiliation-city>Albany</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024099</affiliation-url><afid>60024099</afid><affilname>Montefiore Medical Center</affilname><name-variant>Montefiore Medical Center</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100818391</affiliation-url><afid>100818391</afid><affilname>Texas Cardiac Arrhythmia Institute</affilname><name-variant>Texas Cardiac Arrhythmia Institute</name-variant><affiliation-city>Austin</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013372</affiliation-url><afid>60013372</afid><affilname>University of Texas at Austin</affilname><name-variant>University of Texas</name-variant><affiliation-city>Austin</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023009</affiliation-url><afid>60023009</afid><affilname>University of Pennsylvania, Health System</affilname><name-variant>Hospital of the University of Pennsylvania</name-variant><affiliation-city>Philadelphia</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">15</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:42462679700</author-url><authid>42462679700</authid><authname>Vallakati A.</authname><surname>Vallakati</surname><given-name>Ajay</given-name><initials>A.</initials><afid>60000305</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55434054900</author-url><authid>55434054900</authid><authname>Reddy M.</authname><surname>Reddy</surname><given-name>Madhu</given-name><initials>M.</initials><afid>60023246</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:16064237500</author-url><authid>16064237500</authid><authname>Sharma A.</authname><surname>Sharma</surname><given-name>Abhishek</given-name><initials>A.</initials><afid>60002337</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55853490000</author-url><authid>55853490000</authid><authname>Kanmanthareddy A.</authname><surname>Kanmanthareddy</surname><given-name>Arun</given-name><initials>A.</initials><afid>60023246</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56228560300</author-url><authid>56228560300</authid><authname>Sridhar A.</authname><surname>Sridhar</surname><given-name>Arun</given-name><initials>A.</initials><afid>60023246</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:26768184200</author-url><authid>26768184200</authid><authname>Pillarisetti J.</authname><surname>Pillarisetti</surname><given-name>Jayasree</given-name><initials>J.</initials><afid>60023246</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:44360929600</author-url><authid>44360929600</authid><authname>Atkins D.</authname><surname>Atkins</surname><given-name>Donita</given-name><initials>D.</initials><afid>60023246</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56644562700</author-url><authid>56644562700</authid><authname>Konda B.</authname><surname>Konda</surname><given-name>Bhavana</given-name><initials>B.</initials><afid>60024099</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56340332500</author-url><authid>56340332500</authid><authname>Bommana S.</authname><surname>Bommana</surname><given-name>Sudha</given-name><initials>S.</initials><afid>60023246</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:24328804400</author-url><authid>24328804400</authid><authname>Di Biase L.</authname><surname>Di Biase</surname><given-name>Luigi</given-name><initials>L.</initials><afid>100818391</afid><afid>60013372</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:24328804400</author-url><authid>24328804400</authid><authname>Di Biase L.</authname><surname>Di Biase</surname><given-name>Luigi</given-name><initials>L.</initials><afid>100818391</afid><afid>60013372</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:22941920600</author-url><authid>22941920600</authid><authname>Santangeli P.</authname><surname>Santangeli</surname><given-name>Pasquale</given-name><initials>P.</initials><afid>60023009</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:55551143800</author-url><authid>55551143800</authid><authname>Natale A.</authname><surname>Natale</surname><given-name>Andrea</given-name><initials>A.</initials><afid>100818391</afid><afid>60013372</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:55551143800</author-url><authid>55551143800</authid><authname>Natale A.</authname><surname>Natale</surname><given-name>Andrea</given-name><initials>A.</initials><afid>100818391</afid><afid>60013372</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:6507592793</author-url><authid>6507592793</authid><authname>Lakkireddy D.</authname><surname>Lakkireddy</surname><given-name>Dhanunjaya</given-name><initials>D.</initials><afid>60023246</afid></author><authkeywords>Atrial fibrillation | Atrial fibrillation ablation | Gender | Women</authkeywords><intid>1535943368</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84910059901"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84910059901?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84910059901&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84910059901&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S002191501401226X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84910059901</prism:url><dc:identifier>SCOPUS_ID:84910059901</dc:identifier><eid>2-s2.0-84910059901</eid><dc:title>Insulin resistance and systemic inflammation, but not metabolic syndrome phenotype, predict 9 years mortality in older adults</dc:title><dc:creator>Zuliani G.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>235</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>538-545</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2014.05.959</prism:doi><pii>S002191501401226X</pii><dc:description>Â© 2014 Elsevier Ireland Ltd. Background: Although metabolic syndrome (MS) is a typical condition of middle-aged/older person, the association between MS and mortality risk has not been confirmed in people over 65 years. We hypothesized that while in the elderly MS phenotype might lose its value in predicting mortality risk, the two core factors of MS, i.e. insulin resistance (IR) and low grade systemic inflammation (LGSI) would not. Methods: 1011 community-dwelling older individuals (InCHIANTI study) were included. MS phenotype was defined by NCEP-ATP-III criteria. IR was calculated by HOMA; high-sensitivity C reactive protein was measured by ELISA. Subjects were divided into four groups based on presence/absence of IR (HOMA â¥ 2.27) and LGSI (hs-CRPâ¥3g/L): Group 1: no IR/LGSI (reference); Group 2: LGSI only; Group 3: IR only; Group 4: IR+LGSI. Hazard Ratios (HR) for 9-years cardiovascular (CVD) and total mortality, according to IR/LGSI groups, were estimated in subjects with (n.311) and without MS by Cox model. Results: 31.8% of subjects with MS phenotype had no IR, 45.3% had no LGSI; moreover, 51% of subjects with both IR and LGSI didn't display the MS phenotype. MS phenotype was not associated with CVD (HR: 1.29; 95%C.I.:0.92-1.81) or total (HR: 1.07; 95%C.I.:0.86-1.34) mortality risk, whereas the presence of IR plus LGSI was associated with increased CVD (no MS: HR 2.07, 95%CI: 1.12-3.72; MS: HR 9.88, 95%CI: 2.18-4), and overall (no MS: HR 1.72, 95%CI: 1.001-3.17; MS: HR 1.51, 95%CI: 1.02-2.28) mortality risk. The presence of IR (HR: 6.90, 95%CI: 1.45-32) or LGSI (HR 7.56, 95%CI: 1.63-35) was associated with CVD mortality, only among individuals with MS phenotype. Conclusions: Among community-dwelling older individuals, IR and LGSI, but not MS phenotype, was associated with 9-years overall and CVD mortality risk. Since a reduced "overlap" between MS phenotype and its physiopathological core (IR and LGSI) might be present with aging, we suggest that the definition of MS might be more holistic in advanced age, and probably comprise the measurement of IR and LGSI.</dc:description><citedby-count>1</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024690</affiliation-url><afid>60024690</afid><affilname>University of Ferrara</affilname><name-variant>UniversitÃ  di Ferrara</name-variant><affiliation-city>Ferrara</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004969</affiliation-url><afid>60004969</afid><affilname>Universita degli Studi di Parma</affilname><name-variant>UniversitÃ  di Parma</name-variant><affiliation-city>Parma</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114913685</affiliation-url><afid>114913685</afid><affilname>INNRCA</affilname><name-variant>INNRCA</name-variant><affiliation-city>Ancona</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:106731666</affiliation-url><afid>106731666</afid><affilname>ASF Geriatric Rehabilitation</affilname><name-variant>A.S.F. Geriatric Rehabilitation</name-variant><affiliation-city>Florence</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100416606</affiliation-url><afid>100416606</afid><affilname>IOT</affilname><name-variant>I.O.T.</name-variant><affiliation-city>Florence</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026777</affiliation-url><afid>60026777</afid><affilname>Seconda Universita degli Studi di Napoli</affilname><name-variant>Second University of Naples</name-variant><affiliation-city>Naples</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012957</affiliation-url><afid>60012957</afid><affilname>University of Maryland School of Medicine</affilname><name-variant>Univ. of Maryland School of Medicine</name-variant><affiliation-city>Baltimore</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017252</affiliation-url><afid>60017252</afid><affilname>National Institute on Aging</affilname><name-variant>National Institute on Aging</name-variant><affiliation-city>Bethesda</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><pubmed-id>24956526</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004397138</author-url><authid>7004397138</authid><authname>Zuliani G.</authname><surname>Zuliani</surname><given-name>Giovanni</given-name><initials>G.</initials><afid>60024690</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35191965200</author-url><authid>35191965200</authid><authname>Morieri M.</authname><surname>Morieri</surname><given-name>Mario Luca</given-name><initials>M.L.</initials><afid>60024690</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005525664</author-url><authid>7005525664</authid><authname>Volpato S.</authname><surname>Volpato</surname><given-name>Stefano</given-name><initials>S.</initials><afid>60024690</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56400674900</author-url><authid>56400674900</authid><authname>Maggio M.</authname><surname>Maggio</surname><given-name>Marcello</given-name><initials>M.</initials><afid>60004969</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7005767834</author-url><authid>7005767834</authid><authname>Cherubini A.</authname><surname>Cherubini</surname><given-name>Antonio</given-name><initials>A.</initials><afid>114913685</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56490693000</author-url><authid>56490693000</authid><authname>Francesconi D.</authname><surname>Francesconi</surname><given-name>Daniela</given-name><initials>D.</initials><afid>60024690</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7003381018</author-url><authid>7003381018</authid><authname>Bandinelli S.</authname><surname>Bandinelli</surname><given-name>Stefania</given-name><initials>S.</initials><afid>106731666</afid><afid>100416606</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7003381018</author-url><authid>7003381018</authid><authname>Bandinelli S.</authname><surname>Bandinelli</surname><given-name>Stefania</given-name><initials>S.</initials><afid>106731666</afid><afid>100416606</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7102222857</author-url><authid>7102222857</authid><authname>Paolisso G.</authname><surname>Paolisso</surname><given-name>Giuseppe</given-name><initials>G.</initials><afid>60026777</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:36048591800</author-url><authid>36048591800</authid><authname>Guralnik J.</authname><surname>Guralnik</surname><given-name>Jack M.</given-name><initials>J.M.</initials><afid>60012957</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:55239601400</author-url><authid>55239601400</authid><authname>Ferrucci L.</authname><surname>Ferrucci</surname><given-name>Luigi</given-name><initials>L.</initials><afid>60017252</afid></author><authkeywords>C reactive protein | Elderly | Insulin resistance | Metabolic syndrome | Mortality</authkeywords><intid>2032744843</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929330830"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929330830?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929330830&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929330830&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008311"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929330830</prism:url><dc:identifier>SCOPUS_ID:84929330830</dc:identifier><eid>2-s2.0-84929330830</eid><dc:title>Atrial fibrillation is associated with increased risk of erectile dysfunction: A nationwide population-based cohort study</dc:title><dc:creator>Lin W.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>106-110</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.108</prism:doi><dc:description>Â© 2015 Published by Elsevier Ireland Ltd. Background: Our study aimed to investigate the association between atrial fibrillation (AF) and erectile dysfunction (ED). Methods: A total of 3853 male patients with AF were identified as the AF cohort, and 15,405 male patients without AF were selected randomly as the control group and matched by age and index years of AF diagnosis. The endpoint of interest in this study was the occurrence of ED. Individuals with prior history of ED, female patients, those with missing information, and those aged 20 years and younger were excluded. Results: The mean follow-up duration was 4.67 Â± 3.20 years for the AF patients and 5.04 Â± 3.30 years for the non-AF patients. During the follow-up period, the incidence of ED in the AF cohort was 1.65-fold higher than the non-AF cohort (20.6 vs 12.5 per 10,000 person-years, P &lt; .001). Stratified by age, the incidence of ED was consistently higher in the AF cohort. After adjustment for patient characteristics, multivariate Cox regression analysis demonstrated that AF and hyperlipidemia remained independent risk factors for ED (hazard ratio [HR] = 1.53, 95% confidence interval [CI] = 1.05-2.24 and HR = 1.96, 95% CI = 1.36-2.81, respectively). Relative to the non-AF cohort without hyperlipidemia, the AF patients with hyperlipidemia were at a higher risk of ED (HR = 2.76, 95% CI = 1.52-5.00). Conclusion: In a large-scale cohort, the incidence of ED was significantly higher in male patients with AF than those without AF.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011828</affiliation-url><afid>60011828</afid><affilname>Triservice General Hospital Taiwan</affilname><name-variant>Tri-Service General Hospital</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031941</affiliation-url><afid>60031941</afid><affilname>China Medical University Hospital Taichung</affilname><name-variant>China Medical University Hospital</name-variant><affiliation-city>Taichung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006988</affiliation-url><afid>60006988</afid><affilname>China Medical University Taichung</affilname><name-variant>China Medical University</name-variant><affiliation-city>Taichung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006988</affiliation-url><afid>60006988</afid><affilname>China Medical University Taichung</affilname><name-variant>China Medical University</name-variant><affiliation-city>Taichung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031941</affiliation-url><afid>60031941</afid><affilname>China Medical University Hospital Taichung</affilname><name-variant>China Medical University Hospital</name-variant><affiliation-city>Taichung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56605657500</author-url><authid>56605657500</authid><authname>Lin W.</authname><surname>Lin</surname><given-name>Wen Yu</given-name><initials>W.Y.</initials><afid>60011828</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56561984900</author-url><authid>56561984900</authid><authname>Lin C.</authname><surname>Lin</surname><given-name>Chin Sheng</given-name><initials>C.S.</initials><afid>60011828</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56180975900</author-url><authid>56180975900</authid><authname>Lin C.</authname><surname>Lin</surname><given-name>Cheng Li</given-name><initials>C.L.</initials><afid>60031941</afid><afid>60006988</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56180975900</author-url><authid>56180975900</authid><authname>Lin C.</authname><surname>Lin</surname><given-name>Cheng Li</given-name><initials>C.L.</initials><afid>60031941</afid><afid>60006988</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56480937700</author-url><authid>56480937700</authid><authname>Cheng S.</authname><surname>Cheng</surname><given-name>Shu Meng</given-name><initials>S.M.</initials><afid>60011828</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56640192100</author-url><authid>56640192100</authid><authname>Lin W.</authname><surname>Lin</surname><given-name>Wei Shiang</given-name><initials>W.S.</initials><afid>60011828</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55498675300</author-url><authid>55498675300</authid><authname>Kao C.</authname><surname>Kao</surname><given-name>Chia Hung</given-name><initials>C.H.</initials><afid>60006988</afid><afid>60031941</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55498675300</author-url><authid>55498675300</authid><authname>Kao C.</authname><surname>Kao</surname><given-name>Chia Hung</given-name><initials>C.H.</initials><afid>60006988</afid><afid>60031941</afid></author><authkeywords>Anticoagulation | Atrial fibrillation | Database | Erectile dysfunction | Ischemic stroke | Taiwan national health insurance research</authkeywords><intid>35943592</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84921451621"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84921451621?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84921451621&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84921451621&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915014002299"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84921451621</prism:url><dc:identifier>SCOPUS_ID:84921451621</dc:identifier><eid>2-s2.0-84921451621</eid><dc:title>Relationship between plasma apelin level and coronary collateral circulation</dc:title><dc:creator>Akboga M.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>235</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>289-294</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2014.04.029</prism:doi><pii>S0021915014002299</pii><dc:description>Â© 2014 Elsevier Ireland Ltd. Objective: Coronary collaterals play a crucial role during an acute ischemic attack. Angiogenesis has an important role in the formation of coronary collateral vessels. Previously, it was shown that apelin is a potential angiogenetic factor. Thus, we aimed to investigate relationship between plasma apelin levels and coronary collateral circulation in patients with stable coronary artery disease. Methods: Among patients who underwent coronary angiography with stable angina pectoris, patients with a stenosis of â¥90% were included in our study. Collateral degree was graded according to Rentrop-Cohen classification. Patients with grade 2 or 3 collateral degree were included in good collateral group and patients with grade 0 or 1 collateral degree were included in poor collateral group. Results: Plasma apelin level was significantly higher in good collateral group (0.69Â±0.2 vs 0.59Â±0.2ng/dl, p&lt;0.001). Serum nitric oxide levels were similar between two groups. In multivariate regression analysis apelin [6.95 (1.46-33.15), p=0.015] and presence of total occlusion [4.40 (1.04-18.62), p=0.044] remained as independent predictors for good coronary collateral development. Conclusions: Higher plasma apelin level was related to better coronary collateral development. Demonstration of favorable affects of apelin on good collateral development may lead to consider apelin in antiischemic treatment strategies in order to increase collateral development.</dc:description><citedby-count>2</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60079005</affiliation-url><afid>60079005</afid><affilname>T.C. Saglik Bakanligi,</affilname><name-variant>Ministry of Health</name-variant><affiliation-city>Ankara</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60086651</affiliation-url><afid>60086651</afid><affilname>T. C. Saglik Bakanligi Ankara Diskapi Yildirim Beyazit Egitim ve Arastirma Hastanesi</affilname><name-variant>Diskapi Yildirim Beyazit Education and Research Hospital</name-variant><affiliation-city>Ankara</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021416</affiliation-url><afid>60021416</afid><affilname>Gazi University, Faculty of Medicine</affilname><name-variant>Gazi University Faculty of Medicine</name-variant><affiliation-city>Ankara</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021416</affiliation-url><afid>60021416</afid><affilname>Gazi University, Faculty of Medicine</affilname><name-variant>Gazi University Faculty of Medicine</name-variant><affiliation-city>Ankara</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><pubmed-id>24905139</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:41261015400</author-url><authid>41261015400</authid><authname>Akboga M.</authname><surname>Akboga</surname><given-name>Mehmet Kadri</given-name><initials>M.K.</initials><afid>60079005</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:25639683300</author-url><authid>25639683300</authid><authname>Akyel A.</authname><surname>Akyel</surname><given-name>Ahmet</given-name><initials>A.</initials><afid>60086651</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:8575176400</author-url><authid>8575176400</authid><authname>Sahinarslan A.</authname><surname>Sahinarslan</surname><given-name>Asife</given-name><initials>A.</initials><afid>60021416</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:24398204400</author-url><authid>24398204400</authid><authname>Demirtas C.</authname><surname>Demirtas</surname><given-name>Canan Yilmaz</given-name><initials>C.Y.</initials><afid>60021416</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36100767900</author-url><authid>36100767900</authid><authname>Yayla C.</authname><surname>Yayla</surname><given-name>Cagri</given-name><initials>C.</initials><afid>60021416</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6602486140</author-url><authid>6602486140</authid><authname>Boyaci B.</authname><surname>Boyaci</surname><given-name>Bulent</given-name><initials>B.</initials><afid>60021416</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6701440418</author-url><authid>6701440418</authid><authname>Yalcin R.</authname><surname>Yalcin</surname><given-name>Ridvan</given-name><initials>R.</initials><afid>60021416</afid></author><authkeywords>Angiogenesis | Apelin | Collateral circulation | Coronary artery disease</authkeywords><intid>1784656739</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84921447893"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84921447893?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84921447893&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84921447893&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915014011915"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84921447893</prism:url><dc:identifier>SCOPUS_ID:84921447893</dc:identifier><eid>2-s2.0-84921447893</eid><dc:title>Type 2 diabetes is not associated with an altered plaque phenotype among patients undergoing carotid revascularization. A histological analysis of 1455 carotid plaques</dc:title><dc:creator>Scholtes V.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>235</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>418-423</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2014.05.941</prism:doi><pii>S0021915014011915</pii><dc:description>Â© 2014 Elsevier Ireland Ltd. Aims: Diabetes accelerates progression of atherosclerotic disease, but data on associations between diabetes and advanced atherosclerotic plaque composition are scarce. Methods and results: We used one of the largest biobanks, the Athero-Express study (n= 1455) at carotid endarterectomy (CEA). All plaques were subjected to histological analysis to assess lipid core size, collagen, macrophages, smooth muscle cells, micro-vessel density and calcifications. In addition, within a subset of patients cytokines and chemokines were assessed.The 295 patients (20%) with type-2 diabetes showed a higher proportion of previous cardiovascular interventions and more stringent treatment for hypertension and hypercholesterolaemia compared with patients without type-2 diabetes. Surprisingly, no associations between diabetes and histological plaque characteristics were observed. In addition, no differences were observed in the expression of inflammatory chemokines, cytokines or advanced glycation end products in plaques of diabetic and non-diabetic patients. Conclusion: In patients suffering from significant carotid artery disease, diabetes does not appear to be associated with specific atherosclerotic plaque characteristics.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032724</affiliation-url><afid>60032724</afid><affilname>University Medical Center Utrecht</affilname><name-variant>University Medical Center Utrecht</name-variant><affiliation-city>Utrecht</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003410</affiliation-url><afid>60003410</afid><affilname>Radcliffe Infirmary</affilname><name-variant>Radcliffe Infirmary</name-variant><affiliation-city>Oxford</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025865</affiliation-url><afid>60025865</afid><affilname>St. Antonius Ziekenhuis</affilname><name-variant>St. Antonius Ziekenhuis</name-variant><affiliation-city>Nieuwegein</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032724</affiliation-url><afid>60032724</afid><affilname>University Medical Center Utrecht</affilname><name-variant>University Medical Center Utrecht</name-variant><affiliation-city>Utrecht</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032724</affiliation-url><afid>60032724</afid><affilname>University Medical Center Utrecht</affilname><name-variant>University Medical Center Utrecht</name-variant><affiliation-city>Utrecht</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114096638</affiliation-url><afid>114096638</afid><affilname>Laboratory of Metabolism and Vascular Medicine</affilname><name-variant>Laboratory of Metabolism and Vascular Medicine</name-variant><affiliation-city>Maastricht</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007895</affiliation-url><afid>60007895</afid><affilname>University Hospital Maastricht</affilname><name-variant>University Hospital Maastricht</name-variant><affiliation-city>Maastricht</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032724</affiliation-url><afid>60032724</afid><affilname>University Medical Center Utrecht</affilname><name-variant>University Medical Center Utrecht</name-variant><affiliation-city>Utrecht</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">16</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:25227987600</author-url><authid>25227987600</authid><authname>Scholtes V.</authname><surname>Scholtes</surname><given-name>Vincent P W</given-name><initials>V.P.W.</initials><afid>60032724</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:16481271100</author-url><authid>16481271100</authid><authname>Peeters W.</authname><surname>Peeters</surname><given-name>Wouter</given-name><initials>W.</initials><afid>60032724</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36145526400</author-url><authid>36145526400</authid><authname>van Lammeren G.</authname><surname>van Lammeren</surname><given-name>Guus W.</given-name><initials>G.W.</initials><afid>60032724</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:10440211400</author-url><authid>10440211400</authid><authname>Howard D.</authname><surname>Howard</surname><given-name>Dominic P J</given-name><initials>D.P.J.</initials><afid>60003410</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55628963500</author-url><authid>55628963500</authid><authname>de Vries J.</authname><surname>de Vries</surname><given-name>Jean Paul P M</given-name><initials>J.P.P.M.</initials><afid>60025865</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:24464360800</author-url><authid>24464360800</authid><authname>de Borst G.</authname><surname>de Borst</surname><given-name>Gert Jan</given-name><initials>G.J.</initials><afid>60032724</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:9275578600</author-url><authid>9275578600</authid><authname>Redgrave J.</authname><surname>Redgrave</surname><given-name>Jessica N.</given-name><initials>J.N.</initials><afid>60003410</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55698542200</author-url><authid>55698542200</authid><authname>Kemperman H.</authname><surname>Kemperman</surname><given-name>Hans</given-name><initials>H.</initials><afid>60032724</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7006504041</author-url><authid>7006504041</authid><authname>Schalkwijk C.</authname><surname>Schalkwijk</surname><given-name>Casper G.</given-name><initials>C.G.</initials><afid>114096638</afid><afid>60007895</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7006504041</author-url><authid>7006504041</authid><authname>Schalkwijk C.</authname><surname>Schalkwijk</surname><given-name>Casper G.</given-name><initials>C.G.</initials><afid>114096638</afid><afid>60007895</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:14071039800</author-url><authid>14071039800</authid><authname>den Ruijter H.</authname><surname>den Ruijter</surname><given-name>Hester M.</given-name><initials>H.M.</initials><afid>60032724</afid><afid>60032724</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:14071039800</author-url><authid>14071039800</authid><authname>den Ruijter H.</authname><surname>den Ruijter</surname><given-name>Hester M.</given-name><initials>H.M.</initials><afid>60032724</afid><afid>60032724</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7003654548</author-url><authid>7003654548</authid><authname>de Kleijn D.</authname><surname>de Kleijn</surname><given-name>Dominique P V</given-name><initials>D.P.V.</initials><afid>60032724</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56427625800</author-url><authid>56427625800</authid><authname>Moll F.</authname><surname>Moll</surname><given-name>Frans L.</given-name><initials>F.L.</initials><afid>60032724</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:56467785700</author-url><authid>56467785700</authid><authname>Rothwell P.</authname><surname>Rothwell</surname><given-name>Peter M.</given-name><initials>P.M.</initials><afid>60003410</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:7004573949</author-url><authid>7004573949</authid><authname>Pasterkamp G.</authname><surname>Pasterkamp</surname><given-name>Gerard</given-name><initials>G.</initials><afid>60032724</afid></author><authkeywords>Carotid endarterectomy | Carotid plaque | Diabetes | Histology</authkeywords><intid>1034649720</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929327057"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929327057?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929327057&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929327057&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315005562"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929327057</prism:url><dc:identifier>SCOPUS_ID:84929327057</dc:identifier><eid>2-s2.0-84929327057</eid><dc:title>Potential contribution of virtual histology plaque composition to hemodynamic-morphologic dissociation in patients with non-ST elevation acute coronary syndrome</dc:title><dc:creator>HÃ¼seyinova G.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>33-38</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.316</prism:doi><dc:description>Â© 2015 Published by Elsevier Ireland Ltd. Objective: Histologic plaque characteristics may influence the hemodynamic effect generated by physiologically significant unstable coronary lesions where plaque content and surface related factors are expected to contribute to the maximum translesional pressure drop. In this study, we aimed to identify local lesion specific virtual histological characteristics that may potentially affect hemodynamic outcome measures. Methods: Forty-eight consecutive patients with non-ST-elevation acute coronary syndrome (NSTEACS) having paired hemodynamic and morphological data were enrolled. A dual sensor guide-wire was used for the assessment of fractional flow reserve (FFR) and stenosis resistance (HSR) in the culprit vessel. Virtual histology intravascular ultrasound imaging was performed after obtaining hemodynamic data. Results: In a hemodynamically significant lesion subset (FFR &lt; 0.75 [n = 34]), after controlling for lesion length, MLA and coronary artery compliance, FFR correlated with necrotic core (NC) area (r = -0.423, p = 0.028) at MLA and NC volume (r = -0.497, p = 0.008) and dense calcium (DC) volume (r = -0.332, p = 0.03) across the entire lesion segment. Likewise, NC (r = -0.544, p = 0.005) and DC (r = 0.376, p = 0.03) areas at MLA and NC (r = 0.545, p = 0.005) and DC (r = 0.576, p = 0.003) volumes across the entire lesion segment were associated with HSR in the hemodynamically significant lesion group (HSR &gt; 0.80 [n = 33]). However, no correlation has been observed between intracoronary hemodynamic end-points and plaque components in hemodynamically insignificant lesions. Conclusions: This study demonstrated that for a given coronary stenosis geometry and arterial compliance, plaque composition may influence hemodynamic outcome measures in functionally significant stenoses in patients with NSTEACS.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012324</affiliation-url><afid>60012324</afid><affilname>Istanbul Tip Fakultesi</affilname><name-variant>Istanbul University</name-variant><affiliation-city>Istanbul</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006369</affiliation-url><afid>60006369</afid><affilname>Koc Universitesi</affilname><name-variant>Koc University</name-variant><affiliation-city>Istanbul</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644614200</author-url><authid>56644614200</authid><authname>HÃ¼seyinova G.</authname><surname>HÃ¼seyinova</surname><given-name>GÃ¼neÅ</given-name><initials>G.</initials><afid>60012324</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:25722980300</author-url><authid>25722980300</authid><authname>Aslanger E.</authname><surname>Aslanger</surname><given-name>Emre</given-name><initials>E.</initials><afid>60006369</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56607856100</author-url><authid>56607856100</authid><authname>Ãakir O.</authname><surname>Ãakir</surname><given-name>Ozan</given-name><initials>O.</initials><afid>60012324</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56644445100</author-url><authid>56644445100</authid><authname>Atici A.</authname><surname>Atici</surname><given-name>Adem</given-name><initials>A.</initials><afid>60012324</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56644815700</author-url><authid>56644815700</authid><authname>PanÃ§ C.</authname><surname>PanÃ§</surname><given-name>Cafer</given-name><initials>C.</initials><afid>60012324</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56644513000</author-url><authid>56644513000</authid><authname>Demirkiran A.</authname><surname>Demirkiran</surname><given-name>Ahmet</given-name><initials>A.</initials><afid>60012324</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56644947800</author-url><authid>56644947800</authid><authname>SÃ¼rmen S.</authname><surname>SÃ¼rmen</surname><given-name>Semih</given-name><initials>S.</initials><afid>60012324</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56644475500</author-url><authid>56644475500</authid><authname>Sarikaya R.</authname><surname>Sarikaya</surname><given-name>Remzi</given-name><initials>R.</initials><afid>60012324</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56644869200</author-url><authid>56644869200</authid><authname>ErdoÊan O.</authname><surname>ErdoÊan</surname><given-name>Onur</given-name><initials>O.</initials><afid>60012324</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:17134926000</author-url><authid>17134926000</authid><authname>GÃ¶lcÃ¼k E.</authname><surname>GÃ¶lcÃ¼k</surname><given-name>Ebru</given-name><initials>E.</initials><afid>60006369</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:6701408393</author-url><authid>6701408393</authid><authname>Umman S.</authname><surname>Umman</surname><given-name>Sabahattin</given-name><initials>S.</initials><afid>60012324</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:36178644100</author-url><authid>36178644100</authid><authname>Sezer M.</authname><surname>Sezer</surname><given-name>Murat</given-name><initials>M.</initials><afid>60006369</afid></author><authkeywords>Coronary flow | Intravascular ultrasound (IVUS) | Plaque rupture | Virtual histology</authkeywords><intid>2035938481</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929316485"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929316485?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929316485&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929316485&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007433"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929316485</prism:url><dc:identifier>SCOPUS_ID:84929316485</dc:identifier><eid>2-s2.0-84929316485</eid><dc:title>A predictive score of radial artery spasm in patients undergoing transradial percutaneous coronary intervention</dc:title><dc:creator>Giannopoulos G.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>76-80</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.024</prism:doi><dc:description>Â© 2015 Elsevier Ireland Ltd. All rights reserved. Objective: Radial artery spasm may hinder completion of transradial angiography or PCI, leading to access site crossover, prolonged procedure times and complications. The aim of this study was to derive a radial artery spasm risk score in patients undergoing elective percutaneous coronary intervention (PCI), prospectively validate it, and apply it in a real-life clinical setting. Methods: The study population consisted of 3 cohorts of patients undergoing elective PCI with transradial access: the derivation cohort (N = 1006), the validation cohort (N = 518) and the intervention cohort (N = 140), consisting of patients with high risk score, in whom intensified spasm-preventive measures were applied. Results: Multivariable analysis in the derivation cohort showed that 5 weighted factors could be used to construct a risk score for spasm: body-mass index, height, current smoking, hypertension and peripheral artery disease (c-statistic 0.945, with an optimal cut-off of 4). In the validation cohort, the cut-off of 4 predicted spasm with a sensitivity of 84.5% and a specificity of 74.7%. In the intervention cohort, which included only patients with a spasm-risk score of â¥ 4, the rate of spasm was drastically reduced (odds ratio 0.32, 95% confidence interval 0.17-0.61), compared to the corresponding high spasm risk subgroup of patients of the validation cohort. Conclusion: A spasm risk score can be used to predict radial artery spasm during elective transradial PCI. Using this score, a high spasm risk patient subgroup can be identified, where intensive spasm-preventive measures can lead to a significant reduction in the frequency of spasm.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031193</affiliation-url><afid>60031193</afid><affilname>G. Gennimatas General Hospital</affilname><name-variant>G. Gennimatas Hospital</name-variant><affiliation-city>Athens</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031155</affiliation-url><afid>60031155</afid><affilname>Panepistimion Patron</affilname><name-variant>University of Patras</name-variant><affiliation-city>Patra</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60067083</affiliation-url><afid>60067083</afid><affilname>University of Athens Medical School</affilname><name-variant>University of Athens</name-variant><affiliation-city>Athens</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60067083</affiliation-url><afid>60067083</afid><affilname>University of Athens Medical School</affilname><name-variant>University of Athens</name-variant><affiliation-city>Athens</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017994</affiliation-url><afid>60017994</afid><affilname>Yale University School of Medicine</affilname><name-variant>Yale University School of Medicine</name-variant><affiliation-city>New Haven</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">14</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:15122092900</author-url><authid>15122092900</authid><authname>Giannopoulos G.</authname><surname>Giannopoulos</surname><given-name>Georgios</given-name><initials>G.</initials><afid>60031193</afid><afid>60017994</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:15122092900</author-url><authid>15122092900</authid><authname>Giannopoulos G.</authname><surname>Giannopoulos</surname><given-name>Georgios</given-name><initials>G.</initials><afid>60031193</afid><afid>60017994</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:24449653600</author-url><authid>24449653600</authid><authname>Raisakis K.</authname><surname>Raisakis</surname><given-name>Konstantinos</given-name><initials>K.</initials><afid>60031193</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6603369279</author-url><authid>6603369279</authid><authname>Synetos A.</authname><surname>Synetos</surname><given-name>Andreas</given-name><initials>A.</initials><afid>60067083</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35518331600</author-url><authid>35518331600</authid><authname>Davlouros P.</authname><surname>Davlouros</surname><given-name>Periklis</given-name><initials>P.</initials><afid>60031155</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6602503595</author-url><authid>6602503595</authid><authname>Hahalis G.</authname><surname>Hahalis</surname><given-name>George</given-name><initials>G.</initials><afid>60031155</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7006042805</author-url><authid>7006042805</authid><authname>Alexopoulos D.</authname><surname>Alexopoulos</surname><given-name>Dimitrios</given-name><initials>D.</initials><afid>60031155</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35399054300</author-url><authid>35399054300</authid><authname>Tousoulis D.</authname><surname>Tousoulis</surname><given-name>Dimitrios</given-name><initials>D.</initials><afid>60067083</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7006346875</author-url><authid>7006346875</authid><authname>Lekakis J.</authname><surname>Lekakis</surname><given-name>John</given-name><initials>J.</initials><afid>60067083</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:36045489100</author-url><authid>36045489100</authid><authname>Stefanadis C.</authname><surname>Stefanadis</surname><given-name>Christodoulos</given-name><initials>C.</initials><afid>60067083</afid><afid>60017994</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:36045489100</author-url><authid>36045489100</authid><authname>Stefanadis C.</authname><surname>Stefanadis</surname><given-name>Christodoulos</given-name><initials>C.</initials><afid>60067083</afid><afid>60017994</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7003333377</author-url><authid>7003333377</authid><authname>Cleman M.</authname><surname>Cleman</surname><given-name>Michael W.</given-name><initials>M.W.</initials><afid>60017994</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:55403166300</author-url><authid>55403166300</authid><authname>Deftereos S.</authname><surname>Deftereos</surname><given-name>Spyridon</given-name><initials>S.</initials><afid>60031193</afid><afid>60017994</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:55403166300</author-url><authid>55403166300</authid><authname>Deftereos S.</authname><surname>Deftereos</surname><given-name>Spyridon</given-name><initials>S.</initials><afid>60031193</afid><afid>60017994</afid></author><authkeywords>PCI | Risk score | Spasm | Transradial access | Vascular access</authkeywords><intid>535946974</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928713632"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928713632?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928713632&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928713632&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0195666315001506"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928713632</prism:url><dc:identifier>SCOPUS_ID:84928713632</dc:identifier><eid>2-s2.0-84928713632</eid><dc:title>Health literacy and parent attitudes about weight control for children</dc:title><dc:creator>Liechty J.</dc:creator><prism:publicationName>Appetite</prism:publicationName><prism:issn>01956663</prism:issn><prism:eIssn>10958304</prism:eIssn><prism:volume>91</prism:volume><prism:pageRange>200-208</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.appet.2015.04.010</prism:doi><pii>S0195666315001506</pii><dc:description>Â© 2015 Elsevier Ltd. The purpose of this study was to examine associations between parental health literacy and parent attitudes about weight control strategies for young children. Parental low health literacy has been associated with poor child health outcomes, yet little is known about its relationship to child weight control and weight-related health information-seeking preferences. Data were drawn from the STRONG Kids Study, a Midwest panel survey among parents of preschool aged children (n = 497). Parents endorsed an average of 4.3 (SD = 2.8) weight loss strategies, 53% endorsed all three recommended weight loss strategies for children, and fewer than 1% of parents endorsed any unsafe strategies. Parents were most likely to seek child weight loss information from healthcare professionals but those with low (vs. adequate) health literacy were significantly less likely to use the Internet or books and more likely to use minister/clergy as sources. Poisson and logistic regressions showed that higher health literacy was associated with endorsement of more strategies overall, more recommended strategies, and greater odds of endorsing each specific recommended strategy for child weight control, after adjusting for parent age, education, race/ethnicity, income, marital status, weight concern, and child BMI percentile. Findings suggest that health literacy impacts parental views about child weight loss strategies and health information-seeking preferences. Pediatric weight loss advice to parents should include assessment of parent attitudes and prior knowledge about child weight control and facilitate parent access to reliable sources of evidence-informed child weight control information.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000745</affiliation-url><afid>60000745</afid><affilname>University of Illinois at Urbana-Champaign</affilname><name-variant>University of Illinois</name-variant><affiliation-city>Urbana</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023868</affiliation-url><afid>60023868</afid><affilname>University of Illinois College of Medicine</affilname><name-variant>University of Illinois College of Medicine</name-variant><affiliation-city>Chicago</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000745</affiliation-url><afid>60000745</afid><affilname>University of Illinois at Urbana-Champaign</affilname><name-variant>University of Illinois</name-variant><affiliation-city>Urbana</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000745</affiliation-url><afid>60000745</afid><affilname>University of Illinois at Urbana-Champaign</affilname><name-variant>University of Illinois</name-variant><affiliation-city>Urbana</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">17</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56649469100</author-url><authid>56649469100</authid><authname>Liechty J.</authname><surname>Liechty</surname><given-name>Janet M.</given-name><initials>J.M.</initials><afid>60000745</afid><afid>60023868</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56649469100</author-url><authid>56649469100</authid><authname>Liechty J.</authname><surname>Liechty</surname><given-name>Janet M.</given-name><initials>J.M.</initials><afid>60000745</afid><afid>60023868</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56611600500</author-url><authid>56611600500</authid><authname>Saltzman J.</authname><surname>Saltzman</surname><given-name>Jaclyn A.</given-name><initials>J.A.</initials><afid>60000745</afid><afid>60000745</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56611600500</author-url><authid>56611600500</authid><authname>Saltzman J.</authname><surname>Saltzman</surname><given-name>Jaclyn A.</given-name><initials>J.A.</initials><afid>60000745</afid><afid>60000745</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:26632133200</author-url><authid>26632133200</authid><authname>Musaad S.</authname><surname>Musaad</surname><given-name>Salma M.</given-name><initials>S.M.</initials><afid>60000745</afid><afid>60000745</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:26632133200</author-url><authid>26632133200</authid><authname>Musaad S.</authname><surname>Musaad</surname><given-name>Salma M.</given-name><initials>S.M.</initials><afid>60000745</afid><afid>60000745</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7202397327</author-url><authid>7202397327</authid><authname>Harrison K.</authname><surname>Harrison</surname><given-name>Kristen</given-name><initials>K.</initials><afid>60000745</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35611213400</author-url><authid>35611213400</authid><authname>Bost K.</authname><surname>Bost</surname><given-name>Kelly</given-name><initials>K.</initials><afid>60000745</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7102465595</author-url><authid>7102465595</authid><authname>McBride B.</authname><surname>McBride</surname><given-name>Brent</given-name><initials>B.</initials><afid>60000745</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7103235031</author-url><authid>7103235031</authid><authname>Donovan S.</authname><surname>Donovan</surname><given-name>Sharon</given-name><initials>S.</initials><afid>60000745</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56648367100</author-url><authid>56648367100</authid><authname>Grigsby-Toussaint D.</authname><surname>Grigsby-Toussaint</surname><given-name>Diana</given-name><initials>D.</initials><afid>60000745</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56468173400</author-url><authid>56468173400</authid><authname>Kim J.</authname><surname>Kim</surname><given-name>Juhee</given-name><initials>J.</initials><afid>60000745</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56495675100</author-url><authid>56495675100</authid><authname>Liechty J.</authname><surname>Liechty</surname><given-name>Janet</given-name><initials>J.</initials><afid>60000745</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7006153525</author-url><authid>7006153525</authid><authname>Wiley A.</authname><surname>Wiley</surname><given-name>Angela</given-name><initials>A.</initials><afid>60000745</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:55880931700</author-url><authid>55880931700</authid><authname>Teran-Garcia M.</authname><surname>Teran-Garcia</surname><given-name>Margarita</given-name><initials>M.</initials><afid>60000745</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:56648361200</author-url><authid>56648361200</authid><authname>Fiese B.</authname><surname>Fiese</surname><given-name>Barbara</given-name><initials>B.</initials><afid>60000745</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:56612041500</author-url><authid>56612041500</authid><authname>The STRONG Kids Team </authname><surname>The STRONG Kids Team</surname><given-name/><initials/><afid>60000745</afid></author><authkeywords>Child weight control | Dieting | Health communication | Health literacy | Information-seeking | Weight loss strategies</authkeywords><intid>2035833501</intid><source-id>29994</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929573468"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929573468?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929573468&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929573468&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0303846715001626"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929573468</prism:url><dc:identifier>SCOPUS_ID:84929573468</dc:identifier><eid>2-s2.0-84929573468</eid><dc:title>Admission neurophysiological abnormalities in Guillain-BarrÃ© syndrome: A single-center experience</dc:title><dc:creator>Luigetti M.</dc:creator><prism:publicationName>Clinical Neurology and Neurosurgery</prism:publicationName><prism:issn>03038467</prism:issn><prism:eIssn>18726968</prism:eIssn><prism:volume>135</prism:volume><prism:pageRange>6-10</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.clineuro.2015.05.001</prism:doi><pii>S0303846715001626</pii><dc:description>Â© 2015 Elsevier B.V. Abstract Objective Although patients with Guillain-BarrÃ© syndrome (GBS) are often hospitalized few days after symptoms onset, nerve conduction studies (NCS) abnormalities in early phases of the disease are not well characterized. Our aim was to report early neurophysiological abnormalities from a cohort of GBS patients. Methods In this single-center study, we retrospectively reviewed the NCS data of 71 consecutive GBS patients in whom neurophysiology was performed within two weeks after disease onset. We further divided our cohort in three subgroups according to the interval between disease onset and NCS (â¤4 days; 5-7 days; 8-14 days). Results A great proportion of patients (37%) with an early NCS (â¤4 days) showed normal neurophysiological results. The most altered parameters were F waves and their proportion increases in correspondence to number of days after onset. Conduction blocks were observed preferentially in upper limbs, in about a third of cases. Conclusion This study confirms that NCS may be normal in the early phases of GBS syndrome and suggests to perform an extensive neurophysiological evaluation in these patients. Significance Our results may help the clinicians in the interpretation of NCS in early-onset GBS.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031984</affiliation-url><afid>60031984</afid><affilname>Universita Cattolica del Sacro Cuore, Rome</affilname><name-variant>Catholic University</name-variant><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60103767</affiliation-url><afid>60103767</afid><affilname>IRCCS San Raffaele Pisana</affilname><name-variant>IRCCS San Raffaele Pisana</name-variant><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:25422441400</author-url><authid>25422441400</authid><authname>Luigetti M.</authname><surname>Luigetti</surname><given-name>Marco</given-name><initials>M.</initials><afid>60031984</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35463202600</author-url><authid>35463202600</authid><authname>Servidei S.</authname><surname>Servidei</surname><given-name>Serenella</given-name><initials>S.</initials><afid>60031984</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:8138932500</author-url><authid>8138932500</authid><authname>Modoni A.</authname><surname>Modoni</surname><given-name>Anna</given-name><initials>A.</initials><afid>60031984</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56423288600</author-url><authid>56423288600</authid><authname>Rossini P.</authname><surname>Rossini</surname><given-name>Paolo Maria</given-name><initials>P.M.</initials><afid>60031984</afid><afid>60103767</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56423288600</author-url><authid>56423288600</authid><authname>Rossini P.</authname><surname>Rossini</surname><given-name>Paolo Maria</given-name><initials>P.M.</initials><afid>60031984</afid><afid>60103767</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7003445858</author-url><authid>7003445858</authid><authname>Sabatelli M.</authname><surname>Sabatelli</surname><given-name>Mario</given-name><initials>M.</initials><afid>60031984</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7003630319</author-url><authid>7003630319</authid><authname>Lo Monaco M.</authname><surname>Lo Monaco</surname><given-name>Mauro</given-name><initials>M.</initials><afid>60031984</afid></author><authkeywords>Acute polyneuropathy | Conduction blocks | Early diagnosis | F wave | Guillain-BarrÃ© syndrome | Nerve conduction studies | Sural sparing</authkeywords><intid>1785982485</intid><article-number>4059</article-number><source-id>14895</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84921507329"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84921507329?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84921507329&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84921507329&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915014012131"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84921507329</prism:url><dc:identifier>SCOPUS_ID:84921507329</dc:identifier><eid>2-s2.0-84921507329</eid><dc:title>Requirement of JNK1 for endothelial cell injury in atherogenesis</dc:title><dc:creator>Amini N.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>235</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>613-618</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2014.05.950</prism:doi><pii>S0021915014012131</pii><dc:description>Â© 2014 The Authors. Objective: The c-Jun N-terminal kinase (JNK) family regulates fundamental physiological processes including apoptosis and metabolism. Although JNK2 is known to promote foam cell formation during atherosclerosis, the potential role of JNK1 is uncertain. We examined the potential influence of JNK1 and its negative regulator, MAP kinase phosphatase-1 (MKP-1), on endothelial cell (EC) injury and early lesion formation using hypercholesterolemic LDLR-/- mice. Methods and results: To assess the function of JNK1 in early atherogenesis, we measured EC apoptosis and lesion formation in LDLR-/- or LDLR-/-/JNK1-/- mice exposed to a high fat diet for 6 weeks. En face staining using antibodies that recognise active, cleaved caspase-3 (apoptosis) or using Sudan IV (lipid deposition) revealed that genetic deletion of JNK1 reduced EC apoptosis and lesion formation in hypercholesterolemic mice. By contrast, although EC apoptosis was enhanced in LDLR-/-/MKP-1-/- mice compared to LDLR-/- mice, lesion formation was unaltered. Conclusion: We conclude that JNK1 is required for EC apoptosis and lipid deposition during early atherogenesis. Thus pharmacological inhibitors of JNK may reduce atherosclerosis by preventing EC injury as well as by influencing foam cell formation.</dc:description><citedby-count>1</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60100024</affiliation-url><afid>60100024</afid><affilname>British Heart Foundation</affilname><name-variant>British Heart Foundation</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001881</affiliation-url><afid>60001881</afid><affilname>University of Sheffield</affilname><name-variant>University of Sheffield</name-variant><affiliation-city>Sheffield</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:37002649500</author-url><authid>37002649500</authid><authname>Amini N.</authname><surname>Amini</surname><given-name>Narges</given-name><initials>N.</initials><afid>60100024</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7401974554</author-url><authid>7401974554</authid><authname>Boyle J.</authname><surname>Boyle</surname><given-name>Joseph J.</given-name><initials>J.J.</initials><afid>60100024</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56491345400</author-url><authid>56491345400</authid><authname>Moers B.</authname><surname>Moers</surname><given-name>Britta</given-name><initials>B.</initials><afid>60001881</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:26327205700</author-url><authid>26327205700</authid><authname>Warboys C.</authname><surname>Warboys</surname><given-name>Christina M.</given-name><initials>C.M.</initials><afid>60100024</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:8784161000</author-url><authid>8784161000</authid><authname>Malik T.</authname><surname>Malik</surname><given-name>Talat H.</given-name><initials>T.H.</initials><afid>60100024</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:22959310900</author-url><authid>22959310900</authid><authname>Zakkar M.</authname><surname>Zakkar</surname><given-name>Mustafa</given-name><initials>M.</initials><afid>60100024</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56489881000</author-url><authid>56489881000</authid><authname>Francis S.</authname><surname>Francis</surname><given-name>Sheila E.</given-name><initials>S.E.</initials><afid>60001881</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56489423200</author-url><authid>56489423200</authid><authname>Mason J.</authname><surname>Mason</surname><given-name>Justin C.</given-name><initials>J.C.</initials><afid>60100024</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7102594554</author-url><authid>7102594554</authid><authname>Haskard D.</authname><surname>Haskard</surname><given-name>Dorian O.</given-name><initials>D.O.</initials><afid>60100024</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:34769960600</author-url><authid>34769960600</authid><authname>Evans P.</authname><surname>Evans</surname><given-name>Paul C.</given-name><initials>P.C.</initials><afid>60001881</afid></author><authkeywords>Apoptosis | Atherosclerosis | C-Jun N-terminal kinase | Endothelial cells | MAP kinase phosphatase</authkeywords><intid>1034650826</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929338625"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929338625?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929338625&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929338625&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167947315000511"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929338625</prism:url><dc:identifier>SCOPUS_ID:84929338625</dc:identifier><eid>2-s2.0-84929338625</eid><dc:title>SIMD parallel MCMC sampling with applications for big-data Bayesian analytics</dc:title><dc:creator>Mahani A.</dc:creator><prism:publicationName>Computational Statistics and Data Analysis</prism:publicationName><prism:issn>01679473</prism:issn><prism:volume>88</prism:volume><prism:pageRange>75-99</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.csda.2015.02.010</prism:doi><pii>S0167947315000511</pii><dc:description>Â© 2015 Elsevier B.V. All rights reserved. Computational intensity and sequential nature of estimation techniques for Bayesian methods in statistics and machine learning, combined with their increasing applications for big data analytics, necessitate both the identification of potential opportunities to parallelize techniques such as Monte Carlo Markov Chain (MCMC) sampling, and the development of general strategies for mapping such parallel algorithms to modern CPUs in order to elicit the performance up the compute-based and/or memory-based hardware limits. Two opportunities for Single-Instruction Multiple-Data (SIMD) parallelization of MCMC sampling for probabilistic graphical models are presented. In exchangeable models with many observations such as Bayesian Generalized Linear Models (GLMs), child-node contributions to the conditional posterior of each node can be calculated concurrently. In undirected graphs with discrete-value nodes, concurrent sampling of conditionally-independent nodes can be transformed into a SIMD form. High-performance libraries with multi-threading and vectorization capabilities can be readily applied to such SIMD opportunities to gain decent speedup, while a series of high-level source-code and runtime modifications provide further performance boost by reducing parallelization overhead and increasing data locality for Non-Uniform Memory Access architectures. For big-data Bayesian GLM graphs, the end-result is a routine for evaluating the conditional posterior and its gradient vector that is 5 times faster than a naive implementation using (built-in) multi-threaded Intel MKL BLAS, and reaches within the striking distance of the memory-bandwidth-induced hardware limit. Using multi-threading for cache-friendly, fine-grained parallelization can outperform coarse-grained alternatives which are often less cache-friendly, a likely scenario in modern predictive analytics workflow such as Hierarchical Bayesian GLM, variable selection, and ensemble regression and classification. The proposed optimization strategies improve the scaling of performance with number of cores and width of vector units (applicable to many-core SIMD processors such as Intel Xeon Phi and Graphic Processing Units), resulting in cost-effectiveness, energy efficiency ('green computing'), and higher speed on multi-core x86 processors.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:106378843</affiliation-url><afid>106378843</afid><affilname>Sentrana Inc.</affilname><name-variant>Sentrana Inc.</name-variant><affiliation-city>Washington</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010719</affiliation-url><afid>60010719</afid><affilname>National Heart and Lung Institute</affilname><name-variant>National Heart and Lung Institute</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644544900</author-url><authid>56644544900</authid><authname>Mahani A.</authname><surname>Mahani</surname><given-name>Alireza S.</given-name><initials>A.S.</initials><afid>106378843</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36195655500</author-url><authid>36195655500</authid><authname>Sharabiani M.</authname><surname>Sharabiani</surname><given-name>Mansour T A</given-name><initials>M.T.A.</initials><afid>60010719</afid></author><authkeywords>GPU | Hierarchical Bayesian | Intel Xeon Phi | Logistic regression | OpenMP | Vectorization</authkeywords><intid>2035939843</intid><source-id>28461</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929322848"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929322848?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929322848&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929322848&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008888"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929322848</prism:url><dc:identifier>SCOPUS_ID:84929322848</dc:identifier><eid>2-s2.0-84929322848</eid><dc:title>Effects of depression screening on psychiatric outcomes in patients with acute coronary syndrome: Findings from the K-DEPACS and EsDEPACS studies</dc:title><dc:creator>Kang H.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>114-121</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.164</prism:doi><dc:description>Â© 2015 Elsevier Ireland Ltd. All rights reserved. Background: It has been controversial whether routine screening for depression should be recommended in all patients with acute coronary syndrome (ACS) due to lack of evidence for psychiatric as well as for cardiac outcomes. This study aimed to evaluate the result of screening for treatment and subsequent treatment of depression on one-year psychiatric outcomes in ACS. Methods: At baseline 1152 patients with recently developed ACS were screened with the Beck Depression Inventory (BDI) and depressive disorder diagnoses were applied according to DSM-IV criteria. Of the 446 patients with depressive disorder, 300 were randomized to a 24-week double-blind trial of escitalopram or placebo, while the remaining 146 received conventional medical treatment only (MTO) without randomization. Of all baseline participants, 828 were followed up one year later. Psychiatric outcomes included BDI, Hamilton Depression Rating Scale (HAMD), Montgomery Asberg Depression Rating Scale (MADRS), Social and Occupational Functioning Assessment Scale (SOFAS) and the World Health Organization Disability Assessment Schedule-12 (WHODAS-12). Results: BDI screen-positive ACS patients showed worse one-year outcomes on MADRS, SOFAS, and WHODAS scores (p-values &lt; 0.01) compared to BDI screen-negative patients. Escitalopram treatment was associated with beneficial effects compared to placebo and MTO on one-year outcomes on HAMD, MADRS and SOFAS (p-values &lt; 0.01). Of patients screening positive on the BDI, those with depressive disorder treated with escitalopram had similar outcomes to those without depressive disorder. Conclusions: Routine screening of depressive symptom in ACS patients is helpful to plan further management. Moreover, successive accurate diagnosis of depressive disorder with appropriated treatment is effective at least for psychiatric outcomes.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017234</affiliation-url><afid>60017234</afid><affilname>Chonnam National University, College of Medicine</affilname><name-variant>Chonnam National University Hospital</name-variant><affiliation-city>Gwangju</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011520</affiliation-url><afid>60011520</afid><affilname>King's College London</affilname><name-variant>King's College London</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017234</affiliation-url><afid>60017234</afid><affilname>Chonnam National University, College of Medicine</affilname><name-variant>Chonnam National University Hospital</name-variant><affiliation-city>Gwangju</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:52263660900</author-url><authid>52263660900</authid><authname>Kang H.</authname><surname>Kang</surname><given-name>Hee Ju</given-name><initials>H.J.</initials><afid>60017234</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35594617600</author-url><authid>35594617600</authid><authname>Stewart R.</authname><surname>Stewart</surname><given-name>Robert</given-name><initials>R.</initials><afid>60011520</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35085749900</author-url><authid>35085749900</authid><authname>Bae K.</authname><surname>Bae</surname><given-name>Kyung Yeol</given-name><initials>K.Y.</initials><afid>60017234</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:34975065200</author-url><authid>34975065200</authid><authname>Kim S.</authname><surname>Kim</surname><given-name>Sung Wan</given-name><initials>S.W.</initials><afid>60017234</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7103409198</author-url><authid>7103409198</authid><authname>Shin I.</authname><surname>Shin</surname><given-name>Il Seon</given-name><initials>I.S.</initials><afid>60017234</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:13310329100</author-url><authid>13310329100</authid><authname>Hong Y.</authname><surname>Hong</surname><given-name>Young Joon</given-name><initials>Y.J.</initials><afid>60017234</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7202402413</author-url><authid>7202402413</authid><authname>Ahn Y.</authname><surname>Ahn</surname><given-name>Youngkeun</given-name><initials>Y.</initials><afid>60017234</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7102344356</author-url><authid>7102344356</authid><authname>Jeong M.</authname><surname>Jeong</surname><given-name>Myung Ho</given-name><initials>M.H.</initials><afid>60017234</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:34878067000</author-url><authid>34878067000</authid><authname>Yoon J.</authname><surname>Yoon</surname><given-name>Jin Sang</given-name><initials>J.S.</initials><afid>60017234</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:14007693400</author-url><authid>14007693400</authid><authname>Kim J.</authname><surname>Kim</surname><given-name>Jae Min</given-name><initials>J.M.</initials><afid>60017234</afid></author><authkeywords>Acute coronary syndrome | Depressive disorder | Escitalopram | Psychiatric outcome | Screening</authkeywords><intid>535947532</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84921480162"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84921480162?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84921480162&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84921480162&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915014011769"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84921480162</prism:url><dc:identifier>SCOPUS_ID:84921480162</dc:identifier><eid>2-s2.0-84921480162</eid><dc:title>Abdominal obesity modifies long-term associations between periodontitis and markers of systemic inflammation</dc:title><dc:creator>Gocke C.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>235</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>351-357</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2014.05.926</prism:doi><pii>S0021915014011769</pii><dc:description>Â© 2014 Elsevier Ireland Ltd. Objective: Periodontitis is considered to promote atherosclerosis and cardiovascular diseases through increased low-grade systemic inflammation. However, there is no information on the long-term impact of periodontitis on systemic inflammation from cohort studies. Thus, this study aims to assess the impact of periodontitis on systemic inflammation (fibrinogen and white blood cells (WBC)) in a population-based longitudinal survey in north-eastern Germany. Methods: The study sample comprised 2622 subjects from the Study of Health in Pomerania with complete 5- and 11-year follow-ups. Periodontitis was assessed by probing depth and clinical attachment level. Multilevel regression analyses were applied to evaluate associations between periodontitis measures and i) fibrinogen/WBC count using 11-year follow-up data and ii) respective z-scores of fibrinogen/WBC count using 5- and 11-year follow-up data. We adjusted for common cardiovascular risk factors and stratified analyses by abdominal obesity (. P for interaction &lt;0.10). Results: In lean subjects, beta-coefficients of mean probing depth were B=0.13 (0.08-0.019; P&lt;0.001) for fibrinogen and B=0.50 (0.37-0.64; P&lt;0.001) for WBC count using 11-year follow-up data only. For lean subjects, models using z-scores confirmed that increased mean probing depths were associated with increased fibrinogen z-scores (. B=0.14 (0.09-0.18; P&lt;0.001)) and increased WBC z-scores (. B=0.16 (0.11-0.20; P&lt;0.001)). Consistent results were found for mean clinical attachment levels. For abdominally obese subjects, relations between periodontitis measures and levels of inflammation markers were less pronounced or non-significant. Conclusion: Modified by abdominal obesity, periodontitis affected systemic inflammation in a significant dose-dependent manner. Results contribute to the discussion on how periodontitis is linked to atherosclerosis and cardiovascular diseases.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021311</affiliation-url><afid>60021311</afid><affilname>Ernst-Moritz-Arndt-Universitat Greifswald</affilname><name-variant>University of Greifswald</name-variant><affiliation-city>Greifswald</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021311</affiliation-url><afid>60021311</afid><affilname>Ernst-Moritz-Arndt-Universitat Greifswald</affilname><name-variant>University of Greifswald</name-variant><affiliation-city>Greifswald</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:111695237</affiliation-url><afid>111695237</afid><affilname>University Medicine Greifswald</affilname><name-variant>University Medicine Greifswald</name-variant><affiliation-city>Greifswald</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><pubmed-id>24926536</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56490314100</author-url><authid>56490314100</authid><authname>Gocke C.</authname><surname>Gocke</surname><given-name>Christiane</given-name><initials>C.</initials><afid>60021311</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:14121113900</author-url><authid>14121113900</authid><authname>Holtfreter B.</authname><surname>Holtfreter</surname><given-name>Birte</given-name><initials>B.</initials><afid>60021311</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005109535</author-url><authid>7005109535</authid><authname>Meisel P.</authname><surname>Meisel</surname><given-name>Peter</given-name><initials>P.</initials><afid>60021311</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8548836600</author-url><authid>8548836600</authid><authname>Grotevendt A.</authname><surname>Grotevendt</surname><given-name>Anne</given-name><initials>A.</initials><afid>60021311</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:53986322500</author-url><authid>53986322500</authid><authname>Jablonowski L.</authname><surname>Jablonowski</surname><given-name>Lukasz</given-name><initials>L.</initials><afid>60021311</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56386879500</author-url><authid>56386879500</authid><authname>Nauck M.</authname><surname>Nauck</surname><given-name>Matthias</given-name><initials>M.</initials><afid>60021311</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:8422488600</author-url><authid>8422488600</authid><authname>Markus M.</authname><surname>Markus</surname><given-name>Marcello Ricardo Paulista</given-name><initials>M.R.P.</initials><afid>111695237</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7102674816</author-url><authid>7102674816</authid><authname>Kocher T.</authname><surname>Kocher</surname><given-name>Thomas</given-name><initials>T.</initials><afid>60021311</afid></author><authkeywords>Cohort study | Fibrinogen | Obesity | Periodontitis | Study of health in Pomerania | Systemic inflammation | White blood cell count</authkeywords><intid>1034647638</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84917686584"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84917686584?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84917686584&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84917686584&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915014002329"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84917686584</prism:url><dc:identifier>SCOPUS_ID:84917686584</dc:identifier><eid>2-s2.0-84917686584</eid><dc:title>Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study</dc:title><dc:creator>Fitzpatrick A.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>235</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>384-391</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2014.04.032</prism:doi><pii>S0021915014002329</pii><dc:description>Â© 2014 Elsevier Ireland Ltd. Objective: To evaluate associations between Lipoprotein-associated phospholipase A2 (Lp-PLA2) mass and activity with risk of dementia and its subtypes. Methods: Analysis were completed on 3320 participants of the Cardiovascular Health Study (CHS), a population-based longitudinal study of community-dwelling adults age â¥65 years followed for an average of 5.4 years. Baseline serum Lp-PLA2 mass was measured using a sandwich enzyme immunoassay and Lp-PLA2 activity utilized a tritiated-platelet activating factor activity assay. Cox proportional hazards regression assessed the relative risk of incident dementia with higher baseline Lp-PLA2 adjusting for demographics, cardiovascular disease (CVD) and risk factors, inflammation markers and apolipoprotein E (APOE) genotype. Results: Each standard deviation higher Lp-PLA2 mass and activity were related to increased risk of dementia (fully adjusted HR: 1.11 per SD, 95% CI: 1.00-1.24 for mass; HR: 1.12 per SD, 95% CI: 1.00-1.26 for activity). Persons in the highest quartile of Lp-PLA2 mass were 50% more likely to develop dementia than those in the lowest quartile in adjusted models (HR: 1.49; 95% CI: 1.08-2.06). Among dementia subtypes, the risk of AD was increased two-fold in the highest compared to lowest quartile of Lp-PLA2 mass (adjusted HR: 1.98, 95% CI: 1.22-3.21). Results were attenuated in models of mixed dementia and VaD. Lp-PLA2 activity also doubled the risk of mixed dementia in the highest compared to lowest quartile (HR: 2.21, 95% CI: 1.12-4.373). Interpretation: These data support Lp-PLA2 as a risk factor for dementia independent of CVD and its risk factors. Further study is required to clarify the role of Lp-PLA2-related mechanisms in dementia subtypes.</dc:description><citedby-count>2</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015481</affiliation-url><afid>60015481</afid><affilname>University of Washington Seattle</affilname><name-variant>University of Washington</name-variant><affiliation-city>Seattle</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015481</affiliation-url><afid>60015481</afid><affilname>University of Washington Seattle</affilname><name-variant>University of Washington</name-variant><affiliation-city>Seattle</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020649</affiliation-url><afid>60020649</afid><affilname>GlaxoSmithKline</affilname><name-variant>GlaxoSmithKline</name-variant><affiliation-city>Brentford</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031576</affiliation-url><afid>60031576</afid><affilname>University of Vermont College of Medicine</affilname><name-variant>Univ. of Vermont College of Medicine</name-variant><affiliation-city>Burlington</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031576</affiliation-url><afid>60031576</afid><affilname>University of Vermont College of Medicine</affilname><name-variant>Univ. of Vermont College of Medicine</name-variant><affiliation-city>Burlington</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><pubmed-id>24929287</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:34769627300</author-url><authid>34769627300</authid><authname>Fitzpatrick A.</authname><surname>Fitzpatrick</surname><given-name>Annette L.</given-name><initials>A.L.</initials><afid>60015481</afid><afid>60015481</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:34769627300</author-url><authid>34769627300</authid><authname>Fitzpatrick A.</authname><surname>Fitzpatrick</surname><given-name>Annette L.</given-name><initials>A.L.</initials><afid>60015481</afid><afid>60015481</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35394287000</author-url><authid>35394287000</authid><authname>Irizarry M.</authname><surname>Irizarry</surname><given-name>Michael C.</given-name><initials>M.C.</initials><afid>60020649</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7103113524</author-url><authid>7103113524</authid><authname>Cushman M.</authname><surname>Cushman</surname><given-name>Mary</given-name><initials>M.</initials><afid>60031576</afid><afid>60031576</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7103113524</author-url><authid>7103113524</authid><authname>Cushman M.</authname><surname>Cushman</surname><given-name>Mary</given-name><initials>M.</initials><afid>60031576</afid><afid>60031576</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6506446610</author-url><authid>6506446610</authid><authname>Jenny N.</authname><surname>Jenny</surname><given-name>Nancy S.</given-name><initials>N.S.</initials><afid>60031576</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56490007800</author-url><authid>56490007800</authid><authname>Chi G.</authname><surname>Chi</surname><given-name>Gloria C.</given-name><initials>G.C.</initials><afid>60015481</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6602642327</author-url><authid>6602642327</authid><authname>Koro C.</authname><surname>Koro</surname><given-name>Carol</given-name><initials>C.</initials><afid>60020649</afid></author><authkeywords>Alzheimer's disease | Cardiovascular risk factors | Dementia | Lp-PLA2</authkeywords><intid>1034006896</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930195406"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930195406?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930195406&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930195406&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0166445X15001526"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930195406</prism:url><dc:identifier>SCOPUS_ID:84930195406</dc:identifier><eid>2-s2.0-84930195406</eid><dc:title>Alterations in mitochondrial electron transport system activity in response to warm acclimation, hypoxia-reoxygenation and copper in rainbow trout, Oncorhynchus mykiss</dc:title><dc:creator>Sappal R.</dc:creator><prism:publicationName>Aquatic Toxicology</prism:publicationName><prism:issn>0166445X</prism:issn><prism:eIssn>18791514</prism:eIssn><prism:volume>165</prism:volume><prism:pageRange>51-63</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.aquatox.2015.05.014</prism:doi><pii>S0166445X15001526</pii><dc:description>Â© 2015 Elsevier B.V. Fish expend significant amounts of energy to handle the numerous potentially stressful biotic and abiotic factors that they commonly encounter in aquatic environments. This universal requirement for energy singularizes mitochondria, the primary cellular energy transformers, as fundamental drivers of responses to environmental change. Our study probed the interacting effects of thermal stress, hypoxia-reoxygenation (HRO) and copper (Cu) exposure in rainbow trout to test the prediction that they act jointly to impair mitochondrial function. Rainbow trout were acclimated to 11 (controls) or 20. Â°C for 2 months. Liver mitochondria were then isolated and their responses in vitro to Cu (0-20. Î¼M) without and with HRO were assessed. Sequential inhibition and activation of mitochondrial electron transport system (ETS) enzyme complexes permitted the measurement of respiratory activities supported by complex I-IV (CI-IV) in one run. The results showed that warm acclimation reduced fish and liver weights but increased mitochondrial protein indicating impairment of energy metabolism, increased synthesis of defense proteins and/or reduced liver water content. Whereas acute rise (11 â 20 Â°C) in temperature increased mitochondrial oxidation rates supported by CI-IV, warm acclimation reduced the maximal (state 3) and increased the basal (state 4) respiration leading to global uncoupling of oxidative phosphorylation (OXPHOS). HRO profoundly inhibited both maximal and basal respiration rates supported by CI-IV, reduced RCR for all except CII and lowered CI:CII respiration ratio, an indication of decreased OXPHOS efficiency. The effects of Cu were less pronounced but more variable and included inhibition of CII-IV maximal respiration rates and stimulation of both CI and CIII basal respiration rates. Surprisingly, only CII and CIII indices exhibited significant 3-way interactions whereas 2-way interactions of acclimation either with Cu or HRO were portrayed mostly by CIV, and those of HRO and Cu were most common in CI and II respiratory indices. Our study suggests that warm acclimation blunts sensitivity of the ETS to temperature rise and that HRO and warm acclimation impose mitochondrial changes that sensitize the ETS to Cu. Overall, our study highlights the significance of the ETS in mitochondrial bioenergetic dysfunction caused by thermal stress, HRO and Cu exposure.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007655</affiliation-url><afid>60007655</afid><affilname>University of Prince Edward Island</affilname><name-variant>University of Prince Edward Island</name-variant><affiliation-city>Charlottetown</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007655</affiliation-url><afid>60007655</afid><affilname>University of Prince Edward Island</affilname><name-variant>University of Prince Edward Island</name-variant><affiliation-city>Charlottetown</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019000</affiliation-url><afid>60019000</afid><affilname>Memorial University of Newfoundland</affilname><name-variant>Memorial University</name-variant><affiliation-city>St John's</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100455351</affiliation-url><afid>100455351</afid><affilname>British Columbia Centre for Aquatic Health Sciences</affilname><name-variant>BC Centre for Aquatic Health Sciences</name-variant><affiliation-city/><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:25652016200</author-url><authid>25652016200</authid><authname>Sappal R.</authname><surname>Sappal</surname><given-name>Ravinder</given-name><initials>R.</initials><afid>60007655</afid><afid>60007655</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:25652016200</author-url><authid>25652016200</authid><authname>Sappal R.</authname><surname>Sappal</surname><given-name>Ravinder</given-name><initials>R.</initials><afid>60007655</afid><afid>60007655</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55975250300</author-url><authid>55975250300</authid><authname>MacDougald M.</authname><surname>MacDougald</surname><given-name>Michelle</given-name><initials>M.</initials><afid>60019000</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7004356912</author-url><authid>7004356912</authid><authname>Fast M.</authname><surname>Fast</surname><given-name>Mark</given-name><initials>M.</initials><afid>60007655</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7401572003</author-url><authid>7401572003</authid><authname>Stevens D.</authname><surname>Stevens</surname><given-name>Don</given-name><initials>D.</initials><afid>60007655</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7007116566</author-url><authid>7007116566</authid><authname>Kibenge F.</authname><surname>Kibenge</surname><given-name>Fred</given-name><initials>F.</initials><afid>60007655</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56662990800</author-url><authid>56662990800</authid><authname>Siah A.</authname><surname>Siah</surname><given-name>Ahmed</given-name><initials>A.</initials><afid>100455351</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6602301413</author-url><authid>6602301413</authid><authname>Kamunde C.</authname><surname>Kamunde</surname><given-name>Collins</given-name><initials>C.</initials><afid>60007655</afid></author><authkeywords>Copper | Electron transport system | Hypoxia-reoxygenation | Interactions | Mitochondria | Warm acclimation</authkeywords><intid>2036081867</intid><source-id>24602</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929660074"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929660074?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929660074&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929660074&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0031938415002401"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929660074</prism:url><dc:identifier>SCOPUS_ID:84929660074</dc:identifier><eid>2-s2.0-84929660074</eid><dc:title>Defensive coping and renovascular disease risk - Adrenal fatigue in a cohort of Africans and Caucasians: The SABPA study</dc:title><dc:creator>de Kock A.</dc:creator><prism:publicationName>Physiology and Behavior</prism:publicationName><prism:issn>00319384</prism:issn><prism:eIssn>1873507X</prism:eIssn><prism:volume>147</prism:volume><prism:pageRange>213-219</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.physbeh.2015.04.033</prism:doi><pii>S0031938415002401</pii><dc:description>Â© 2015 Elsevier Inc. Background: Defensive coping is an established cardiovascular risk factor in Africans. Additionally, chronic, excessive or inadequate hypothalamic-pituitary-adrenal axis (HPAA) stress responses could either increase or decrease cortisol responses, which may relate to renal impairment. We scrutinised the relationship between urinary cortisol levels and renovascular disease risk in Africans and Caucasians utilising defensive coping. Methods: Africans (. n=. 168) and Caucasians (. n=. 207) from the SABPA (Sympathetic activity and Ambulatory Blood Pressure in Africans) study were included in our analyses, excluding HIV positive, diabetic, renal impairment, and cortisone users. The Coping Strategy Indicator questionnaire assessed preferred coping responses. Ambulatory blood pressure was recorded together with 8. h fasting blood and urine sampling. Renovascular disease risk markers included the albumin-to-creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR). Results: The main findings revealed that Caucasians with high cortisol showed augmented renovascular disease risk. Conversely, Africans revealed low cortisol levels whilst 21.84% reported experience of severe stress, possibly depicting HPAA hypoactivity. Additionally, these Africans with low cortisol revealed increased ACR and decreased eGFR, which was further enhanced by defensive coping. Conclusions: Defensive coping enhanced renovascular risk in Africans, especially in those with lower cortisol, which may be due to HPAA dysfunction and/or adrenal fatigue.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029714</affiliation-url><afid>60029714</afid><affilname>North-West University</affilname><name-variant>North-West University</name-variant><affiliation-city>Potchefstroom</affiliation-city><affiliation-country>South Africa</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029714</affiliation-url><afid>60029714</afid><affilname>North-West University</affilname><name-variant>North-West University</name-variant><affiliation-city>Potchefstroom</affiliation-city><affiliation-country>South Africa</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022148</affiliation-url><afid>60022148</afid><affilname>UCL</affilname><name-variant>University College</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029714</affiliation-url><afid>60029714</afid><affilname>North-West University</affilname><name-variant>North-West University</name-variant><affiliation-city>Potchefstroom</affiliation-city><affiliation-country>South Africa</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55228189700</author-url><authid>55228189700</authid><authname>de Kock A.</authname><surname>de Kock</surname><given-name>Andrea</given-name><initials>A.</initials><afid>60029714</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603640259</author-url><authid>6603640259</authid><authname>Malan L.</authname><surname>Malan</surname><given-name>LeonÃ©</given-name><initials>L.</initials><afid>60029714</afid><afid>60029714</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603640259</author-url><authid>6603640259</authid><authname>Malan L.</authname><surname>Malan</surname><given-name>LeonÃ©</given-name><initials>L.</initials><afid>60029714</afid><afid>60029714</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:8502496600</author-url><authid>8502496600</authid><authname>Hamer M.</authname><surname>Hamer</surname><given-name>Mark</given-name><initials>M.</initials><afid>60029714</afid><afid>60022148</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:8502496600</author-url><authid>8502496600</authid><authname>Hamer M.</authname><surname>Hamer</surname><given-name>Mark</given-name><initials>M.</initials><afid>60029714</afid><afid>60022148</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55865240900</author-url><authid>55865240900</authid><authname>Cockeran M.</authname><surname>Cockeran</surname><given-name>Marike</given-name><initials>M.</initials><afid>60029714</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35518988000</author-url><authid>35518988000</authid><authname>Malan N.</authname><surname>Malan</surname><given-name>Nico T.</given-name><initials>N.T.</initials><afid>60029714</afid></author><authkeywords>Adrenal fatigue | Coping | Cortisol | Ethnicity | Hypothalamic-pituitary-adrenal axis | Renovascular disease</authkeywords><intid>1535991422</intid><source-id>24007</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930204022"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930204022?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930204022&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930204022&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0149763415001335"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930204022</prism:url><dc:identifier>SCOPUS_ID:84930204022</dc:identifier><eid>2-s2.0-84930204022</eid><dc:title>Psychiatric disorders and leukocyte telomere length: Underlying mechanisms linking mental illness with cellular aging</dc:title><dc:creator>Lindqvist D.</dc:creator><prism:publicationName>Neuroscience and Biobehavioral Reviews</prism:publicationName><prism:issn>01497634</prism:issn><prism:eIssn>18737528</prism:eIssn><prism:volume>55</prism:volume><prism:pageRange>333-364</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.neubiorev.2015.05.007</prism:doi><pii>S0149763415001335</pii><dc:description>Â© 2015 Elsevier Ltd. Many psychiatric illnesses are associated with early mortality and with an increased risk of developing physical diseases that are more typically seen in the elderly. Moreover, certain psychiatric illnesses may be associated with accelerated cellular aging, evidenced by shortened leukocyte telomere length (LTL), which could underlie this association. Shortened LTL reflects a cell's mitotic history and cumulative exposure to inflammation and oxidation as well as the availability of telomerase, a telomere-lengthening enzyme. Critically short telomeres can cause cells to undergo senescence, apoptosis or genomic instability, and shorter LTL correlates with poorer health and predicts mortality. Emerging data suggest that LTL may be reduced in certain psychiatric illnesses, perhaps in proportion to exposure to the psychiatric illnesses, although conflicting data exist. Telomerase has been less well characterized in psychiatric illnesses, but a role in depression and in antidepressant and neurotrophic effects has been suggested by preclinical and clinical studies. In this article, studies on LTL and telomerase activity in psychiatric illnesses are critically reviewed, potential mediators are discussed, and future directions are suggested. A deeper understanding of cellular aging in psychiatric illnesses could lead to re-conceptualizing them as systemic illnesses with manifestations inside and outside the brain and could identify new treatment targets.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029170</affiliation-url><afid>60029170</afid><affilname>Lunds Universitet</affilname><name-variant>University of Lund</name-variant><affiliation-city>Lund</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031970</affiliation-url><afid>60031970</afid><affilname>UCSF School of Medicine</affilname><name-variant>University of California School of Medicine</name-variant><affiliation-city>San Francisco</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031970</affiliation-url><afid>60031970</afid><affilname>UCSF School of Medicine</affilname><name-variant>University of California School of Medicine</name-variant><affiliation-city>San Francisco</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013243</affiliation-url><afid>60013243</afid><affilname>Institute for Research in Extramural Medicine - EMGO</affilname><name-variant>VU University Medical Center</name-variant><affiliation-city>Amsterdam</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031970</affiliation-url><afid>60031970</afid><affilname>UCSF School of Medicine</affilname><name-variant>University of California School of Medicine</name-variant><affiliation-city>San Francisco</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032350</affiliation-url><afid>60032350</afid><affilname>Universita degli Studi di Roma La Sapienza</affilname><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">16</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36977574800</author-url><authid>36977574800</authid><authname>Lindqvist D.</authname><surname>Lindqvist</surname><given-name>Daniel</given-name><initials>D.</initials><afid>60029170</afid><afid>60031970</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36977574800</author-url><authid>36977574800</authid><authname>Lindqvist D.</authname><surname>Lindqvist</surname><given-name>Daniel</given-name><initials>D.</initials><afid>60029170</afid><afid>60031970</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35416705700</author-url><authid>35416705700</authid><authname>Epel E.</authname><surname>Epel</surname><given-name>Elissa S.</given-name><initials>E.S.</initials><afid>60031970</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005582799</author-url><authid>7005582799</authid><authname>Mellon S.</authname><surname>Mellon</surname><given-name>Synthia H.</given-name><initials>S.H.</initials><afid>60031970</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:34571588500</author-url><authid>34571588500</authid><authname>Penninx B.</authname><surname>Penninx</surname><given-name>Brenda W.</given-name><initials>B.W.</initials><afid>60013243</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55856388600</author-url><authid>55856388600</authid><authname>RÃ©vÃ©sz D.</authname><surname>RÃ©vÃ©sz</surname><given-name>DÃ³ra</given-name><initials>D.</initials><afid>60013243</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55919468900</author-url><authid>55919468900</authid><authname>Verhoeven J.</authname><surname>Verhoeven</surname><given-name>Josine E.</given-name><initials>J.E.</initials><afid>60013243</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7005444248</author-url><authid>7005444248</authid><authname>Reus V.</authname><surname>Reus</surname><given-name>Victor I.</given-name><initials>V.I.</initials><afid>60031970</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7501725008</author-url><authid>7501725008</authid><authname>Lin J.</authname><surname>Lin</surname><given-name>Jue</given-name><initials>J.</initials><afid>60031970</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56346212500</author-url><authid>56346212500</authid><authname>Mahan L.</authname><surname>Mahan</surname><given-name>Laura</given-name><initials>L.</initials><afid>60031970</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56662841300</author-url><authid>56662841300</authid><authname>Hough C.</authname><surname>Hough</surname><given-name>Christina M.</given-name><initials>C.M.</initials><afid>60031970</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:35068477900</author-url><authid>35068477900</authid><authname>Rosser R.</authname><surname>Rosser</surname><given-name>Rebecca</given-name><initials>R.</initials><afid>60031970</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:37064445400</author-url><authid>37064445400</authid><authname>Bersani F.</authname><surname>Bersani</surname><given-name>F. Saverio</given-name><initials>F.S.</initials><afid>60031970</afid><afid>60032350</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:37064445400</author-url><authid>37064445400</authid><authname>Bersani F.</authname><surname>Bersani</surname><given-name>F. Saverio</given-name><initials>F.S.</initials><afid>60031970</afid><afid>60032350</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:7103349740</author-url><authid>7103349740</authid><authname>Blackburn E.</authname><surname>Blackburn</surname><given-name>Elizabeth H.</given-name><initials>E.H.</initials><afid>60031970</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:7007166456</author-url><authid>7007166456</authid><authname>Wolkowitz O.</authname><surname>Wolkowitz</surname><given-name>Owen M.</given-name><initials>O.M.</initials><afid>60031970</afid></author><authkeywords>Aging | Antidepressant | Anxiety | Bipolar affective disorder | Depression | Disease | Early life adversity | Inflammation | Leukocytes | Major depressive disorder | Manic-depression | Mortality | Neurotrophic | Oxidative stress | Post-traumatic stress disorder | Psychosis | Schizophrenia | Stress | Telomerase | Telomeres</authkeywords><intid>536087838</intid><source-id>18045</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84920573648"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84920573648?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84920573648&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84920573648&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915014011770"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84920573648</prism:url><dc:identifier>SCOPUS_ID:84920573648</dc:identifier><eid>2-s2.0-84920573648</eid><dc:title>A decrease in total bilirubin predicted hyper-LDL cholesterolemia in a health screening population</dc:title><dc:creator>Oda E.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>235</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>334-338</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2014.05.927</prism:doi><pii>S0021915014011770</pii><dc:description>Â© 2014 Elsevier Ireland Ltd. Objective: To investigate cross-sectional and longitudinal associations between serum total bilirubin (TB) and LDL cholesterol. Methods: It is a retrospective observational study. Cross-sectional and longitudinal associations between TB and hyper-LDL cholesterolemia were investigated in a health screening population. Odds ratios (ORs) of coexisting hyper-LDL cholesterolemia for TB were calculated in 3,866 subjects, Spearman's correlation coefficients between baseline TB and LDL cholesterol at baseline and after 4 years were calculated in 1,735 subjects who did not use antihyperlipidemic drugs and hazard ratios (HRs) of incident hyper-LDL cholesterolemia for TB were calculated in 1,992 followed subjects. Results: The ORs (. p values) of coexisting hyper-LDL cholesterolemia for each 1 SD increase in TB was 1.04 (0.998) adjusted for sex, age, smoking, LDL cholesterol and other confounders. Spearman's correlation coefficients (. p values) between baseline TB and LDL cholesterol at baseline and after 4 years and changes in LDL cholesterol were-0.026 (0.271),-0.078 (0.001) and-0.062 (0.010), respectively. Among 1,992 followed subjects, 481 developed hyper-LDL cholesterolemia during 4 years (60.4 per 1,000 person-years). The HRs (95% confidence intervals; p values) of incident hyper-LDL cholesterolemia for each 1 SD increase in TB was 0.86 (0.77-0.96; 0.006) adjusted for sex, age, smoking, LDL cholesterol, body mass index, triglycerides, HDL cholesterol, fasting glucose and other confounders. The quintiles of TB were significantly associated with the incident hyper-LDL cholesterolemia adjusted for the above covariates (. p for trend=0.008). Conclusion: A decrease in TB predicted incident hyper-LDL cholesterolemia in a health screening population.</dc:description><citedby-count>1</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114711069</affiliation-url><afid>114711069</afid><affilname>Tachikawa Medical Center</affilname><name-variant>Tachikawa Medical Center</name-variant><affiliation-city>Niigata</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><pubmed-id>24911637</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:12796326500</author-url><authid>12796326500</authid><authname>Oda E.</authname><surname>Oda</surname><given-name>Eiji</given-name><initials>E.</initials><afid>114711069</afid></author><authkeywords>Antioxidant | Bilirubin | Cardiovascular disease | LDL cholesterol</authkeywords><intid>34502229</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84920871755"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84920871755?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84920871755&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84920871755&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915014011678"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84920871755</prism:url><dc:identifier>SCOPUS_ID:84920871755</dc:identifier><eid>2-s2.0-84920871755</eid><dc:title>Markers of atherosclerotic development in children with familial hypercholesterolemia: A literature review</dc:title><dc:creator>Narverud I.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>235</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>299-309</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2014.05.917</prism:doi><pii>S0021915014011678</pii><dc:description>Â© 2014 Elsevier Ireland Ltd. Objective: Atherosclerosis is a multi-step process, where lipids, inflammatory and hemostatic mediators orchestrate plaque formation and progression, which subsequently may lead to myocardial infarction and ischemic stroke. Familial hypercholesterolemia (FH) is associated with increased risk of premature atherosclerosis due to the genetically determined elevated low density lipoprotein (LDL)-cholesterol seen in these individuals. Children with FH are suitable to investigate the isolated effect of elevated LDL-cholesterol on early markers of atherosclerosis. The aim of the present paper was to review the literature to summarize the findings of atherosclerotic markers in children with FH to better understand how elevated LDL-cholesterol per se promotes atherogenesis. Methods: We conducted a systematic literature search from the years 1990-2013, resulting in identification of 903 articles. In order to investigate whether intima-media thickness (IMT) is different in children with and without FH, we conducted a meta-analysis of the studies comparing FH children with a control group. Results: 37 original articles were included. Among these, 24 reported subclinical measurements, whereas other articles reported measurements of atherogenic lipids (. n=9), inflammatory markers (. n=10), hemostatic markers (. n=6) and other surrogate markers of atherosclerosis (. n=7). In the meta-analysis (. n=8), IMT was significantly thicker in children with FH than in control children (weighted mean difference 0.06, 95% confidence interval [0.01, 0.11]). Conclusion: Elevated LDL-cholesterol distinguishes children with and without FH, but these groups of children also differ in several other ways. In particular, children with FH display a variety of changes reflecting both the lipid and the inflammatory arm of atherosclerosis. The IMT-meta-analysis result strengthens the evidence of early atherosclerotic development in children with FH. In a clinical perspective, early diagnosing and treatment of children with FH is of high importance to attenuate development of the potential ongoing early atherosclerotic process in these individuals.</dc:description><citedby-count>1</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010348</affiliation-url><afid>60010348</afid><affilname>Universitetet i Oslo</affilname><name-variant>University of Oslo</name-variant><affiliation-city>Oslo</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60068730</affiliation-url><afid>60068730</afid><affilname>HÃ¸gskolen i Oslo og Akershus</affilname><name-variant>Oslo University College</name-variant><affiliation-city>Oslo</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026108</affiliation-url><afid>60026108</afid><affilname>Rikshospitalet-Radiumhospitalet HF</affilname><name-variant>Rikshospitalet-Radiumhospitalet Medical Centre</name-variant><affiliation-city>Oslo</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60105037</affiliation-url><afid>60105037</afid><affilname>Oslo University Hospital</affilname><name-variant>Oslo University Hospital</name-variant><affiliation-city>Oslo</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60069109</affiliation-url><afid>60069109</afid><affilname>Research Institute of Internal Medicine</affilname><name-variant>Research Institute for Internal Medicine</name-variant><affiliation-city>Oslo</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010348</affiliation-url><afid>60010348</afid><affilname>Universitetet i Oslo</affilname><name-variant>University of Oslo</name-variant><affiliation-city>Oslo</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026108</affiliation-url><afid>60026108</afid><affilname>Rikshospitalet-Radiumhospitalet HF</affilname><name-variant>Rikshospitalet-Radiumhospitalet Medical Centre</name-variant><affiliation-city>Oslo</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114912012</affiliation-url><afid>114912012</afid><affilname>K.G. Jebsen Inflammatory Research Center</affilname><name-variant>K.G. Jebsen Inflammatory Research Center</name-variant><affiliation-city>Oslo</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010348</affiliation-url><afid>60010348</afid><affilname>Universitetet i Oslo</affilname><name-variant>University of Oslo</name-variant><affiliation-city>Oslo</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><pubmed-id>24908240</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">20</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36866438100</author-url><authid>36866438100</authid><authname>Narverud I.</authname><surname>Narverud</surname><given-name>Ingunn</given-name><initials>I.</initials><afid>60010348</afid><afid>60026108</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36866438100</author-url><authid>36866438100</authid><authname>Narverud I.</authname><surname>Narverud</surname><given-name>Ingunn</given-name><initials>I.</initials><afid>60010348</afid><afid>60026108</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603600207</author-url><authid>6603600207</authid><authname>RetterstÃ¸l K.</authname><surname>RetterstÃ¸l</surname><given-name>Kjetil</given-name><initials>K.</initials><afid>60010348</afid><afid>60026108</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603600207</author-url><authid>6603600207</authid><authname>RetterstÃ¸l K.</authname><surname>RetterstÃ¸l</surname><given-name>Kjetil</given-name><initials>K.</initials><afid>60010348</afid><afid>60026108</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7102956875</author-url><authid>7102956875</authid><authname>Iversen P.</authname><surname>Iversen</surname><given-name>Per Ole</given-name><initials>P.O.</initials><afid>60010348</afid><afid>60105037</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7102956875</author-url><authid>7102956875</authid><authname>Iversen P.</authname><surname>Iversen</surname><given-name>Per Ole</given-name><initials>P.O.</initials><afid>60010348</afid><afid>60105037</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003740090</author-url><authid>7003740090</authid><authname>Halvorsen B.</authname><surname>Halvorsen</surname><given-name>Bente</given-name><initials>B.</initials><afid>60069109</afid><afid>60010348</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003740090</author-url><authid>7003740090</authid><authname>Halvorsen B.</authname><surname>Halvorsen</surname><given-name>Bente</given-name><initials>B.</initials><afid>60069109</afid><afid>60010348</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7007162539</author-url><authid>7007162539</authid><authname>Ueland T.</authname><surname>Ueland</surname><given-name>Thor</given-name><initials>T.</initials><afid>60069109</afid><afid>60010348</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7007162539</author-url><authid>7007162539</authid><authname>Ueland T.</authname><surname>Ueland</surname><given-name>Thor</given-name><initials>T.</initials><afid>60069109</afid><afid>60010348</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6507729473</author-url><authid>6507729473</authid><authname>Ulven S.</authname><surname>Ulven</surname><given-name>Stine M.</given-name><initials>S.M.</initials><afid>60068730</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7006233403</author-url><authid>7006233403</authid><authname>Ose L.</authname><surname>Ose</surname><given-name>Leiv</given-name><initials>L.</initials><afid>60010348</afid><afid>60026108</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7006233403</author-url><authid>7006233403</authid><authname>Ose L.</authname><surname>Ose</surname><given-name>Leiv</given-name><initials>L.</initials><afid>60010348</afid><afid>60026108</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7101644682</author-url><authid>7101644682</authid><authname>Aukrust P.</authname><surname>Aukrust</surname><given-name>PÃ¥l</given-name><initials>P.</initials><afid>60069109</afid><afid>60010348</afid><afid>60026108</afid><afid>114912012</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7101644682</author-url><authid>7101644682</authid><authname>Aukrust P.</authname><surname>Aukrust</surname><given-name>PÃ¥l</given-name><initials>P.</initials><afid>60069109</afid><afid>60010348</afid><afid>60026108</afid><afid>114912012</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7101644682</author-url><authid>7101644682</authid><authname>Aukrust P.</authname><surname>Aukrust</surname><given-name>PÃ¥l</given-name><initials>P.</initials><afid>60069109</afid><afid>60010348</afid><afid>60026108</afid><afid>114912012</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7101644682</author-url><authid>7101644682</authid><authname>Aukrust P.</authname><surname>Aukrust</surname><given-name>PÃ¥l</given-name><initials>P.</initials><afid>60069109</afid><afid>60010348</afid><afid>60026108</afid><afid>114912012</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:35417291900</author-url><authid>35417291900</authid><authname>VeierÃ¸d M.</authname><surname>VeierÃ¸d</surname><given-name>Marit B.</given-name><initials>M.B.</initials><afid>60010348</afid><afid>60010348</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:35417291900</author-url><authid>35417291900</authid><authname>VeierÃ¸d M.</authname><surname>VeierÃ¸d</surname><given-name>Marit B.</given-name><initials>M.B.</initials><afid>60010348</afid><afid>60010348</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6603578893</author-url><authid>6603578893</authid><authname>Holven K.</authname><surname>Holven</surname><given-name>Kirsten B.</given-name><initials>K.B.</initials><afid>60010348</afid></author><authkeywords>Atherosclerosis | Children | Familial hypercholesterolemia | Literature review | Markers of atherosclerosis</authkeywords><intid>1034542006</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930203907"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930203907?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930203907&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930203907&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S002228281500156X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930203907</prism:url><dc:identifier>SCOPUS_ID:84930203907</dc:identifier><eid>2-s2.0-84930203907</eid><dc:title>Elevated expression levels of lysyl oxidases protect against aortic aneurysm progression in Marfan syndrome</dc:title><dc:creator>Busnadiego O.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>85</prism:volume><prism:pageRange>48-57</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.05.008</prism:doi><pii>S002228281500156X</pii><dc:description>Â© 2015 Elsevier Ltd. Patients with Marfan syndrome (MFS) are at high risk of life-threatening aortic dissections. The condition is caused by mutations in the gene encoding fibrillin-1, an essential component in the formation of elastic fibers. While experimental findings in animal models of the disease have shown the involvement of transforming growth factor-Î² (TGF-Î²)- and angiotensin II-dependent pathways, alterations in the vascular extracellular matrix (ECM) may also play a role in the onset and progression of the aortic disease. Lysyl oxidases (LOX) are extracellular enzymes, which initiates the formation of covalent cross-linking of collagens and elastin, thereby contributing to the maturation of the ECM. Here we have explored the role of LOX in the formation of aortic aneurysms in MFS. We show that aortic tissue from MFS patients and MFS mouse model (Fbn1&lt;sup&gt;C1039G/+&lt;/sup&gt;) displayed enhanced expression of the members of the LOX family, LOX and LOX-like 1 (LOXL1), and this is associated with the formation of mature collagen fibers. Administration of a LOX inhibitor for 8weeks blocked collagen accumulation and aggravated elastic fiber impairment, and these effects correlated with the induction of a strong and rapidly progressing aortic dilatation, and with premature death in the more severe MFS mouse model, Fbn1&lt;sup&gt;mgR/mgR&lt;/sup&gt;, without any significant effect on wild type animals. This detrimental effect occurred preferentially in the ascending portion of the aorta, with little or no involvement of the aortic root, and was associated to an overactivation of both canonical and non-canonical TGF-Î² signaling pathways. The blockade of angiotensin II type I receptor with losartan restored TGF-Î² signaling activation, normalized elastic fiber impairment and prevented the aortic dilatation induced by LOX inhibition in Fbn1&lt;sup&gt;C1039G/+&lt;/sup&gt; mice. Our data indicate that LOX enzymes and LOX-mediated collagen accumulation play a critical protective role in aneurysm formation in MFS.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026796</affiliation-url><afid>60026796</afid><affilname>Universidad Autonoma de Madrid</affilname><name-variant>Universidad AutÃ³noma de Madrid</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001576</affiliation-url><afid>60001576</afid><affilname>Universitat de Barcelona</affilname><name-variant>Universitat de Barcelona</name-variant><affiliation-city>Barcelona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010814</affiliation-url><afid>60010814</afid><affilname>Institut d'Investigacions BiomÃ¨diques August Pi i Sunyer - IDIBAPS</affilname><name-variant>IDIBAPS</name-variant><affiliation-city>Barcelona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001117</affiliation-url><afid>60001117</afid><affilname>The Johns Hopkins School of Medicine</affilname><name-variant>Johns Hopkins School of Medicine</name-variant><affiliation-city>Baltimore</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008948</affiliation-url><afid>60008948</afid><affilname>Centro Nacional de Investigaciones Oncologicas</affilname><name-variant>Spanish National Cancer Research Centre (CNIO)</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019984</affiliation-url><afid>60019984</afid><affilname>Netherlands Organisation for Applied Scientific Research - TNO</affilname><name-variant>TNO</name-variant><affiliation-city>Delft</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004024</affiliation-url><afid>60004024</afid><affilname>Hospital 12 Octubre</affilname><name-variant>Hospital 12 de Octubre</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">18</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35621476900</author-url><authid>35621476900</authid><authname>Busnadiego O.</authname><surname>Busnadiego</surname><given-name>O.</given-name><initials>O.</initials><afid>60026796</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:52363678300</author-url><authid>52363678300</authid><authname>Gorbenko del Blanco D.</authname><surname>Gorbenko del Blanco</surname><given-name>D.</given-name><initials>D.</initials><afid>60001576</afid><afid>60010814</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:52363678300</author-url><authid>52363678300</authid><authname>Gorbenko del Blanco D.</authname><surname>Gorbenko del Blanco</surname><given-name>D.</given-name><initials>D.</initials><afid>60001576</afid><afid>60010814</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:33767658500</author-url><authid>33767658500</authid><authname>GonzÃ¡lez-SantamarÃ­a J.</authname><surname>GonzÃ¡lez-SantamarÃ­a</surname><given-name>J.</given-name><initials>J.</initials><afid>60026796</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56664671500</author-url><authid>56664671500</authid><authname>Habashi J.</authname><surname>Habashi</surname><given-name>J. P.</given-name><initials>J.P.</initials><afid>60001117</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:15070012900</author-url><authid>15070012900</authid><authname>Calderon J.</authname><surname>Calderon</surname><given-name>J. F.</given-name><initials>J.F.</initials><afid>60001117</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:37032044400</author-url><authid>37032044400</authid><authname>Sandoval P.</authname><surname>Sandoval</surname><given-name>P.</given-name><initials>P.</initials><afid>60026796</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6507600123</author-url><authid>6507600123</authid><authname>Bedja D.</authname><surname>Bedja</surname><given-name>D.</given-name><initials>D.</initials><afid>60001117</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:25624502500</author-url><authid>25624502500</authid><authname>Guinea-Viniegra J.</authname><surname>Guinea-Viniegra</surname><given-name>J.</given-name><initials>J.</initials><afid>60008948</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7003791247</author-url><authid>7003791247</authid><authname>Lopez-Cabrera M.</authname><surname>Lopez-Cabrera</surname><given-name>M.</given-name><initials>M.</initials><afid>60026796</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56663300600</author-url><authid>56663300600</authid><authname>Rosell-Garcia T.</authname><surname>Rosell-Garcia</surname><given-name>T.</given-name><initials>T.</initials><afid>60026796</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:26027214200</author-url><authid>26027214200</authid><authname>Snabel J.</authname><surname>Snabel</surname><given-name>J. M.</given-name><initials>J.M.</initials><afid>60019984</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7003651659</author-url><authid>7003651659</authid><authname>Hanemaaijer R.</authname><surname>Hanemaaijer</surname><given-name>R.</given-name><initials>R.</initials><afid>60019984</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:7003934084</author-url><authid>7003934084</authid><authname>Forteza A.</authname><surname>Forteza</surname><given-name>A.</given-name><initials>A.</initials><afid>60004024</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:56664655700</author-url><authid>56664655700</authid><authname>Dietz H.</authname><surname>Dietz</surname><given-name>H. C.</given-name><initials>H.C.</initials><afid>60001117</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:7003420161</author-url><authid>7003420161</authid><authname>Egea G.</authname><surname>Egea</surname><given-name>G.</given-name><initials>G.</initials><afid>60001576</afid><afid>60010814</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:7003420161</author-url><authid>7003420161</authid><authname>Egea G.</authname><surname>Egea</surname><given-name>G.</given-name><initials>G.</initials><afid>60001576</afid><afid>60010814</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:6603047593</author-url><authid>6603047593</authid><authname>Rodriguez-Pascual F.</authname><surname>Rodriguez-Pascual</surname><given-name>F.</given-name><initials>F.</initials><afid>60026796</afid></author><authkeywords>Aneurysm | Collagen | Extracellular matrix | Lysyl oxidases | Marfan syndrome | Transforming growth factor-Î²</authkeywords><intid>1536087268</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928319630"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928319630?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928319630&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928319630&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1751616115001046"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928319630</prism:url><dc:identifier>SCOPUS_ID:84928319630</dc:identifier><eid>2-s2.0-84928319630</eid><dc:title>Mechanical biocompatibility of highly deformable biomedical materials</dc:title><dc:creator>Mazza E.</dc:creator><prism:publicationName>Journal of the Mechanical Behavior of Biomedical Materials</prism:publicationName><prism:issn>17516161</prism:issn><prism:eIssn>18780180</prism:eIssn><prism:volume>48</prism:volume><prism:pageRange>100-124</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jmbbm.2015.03.023</prism:doi><pii>S1751616115001046</pii><dc:description>Â© 2015 Elsevier Ltd. Mismatch of mechanical properties between highly deformable biomedical materials and adjacent native tissue might lead to short and long term health impairment. The capability of implants to deform at the right level, i.e. similar to the macroscopic mechanical response of the surrounding biological materials, is often associated with dissimilar microstructural deformation mechanisms. This mismatch on smaller length scales might lead to micro-injuries, cell damage, inflammation, fibrosis or necrosis. Hence, the mechanical biocompatibility of soft implants depends not only on the properties and composition of the implant material, but also on its organization, distribution and motion at one or several length scales. The challenges related to the analysis and attainment of mechanical biocompatibility are illustrated with two examples: prosthetic meshes for hernia and pelvic repair and electrospun scaffolds for tissue engineering. For these material systems we describe existing methods for characterization and analysis of the non-linear response to uniaxial and multiaxial stress states, its time and history dependence, and the changes in deformation behavior associated with tissue in-growth and material resorption. We discuss the multi-scale deformation behavior of biomaterials and adjacent tissue, and indicate major interdisciplinary questions to be addressed in future research.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025858</affiliation-url><afid>60025858</afid><affilname>Eidgenossische Technische Hochschule Zurich</affilname><name-variant>ETH Zurich</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020086</affiliation-url><afid>60020086</afid><affilname>Forschungsinstitution fur Materialwissenschaften Und Technologie Eth-Bereichs</affilname><name-variant>EMPA</name-variant><affiliation-city>Dubendorf</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55397367400</author-url><authid>55397367400</authid><authname>Mazza E.</authname><surname>Mazza</surname><given-name>Edoardo</given-name><initials>E.</initials><afid>60025858</afid><afid>60020086</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55397367400</author-url><authid>55397367400</authid><authname>Mazza E.</authname><surname>Mazza</surname><given-name>Edoardo</given-name><initials>E.</initials><afid>60025858</afid><afid>60020086</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:12446027600</author-url><authid>12446027600</authid><authname>Ehret A.</authname><surname>Ehret</surname><given-name>Alexander E.</given-name><initials>A.E.</initials><afid>60025858</afid></author><intid>1535767417</intid><source-id>8000153139</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930209356"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930209356?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930209356&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930209356&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0027510715001062"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930209356</prism:url><dc:identifier>SCOPUS_ID:84930209356</dc:identifier><eid>2-s2.0-84930209356</eid><dc:title>Genetic determinants of quantitative traits associated with cardiovascular disease risk</dc:title><dc:creator>SmolkovÃ¡ B.</dc:creator><prism:publicationName>Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis</prism:publicationName><prism:issn>00275107</prism:issn><prism:eIssn>18792871</prism:eIssn><prism:volume>778</prism:volume><prism:pageRange>18-25</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.mrfmmm.2015.05.005</prism:doi><pii>S0027510715001062</pii><dc:description>Â© 2015 Elsevier B.V. Established risk factors for cardiovascular diseases (CVD) may be moderated by genetic variants. In 2403 unrelated individuals from general practice (mean age 40.5 years), we evaluated the influence of 15 variants in 12 candidate genes on quantitative traits (QT) associated with CVD (body mass index, abdominal obesity, glucose, serum lipids, and blood pressure). Prior to multiple testing correction, univariate analysis associated APOE rs429358, rs7412 and ATG16L1 rs2241880 variants with serum lipid levels, while LEPR rs1137100 and ATG16L1 rs2241880 variants were linked to obesity related QTs. After taking into account confounding factors and correcting for multiple comparisons only APOE rs429358 and rs7412 variants remained significantly associated with risk of dyslipidemia. APOE rs429358 variant almost tripled the risk in homozygous subjects (OR. =. 2.97; 95% CI 1.09-8.10, p&lt;. 0.03) and had a lesser but still highly significant association also in heterozygous individuals (OR. =. 1.67; 95% CI 1.24-2.10; p&lt;. 0.001). Associations with hypertension, diabetes mellitus, and metabolic syndrome were not significant after Bonferroni correction. The influence of genetic variation is more evident in dyslipidemia than in other analyzed QTs. These results may contribute to strategic research aimed at including genetic variation in the set of data required to identify subjects at high risk of CVD.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015361</affiliation-url><afid>60015361</afid><affilname>Slovak Medical University</affilname><name-variant>Slovak Medical University</name-variant><affiliation-city>Bratislava</affiliation-city><affiliation-country>Slovakia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113875327</affiliation-url><afid>113875327</afid><affilname>IRCCS San Raffaele</affilname><name-variant>IRCCS San Raffaele</name-variant><affiliation-city>Cassino</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113875371</affiliation-url><afid>113875371</afid><affilname>National Transplantation Organisation</affilname><name-variant>National Transplantation Organisation</name-variant><affiliation-city>Bratislava</affiliation-city><affiliation-country>Slovakia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015361</affiliation-url><afid>60015361</afid><affilname>Slovak Medical University</affilname><name-variant>Slovak Medical University</name-variant><affiliation-city>Bratislava</affiliation-city><affiliation-country>Slovakia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015361</affiliation-url><afid>60015361</afid><affilname>Slovak Medical University</affilname><name-variant>Slovak Medical University</name-variant><affiliation-city>Bratislava</affiliation-city><affiliation-country>Slovakia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013641</affiliation-url><afid>60013641</afid><affilname>Istituto Nazionale per la Ricerca sul Cancro, Genoa</affilname><name-variant>Istituto Nazionale per la Ricerca sul Cancro</name-variant><affiliation-city>Genoa</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015361</affiliation-url><afid>60015361</afid><affilname>Slovak Medical University</affilname><name-variant>Slovak Medical University</name-variant><affiliation-city>Bratislava</affiliation-city><affiliation-country>Slovakia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033194</affiliation-url><afid>60033194</afid><affilname>Cancer Research Institute of Slovak Academy of Sciences</affilname><name-variant>Slovak Acad. Sci.</name-variant><affiliation-city>Bratislava</affiliation-city><affiliation-country>Slovakia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012050</affiliation-url><afid>60012050</afid><affilname>Norsk institutt for luftforskning</affilname><name-variant>Norwegian Institute for Air Research (NILU)</name-variant><affiliation-city>Skedsmokorset</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115294052</affiliation-url><afid>115294052</afid><affilname>Research Institute for Molecular Pathology</affilname><name-variant>Research Institute for Molecular Pathology</name-variant><affiliation-city/><affiliation-country>Austria</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030351</affiliation-url><afid>60030351</afid><affilname>Veterinary University Medicine in Kosice</affilname><name-variant>University of Veterinary Medicine</name-variant><affiliation-city>Kosice</affiliation-city><affiliation-country>Slovakia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">18</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8764305000</author-url><authid>8764305000</authid><authname>SmolkovÃ¡ B.</authname><surname>SmolkovÃ¡</surname><given-name>BoÅ¾ena</given-name><initials>B.</initials><afid>60015361</afid><afid>60033194</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8764305000</author-url><authid>8764305000</authid><authname>SmolkovÃ¡ B.</authname><surname>SmolkovÃ¡</surname><given-name>BoÅ¾ena</given-name><initials>B.</initials><afid>60015361</afid><afid>60033194</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7006233898</author-url><authid>7006233898</authid><authname>Bonassi S.</authname><surname>Bonassi</surname><given-name>Stefano</given-name><initials>S.</initials><afid>113875327</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56663174100</author-url><authid>56663174100</authid><authname>BuocikovÃ¡ V.</authname><surname>BuocikovÃ¡</surname><given-name>Verona</given-name><initials>V.</initials><afid>60015361</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003881158</author-url><authid>7003881158</authid><authname>DuÅ¡inskÃ¡ M.</authname><surname>DuÅ¡inskÃ¡</surname><given-name>MÃ¡ria</given-name><initials>M.</initials><afid>60015361</afid><afid>60012050</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003881158</author-url><authid>7003881158</authid><authname>DuÅ¡inskÃ¡ M.</authname><surname>DuÅ¡inskÃ¡</surname><given-name>MÃ¡ria</given-name><initials>M.</initials><afid>60015361</afid><afid>60012050</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7003602240</author-url><authid>7003602240</authid><authname>HorskÃ¡ A.</authname><surname>HorskÃ¡</surname><given-name>Alexandra</given-name><initials>A.</initials><afid>60015361</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56663093600</author-url><authid>56663093600</authid><authname>Kuba D.</authname><surname>Kuba</surname><given-name>Daniel</given-name><initials>D.</initials><afid>113875371</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:14014406500</author-url><authid>14014406500</authid><authname>DÅ¾upinkovÃ¡ Z.</authname><surname>DÅ¾upinkovÃ¡</surname><given-name>Zuzana</given-name><initials>Z.</initials><afid>113875371</afid><afid>115294052</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:14014406500</author-url><authid>14014406500</authid><authname>DÅ¾upinkovÃ¡ Z.</authname><surname>DÅ¾upinkovÃ¡</surname><given-name>Zuzana</given-name><initials>Z.</initials><afid>113875371</afid><afid>115294052</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56617593500</author-url><authid>56617593500</authid><authname>RaÅ¡lovÃ¡ K.</authname><surname>RaÅ¡lovÃ¡</surname><given-name>KatarÃ­na</given-name><initials>K.</initials><afid>60015361</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:6507372768</author-url><authid>6507372768</authid><authname>GaÅ¡paroviÄ J.</authname><surname>GaÅ¡paroviÄ</surname><given-name>Juraj</given-name><initials>J.</initials><afid>60015361</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56389604000</author-url><authid>56389604000</authid><authname>SlÃ­Å¾ I.</authname><surname>SlÃ­Å¾</surname><given-name>Ivan</given-name><initials>I.</initials><afid>60015361</afid><afid>60030351</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56389604000</author-url><authid>56389604000</authid><authname>SlÃ­Å¾ I.</authname><surname>SlÃ­Å¾</surname><given-name>Ivan</given-name><initials>I.</initials><afid>60015361</afid><afid>60030351</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7004697024</author-url><authid>7004697024</authid><authname>Ceppi M.</authname><surname>Ceppi</surname><given-name>Marcello</given-name><initials>M.</initials><afid>60013641</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:6602372073</author-url><authid>6602372073</authid><authname>Vohnout B.</authname><surname>Vohnout</surname><given-name>Branislav</given-name><initials>B.</initials><afid>60015361</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:35513102500</author-url><authid>35513102500</authid><authname>WsÃ³lovÃ¡ L.</authname><surname>WsÃ³lovÃ¡</surname><given-name>Ladislava</given-name><initials>L.</initials><afid>60015361</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:6701819934</author-url><authid>6701819934</authid><authname>VolkovovÃ¡ K.</authname><surname>VolkovovÃ¡</surname><given-name>KatarÃ­na</given-name><initials>K.</initials><afid>60015361</afid></author><authkeywords>Candidate gene | Cardiovascular disease | Genetic susceptibility | Quantitative trait | Risk factor</authkeywords><intid>36085800</intid><source-id>4800154008</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927739376"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927739376?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927739376&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927739376&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021979715003550"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927739376</prism:url><dc:identifier>SCOPUS_ID:84927739376</dc:identifier><eid>2-s2.0-84927739376</eid><dc:title>Controlled delivery of stromal derived factor-1Î± from poly lactic-co-glycolic acid core-shell particles to recruit mesenchymal stem cells for cardiac regeneration</dc:title><dc:creator>Zamani M.</dc:creator><prism:publicationName>Journal of Colloid and Interface Science</prism:publicationName><prism:issn>00219797</prism:issn><prism:eIssn>10957103</prism:eIssn><prism:volume>451</prism:volume><prism:pageRange>144-152</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jcis.2015.04.005</prism:doi><pii>S0021979715003550</pii><dc:description>Â© 2015 Elsevier Inc. Stromal derived factor-1Î± (SDF-1Î±) has shown promising results in treatment of myocardial infarction (MI), via recruitment of endogenous stem cells into the injured myocardium. However, the bioactivity of this susceptible signalling chemokine is reduced significantly during the common fabrication processes of drug delivery systems, due to the exposure to organic-aqueous interfaces or elevated temperature. In this study, we developed a novel SDF-1Î± delivery system using coaxial electrospraying, the technique which enables fabrication of core-shell particles with minimized contact of organic-aqueous phases. The SDF-1Î± incorporated PLGA particles exhibited distinct core-shell structure, confirmed by transmission electron microscopy (TEM). Controlled release of SDF-1Î± was obtained for at least 40. days, and the release rate was tailored by co-encapsulation of bovine serum albumin (BSA) into the core of the particles. The SDF-1Î± released from PLGA/SDF-1Î± and PLGA/BSA-SDF-1Î± particles retained its chemotactic activity, and enhanced the number of migrated mesenchymal stem cells (MSCs) by 38% and 54%, respectively, compared to basal medium used as the control. Moreover, both SDF-1Î± and BSA supported the proliferation of MSCs within 3. days of cell culture. The SDF-1Î± incorporated core-shell particles developed by electrospraying technique, can be effectively employed as injectable drug delivery system for in situ cardiac regeneration.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017161</affiliation-url><afid>60017161</afid><affilname>National University of Singapore</affilname><name-variant>National University of Singapore</name-variant><affiliation-city>Singapore City</affiliation-city><affiliation-country>Singapore</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017161</affiliation-url><afid>60017161</afid><affilname>National University of Singapore</affilname><name-variant>National University of Singapore</name-variant><affiliation-city>Singapore City</affiliation-city><affiliation-country>Singapore</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35757217500</author-url><authid>35757217500</authid><authname>Zamani M.</authname><surname>Zamani</surname><given-name>Maedeh</given-name><initials>M.</initials><afid>60017161</afid><afid>60017161</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35757217500</author-url><authid>35757217500</authid><authname>Zamani M.</authname><surname>Zamani</surname><given-name>Maedeh</given-name><initials>M.</initials><afid>60017161</afid><afid>60017161</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8267353900</author-url><authid>8267353900</authid><authname>Prabhakaran M.</authname><surname>Prabhakaran</surname><given-name>Molamma P.</given-name><initials>M.P.</initials><afid>60017161</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56273187600</author-url><authid>56273187600</authid><authname>Thian E.</authname><surname>Thian</surname><given-name>Eng San</given-name><initials>E.S.</initials><afid>60017161</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7102114638</author-url><authid>7102114638</authid><authname>Ramakrishna S.</authname><surname>Ramakrishna</surname><given-name>Seeram</given-name><initials>S.</initials><afid>60017161</afid><afid>60017161</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7102114638</author-url><authid>7102114638</authid><authname>Ramakrishna S.</authname><surname>Ramakrishna</surname><given-name>Seeram</given-name><initials>S.</initials><afid>60017161</afid><afid>60017161</afid></author><authkeywords>Cardiac tissue engineering | Coaxial electrospraying | Microencapsulation | Poly lactic-co-glycolic acid | Stromal derived factor-1Î±</authkeywords><intid>1535665088</intid><source-id>26950</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84920513669"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84920513669?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84920513669&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84920513669&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915014011812"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84920513669</prism:url><dc:identifier>SCOPUS_ID:84920513669</dc:identifier><eid>2-s2.0-84920513669</eid><dc:title>CETP inhibitors downregulate hepatic LDL receptor and PCSK9 expression invitro and invivo through a SREBP2 dependent mechanism</dc:title><dc:creator>Dong B.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>235</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>449-462</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2014.05.931</prism:doi><pii>S0021915014011812</pii><dc:description>Background: CETP inhibitors block the transfer of cholesteryl ester from HDL-C to VLDL-C and LDL-C, thereby raising HDL-C and lowering LDL-C. In this study, we explored the effect of CETP inhibitors on hepatic LDL receptor (LDLR) and PCSK9 expression and further elucidated the underlying regulatory mechanism. Results: We first examined the effect of anacetrapib (ANA) and dalcetrapib (DAL) on LDLR and PCSK9 expression in hepatic cells invitro. ANA exhibited a dose-dependent inhibition on both LDLR and PCSK9 expression in CETP-positive HepG2 cells and human primary hepatocytes as well as CETP-negative mouse primary hepatocytes (MPH). Moreover, the induction of LDLR protein expression by rosuvastatin in MPH was blunted by cotreatment with ANA. In both HepG2 and MPH ANA treatment reduced the amount of mature form of SREBP2 (SREBP2-M). Invivo, oral administration of ANA to dyslipidemic C57BL/6J mice at a daily dose of 50mg/kg for 1 week elevated serum total cholesterol by approximately 24.5% (p&lt;0.05%) and VLDL-C by 70% (p&lt;0.05%) with concomitant reductions of serum PCSK9 and liver LDLR/SREBP2-M protein. Finally, we examined the invitro effect of two other strong CETP inhibitors evacetrapib and torcetrapib on LDLR/PCSK9 expression and observed a similar inhibitory effect as ANA in a concentration range of 1-10Î¼M. Conclusion: Our study revealed an unexpected off-target effect of CETP inhibitors that reduce the mature form of SREBP2, leading to attenuated transcription of hepatic LDLR and PCSK9. This negative regulation of SREBP pathway by ANA manifested in mice where CETP activity was absent and affected serum cholesterol metabolism.</dc:description><citedby-count>5</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023695</affiliation-url><afid>60023695</afid><affilname>Department of Veterans Affairs</affilname><name-variant>Department of Veterans Affairs</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56489568700</author-url><authid>56489568700</authid><authname>Dong B.</authname><surname>Dong</surname><given-name>Bin</given-name><initials>B.</initials><afid>60023695</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56470957100</author-url><authid>56470957100</authid><authname>Singh A.</authname><surname>Singh</surname><given-name>Amar Bahadur</given-name><initials>A.B.</initials><afid>60023695</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56489843300</author-url><authid>56489843300</authid><authname>Fung C.</authname><surname>Fung</surname><given-name>Chin</given-name><initials>C.</initials><afid>60023695</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56490078100</author-url><authid>56490078100</authid><authname>Kan K.</authname><surname>Kan</surname><given-name>Kelvin</given-name><initials>K.</initials><afid>60023695</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7410104465</author-url><authid>7410104465</authid><authname>Liu J.</authname><surname>Liu</surname><given-name>Jingwen</given-name><initials>J.</initials><afid>60023695</afid></author><authkeywords>CETP inhibitors | Hyperlipidemia | LDL receptor | PCSK9 | SREBP2</authkeywords><intid>1784491353</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929334367"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929334367?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929334367&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929334367&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008529"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929334367</prism:url><dc:identifier>SCOPUS_ID:84929334367</dc:identifier><eid>2-s2.0-84929334367</eid><dc:title>Inhaled bronchodilators and the risk of tachyarrhythmias</dc:title><dc:creator>Lee C.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>133-139</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.129</prism:doi><dc:description>Â© 2015 Published by Elsevier Ireland Ltd. Background/objectives: There have been controversies about whether inhaled bronchodilators could increase the risk of clinically important tachyarrhythmias. We investigated the association between inhaled bronchodilators and the development of tachyarrhythmias, including atrial fibrillation and other paroxysmal tachyarrhythmias in real practice. Methods: We conducted a nested case-control study with the use of the nationwide insurance claims database of the Health Insurance Review and Assessment Service (Seoul, Republic of Korea). Overall, 3312 cases with newly developed tachyarrhythmias including atrial fibrillation and other paroxysmal tachyarrhythmias and 9732 matched (up to 1:5) controls were identified from 545,508 subjects without acute major cardiovascular events in the past year between January 1, 2011 and December 31, 2011. Conditional logistic regression analysis adjusted by comorbidities, cardiovascular drugs and healthcare utilization was performed. Results: In various multivariate models, the use of inhaled long-acting muscarinic antagonists (LAMAs) or longacting inhaled Î²2 agonists (LABAs) was significantly associated with tachyarrhythmias. Statistically significant effects of LAMAs on tachyarrhythmias were found only in the non-users of Î²-blockers. We did not find a statistically significant difference in the impact of a LABA without a LAMA vs a LAMA without a LABA (aOR, 0.93; 95% CI, 0.74-1.18), or a multiplicative or additive interaction between a LABA and a LAMA. Conclusions: Inhaled LAMAs and LABAs were significantly and comparably associated with an increased risk of tachyarrhythmias.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:109985080</affiliation-url><afid>109985080</afid><affilname>National Evidence-based Healthcare Collaborating Agency</affilname><name-variant>National Evidence-Based Healthcare Collaborating Agency</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021119</affiliation-url><afid>60021119</afid><affilname>Seoul National University Hospital</affilname><name-variant>Seoul National University Hospital</name-variant><affiliation-city>Jongno-gu</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115242129</affiliation-url><afid>115242129</afid><affilname>Real Estate R andD Institute</affilname><name-variant>Real Estate R andD Institute</name-variant><affiliation-city>Daegu</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000763</affiliation-url><afid>60000763</afid><affilname>Andong National University</affilname><name-variant>Andong National University</name-variant><affiliation-city>Andong</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60098516</affiliation-url><afid>60098516</afid><affilname>Seoul National University Bundang Hospital</affilname><name-variant>Seoul National University College of Medicine</name-variant><affiliation-city>Seongnam</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000656</affiliation-url><afid>60000656</afid><affilname>Seoul National University College of Medicine</affilname><name-variant>Seoul Natl. Univ. Coll. of Medicine</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">15</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56643334100</author-url><authid>56643334100</authid><authname>Lee C.</authname><surname>Lee</surname><given-name>Chang Hoon</given-name><initials>C.H.</initials><afid>109985080</afid><afid>60021119</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56643334100</author-url><authid>56643334100</authid><authname>Lee C.</authname><surname>Lee</surname><given-name>Chang Hoon</given-name><initials>C.H.</initials><afid>109985080</afid><afid>60021119</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56643441100</author-url><authid>56643441100</authid><authname>Choi S.</authname><surname>Choi</surname><given-name>Seongmi</given-name><initials>S.</initials><afid>109985080</afid><afid>115242129</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56643441100</author-url><authid>56643441100</authid><authname>Choi S.</authname><surname>Choi</surname><given-name>Seongmi</given-name><initials>S.</initials><afid>109985080</afid><afid>115242129</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56644128200</author-url><authid>56644128200</authid><authname>Jang E.</authname><surname>Jang</surname><given-name>Eun Jin</given-name><initials>E.J.</initials><afid>109985080</afid><afid>60000763</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56644128200</author-url><authid>56644128200</authid><authname>Jang E.</authname><surname>Jang</surname><given-name>Eun Jin</given-name><initials>E.J.</initials><afid>109985080</afid><afid>60000763</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56196225500</author-url><authid>56196225500</authid><authname>Yang H.</authname><surname>Yang</surname><given-name>Han Mo</given-name><initials>H.M.</initials><afid>60021119</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56612780100</author-url><authid>56612780100</authid><authname>Yoon H.</authname><surname>Yoon</surname><given-name>Ho Il</given-name><initials>H.I.</initials><afid>109985080</afid><afid>60098516</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56612780100</author-url><authid>56612780100</authid><authname>Yoon H.</authname><surname>Yoon</surname><given-name>Ho Il</given-name><initials>H.I.</initials><afid>109985080</afid><afid>60098516</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56643483100</author-url><authid>56643483100</authid><authname>Kim Y.</authname><surname>Kim</surname><given-name>Yun Jung</given-name><initials>Y.J.</initials><afid>109985080</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56644293100</author-url><authid>56644293100</authid><authname>Kim J.</authname><surname>Kim</surname><given-name>Jimin</given-name><initials>J.</initials><afid>109985080</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56664761600</author-url><authid>56664761600</authid><authname>Yim J.</authname><surname>Yim</surname><given-name>Jae Joon</given-name><initials>J.J.</initials><afid>109985080</afid><afid>60021119</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56664761600</author-url><authid>56664761600</authid><authname>Yim J.</authname><surname>Yim</surname><given-name>Jae Joon</given-name><initials>J.J.</initials><afid>109985080</afid><afid>60021119</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56352314800</author-url><authid>56352314800</authid><authname>Kim D.</authname><surname>Kim</surname><given-name>Deog Kyeom</given-name><initials>D.K.</initials><afid>109985080</afid><afid>60000656</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56352314800</author-url><authid>56352314800</authid><authname>Kim D.</authname><surname>Kim</surname><given-name>Deog Kyeom</given-name><initials>D.K.</initials><afid>109985080</afid><afid>60000656</afid></author><authkeywords>Inhaled muscarinic antagonists | Inhaled Î²2 agonists | Tachyarrhythmias</authkeywords><intid>1535945224</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84910133705"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84910133705?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84910133705&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84910133705&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915014012258"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84910133705</prism:url><dc:identifier>SCOPUS_ID:84910133705</dc:identifier><eid>2-s2.0-84910133705</eid><dc:title>Relationship between measures of central and general adiposity with aortic stiffness in the general population</dc:title><dc:creator>Wohlfahrt P.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>235</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>625-631</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2014.05.958</prism:doi><pii>S0021915014012258</pii><dc:description>Â© 2014 Elsevier Ireland Ltd. Objective: Increased aortic stiffness may be one of the mechanisms by which obesity increases cardiovascular risk independently of traditional risk factors. While body mass index (BMI) is generally used to define excess adiposity, several studies have suggested that measures of central obesity may be better predictors of cardiovascular risk. However, data comparing the association between several measures of central and general obesity with aortic stiffness in the general population are inconclusive. Methods: In 1031 individuals (age 53Â±13 years, 45% men) without manifest cardiovascular disease randomly selected from population, we tested the association between parameters of central obesity (waist circumference - WC, waist-to-hip-ratio - WHR, waist-to-height ratio - WHtR) and general obesity (BMI) with carotid-femoral pulse wave velocity (cfPWV). Results: In univariate analysis, WC and WHtR were more strongly associated with cfPWV than BMI in both genders, while WHR showed a stronger association with cfPWV only in women. WHtR was more closely associated with cfPVW than WHR. This difference between obesity measures remained after multivariate adjustment. When the fully adjusted hierarchical regression was used, among central obesity measures, WHtR had the largest additive value on top of BMI, while there was no additive value of BMI on top of WHtR. Conclusion: Central obesity parameters are more closely associated with aortic stiffness than BMI. Of central adiposity measures, WHtR has the strongest association with aortic stiffness beyond body mass index and cardiovascular risk factors. Our results suggest that WHtR may be the best anthropometric measure of excess adiposity in the general population.</dc:description><citedby-count>3</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005558</affiliation-url><afid>60005558</afid><affilname>Mayo Clinic</affilname><name-variant>Mayo Clinic</name-variant><affiliation-city>Rochester</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60068899</affiliation-url><afid>60068899</afid><affilname>St. Anne's University Hospital Brno</affilname><name-variant>St. Anne's University Hospital Brno</name-variant><affiliation-city>Brno</affiliation-city><affiliation-country>Czech Republic</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016605</affiliation-url><afid>60016605</afid><affilname>Charles University in Prague</affilname><name-variant>Charles University in Prague</name-variant><affiliation-city>Prague</affiliation-city><affiliation-country>Czech Republic</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020529</affiliation-url><afid>60020529</afid><affilname>Institutu Klinicke a Experimentalni Mediciny</affilname><name-variant>IKEM</name-variant><affiliation-city>Prague</affiliation-city><affiliation-country>Czech Republic</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016605</affiliation-url><afid>60016605</afid><affilname>Charles University in Prague</affilname><name-variant>Charles University in Prague</name-variant><affiliation-city>Prague</affiliation-city><affiliation-country>Czech Republic</affiliation-country></affiliation><pubmed-id>24968316</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">14</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:9232678100</author-url><authid>9232678100</authid><authname>Wohlfahrt P.</authname><surname>Wohlfahrt</surname><given-name>Peter</given-name><initials>P.</initials><afid>60005558</afid><afid>60068899</afid><afid>60016605</afid><afid>60020529</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:9232678100</author-url><authid>9232678100</authid><authname>Wohlfahrt P.</authname><surname>Wohlfahrt</surname><given-name>Peter</given-name><initials>P.</initials><afid>60005558</afid><afid>60068899</afid><afid>60016605</afid><afid>60020529</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:9232678100</author-url><authid>9232678100</authid><authname>Wohlfahrt P.</authname><surname>Wohlfahrt</surname><given-name>Peter</given-name><initials>P.</initials><afid>60005558</afid><afid>60068899</afid><afid>60016605</afid><afid>60020529</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:9232678100</author-url><authid>9232678100</authid><authname>Wohlfahrt P.</authname><surname>Wohlfahrt</surname><given-name>Peter</given-name><initials>P.</initials><afid>60005558</afid><afid>60068899</afid><afid>60016605</afid><afid>60020529</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7006121082</author-url><authid>7006121082</authid><authname>Somers V.</authname><surname>Somers</surname><given-name>Virend K.</given-name><initials>V.K.</initials><afid>60005558</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7004832017</author-url><authid>7004832017</authid><authname>Cifkova R.</authname><surname>Cifkova</surname><given-name>Renata</given-name><initials>R.</initials><afid>60068899</afid><afid>60016605</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7004832017</author-url><authid>7004832017</authid><authname>Cifkova R.</authname><surname>Cifkova</surname><given-name>Renata</given-name><initials>R.</initials><afid>60068899</afid><afid>60016605</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:12774824000</author-url><authid>12774824000</authid><authname>Filipovsky J.</authname><surname>Filipovsky</surname><given-name>Jan</given-name><initials>J.</initials><afid>60016605</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:14523754400</author-url><authid>14523754400</authid><authname>Seidlerova J.</authname><surname>Seidlerova</surname><given-name>Jitka</given-name><initials>J.</initials><afid>60016605</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:36015426500</author-url><authid>36015426500</authid><authname>Krajcoviechova A.</authname><surname>Krajcoviechova</surname><given-name>Alena</given-name><initials>A.</initials><afid>60016605</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:23993357300</author-url><authid>23993357300</authid><authname>Sochor O.</authname><surname>Sochor</surname><given-name>Ondrej</given-name><initials>O.</initials><afid>60005558</afid><afid>60068899</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:23993357300</author-url><authid>23993357300</authid><authname>Sochor O.</authname><surname>Sochor</surname><given-name>Ondrej</given-name><initials>O.</initials><afid>60005558</afid><afid>60068899</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6701817256</author-url><authid>6701817256</authid><authname>Kullo I.</authname><surname>Kullo</surname><given-name>Iftikhar J.</given-name><initials>I.J.</initials><afid>60005558</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:26643341500</author-url><authid>26643341500</authid><authname>Lopez-Jimenez F.</authname><surname>Lopez-Jimenez</surname><given-name>Francisco</given-name><initials>F.</initials><afid>60005558</afid></author><authkeywords>Aortic stiffness | Body mass index | Obesity | Pulse wave velocity | Waist circumference | Waist-to-height ratio | Waist-to-hip ratio</authkeywords><intid>32759059</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929167927"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929167927?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929167927&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929167927&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0014480015001057"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929167927</prism:url><dc:identifier>SCOPUS_ID:84929167927</dc:identifier><eid>2-s2.0-84929167927</eid><dc:title>Quantitative analysis of the expression of caspase 3 and caspase 9 in different types of atherosclerotic lesions in the human aorta</dc:title><dc:creator>Sobenin I.</dc:creator><prism:publicationName>Experimental and Molecular Pathology</prism:publicationName><prism:issn>00144800</prism:issn><prism:eIssn>10960945</prism:eIssn><prism:volume>99</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>1-6</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yexmp.2015.05.004</prism:doi><pii>S0014480015001057</pii><dc:description>Â© 2015 Elsevier Inc. The existing data on apoptotic processes in human atherosclerotic lesions is insufficient and is often contradictory. This study was undertaken to evaluate the levels of the expression of key apoptosis-related genes, namely, caspase 3 (CASP3) and caspase 9 (CASP9) in the normal (non-atherosclerotic) intima of the human aorta in comparison with those in different types of atherosclerotic lesions. Twenty-five autopsy samples of thoracic aorta were examined by polymerase chain reaction (PCR) analysis. The study revealed that the expressions of CASP3 and CASP9 genes were changed in different types of atherosclerotic lesions in course of the progression of the disease, but not in a unanimous way. The mRNA expression of CASP3 was found to be steadily decreasing with the progression of atherosclerosis while the expression of CASP9 showed a pattern which can be described as a "bell-shaped" relationship between gene mRNA expression and the type of atherosclerotic lesion, with the maximum being observed in fatty streaks. The fall in CASP3 expression may be associated with cellular senescence as well as with the domination of necrotic processes in atherosclerotic lesions, as shown by electron microscopic analysis. Our study provides novel quantitative data on the expression of CASP3 and CASP9 genes in different atherosclerotic lesions in the human aorta and thus, might assist in better understanding of the processes occurring during the development of lesions in human atherogenesis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60068670</affiliation-url><afid>60068670</afid><affilname>Russian Academy of Medical Sciences</affilname><name-variant>Russian Academy of Medical Sciences</name-variant><affiliation-city>Moscow</affiliation-city><affiliation-country>Russian Federation</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:105291195</affiliation-url><afid>105291195</afid><affilname>Russian Cardiology Research and Production Complex</affilname><name-variant>Russian Cardiology Research-and-Production Complex</name-variant><affiliation-city>Moscow</affiliation-city><affiliation-country>Russian Federation</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113225404</affiliation-url><afid>113225404</afid><affilname>Skolkovo Innovative Center</affilname><name-variant>Skolkovo Innovative Center</name-variant><affiliation-city>Moscow</affiliation-city><affiliation-country>Russian Federation</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028333</affiliation-url><afid>60028333</afid><affilname>University of New South Wales (UNSW) Australia</affilname><name-variant>University of New South Wales</name-variant><affiliation-city>Sydney</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017803</affiliation-url><afid>60017803</afid><affilname>University of Western Sydney</affilname><name-variant>University of Western Sydney</name-variant><affiliation-city>Penrith</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007457</affiliation-url><afid>60007457</afid><affilname>Lomonosov Moscow State University</affilname><name-variant>Moscow State University</name-variant><affiliation-city>Moscow</affiliation-city><affiliation-country>Russian Federation</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004029063</author-url><authid>7004029063</authid><authname>Sobenin I.</authname><surname>Sobenin</surname><given-name>Igor A.</given-name><initials>I.A.</initials><afid>60068670</afid><afid>105291195</afid><afid>113225404</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004029063</author-url><authid>7004029063</authid><authname>Sobenin I.</authname><surname>Sobenin</surname><given-name>Igor A.</given-name><initials>I.A.</initials><afid>60068670</afid><afid>105291195</afid><afid>113225404</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004029063</author-url><authid>7004029063</authid><authname>Sobenin I.</authname><surname>Sobenin</surname><given-name>Igor A.</given-name><initials>I.A.</initials><afid>60068670</afid><afid>105291195</afid><afid>113225404</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7006463929</author-url><authid>7006463929</authid><authname>Bobryshev Y.</authname><surname>Bobryshev</surname><given-name>Yuri V.</given-name><initials>Y.V.</initials><afid>60068670</afid><afid>60028333</afid><afid>60017803</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7006463929</author-url><authid>7006463929</authid><authname>Bobryshev Y.</authname><surname>Bobryshev</surname><given-name>Yuri V.</given-name><initials>Y.V.</initials><afid>60068670</afid><afid>60028333</afid><afid>60017803</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7006463929</author-url><authid>7006463929</authid><authname>Bobryshev Y.</authname><surname>Bobryshev</surname><given-name>Yuri V.</given-name><initials>Y.V.</initials><afid>60068670</afid><afid>60028333</afid><afid>60017803</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56641582500</author-url><authid>56641582500</authid><authname>Korobov G.</authname><surname>Korobov</surname><given-name>Gleb A.</given-name><initials>G.A.</initials><afid>60068670</afid><afid>113225404</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56641582500</author-url><authid>56641582500</authid><authname>Korobov G.</authname><surname>Korobov</surname><given-name>Gleb A.</given-name><initials>G.A.</initials><afid>60068670</afid><afid>113225404</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56641842700</author-url><authid>56641842700</authid><authname>Borodachev E.</authname><surname>Borodachev</surname><given-name>Evgeny N.</given-name><initials>E.N.</initials><afid>113225404</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7004078736</author-url><authid>7004078736</authid><authname>Postnov A.</authname><surname>Postnov</surname><given-name>Anton Y.</given-name><initials>A.Y.</initials><afid>105291195</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7102417184</author-url><authid>7102417184</authid><authname>Orekhov A.</authname><surname>Orekhov</surname><given-name>Alexander N.</given-name><initials>A.N.</initials><afid>60068670</afid><afid>113225404</afid><afid>60007457</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7102417184</author-url><authid>7102417184</authid><authname>Orekhov A.</authname><surname>Orekhov</surname><given-name>Alexander N.</given-name><initials>A.N.</initials><afid>60068670</afid><afid>113225404</afid><afid>60007457</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7102417184</author-url><authid>7102417184</authid><authname>Orekhov A.</authname><surname>Orekhov</surname><given-name>Alexander N.</given-name><initials>A.N.</initials><afid>60068670</afid><afid>113225404</afid><afid>60007457</afid></author><authkeywords>Apoptosis | Atherogenesis | Atherosclerosis | Caspase 3 | Caspase 9 | Electron microscopy | Gene expression | Necrosis | Polymerase chain reaction (PCR) analysis</authkeywords><intid>1785919460</intid><source-id>13247</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927782396"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927782396?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927782396&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927782396&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021999115001680"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927782396</prism:url><dc:identifier>SCOPUS_ID:84927782396</dc:identifier><eid>2-s2.0-84927782396</eid><dc:title>Numerical simulation of particle motion using a combined MacCormack and immersed boundary method</dc:title><dc:creator>Zhang P.</dc:creator><prism:publicationName>Journal of Computational Physics</prism:publicationName><prism:issn>00219991</prism:issn><prism:eIssn>10902716</prism:eIssn><prism:volume>294</prism:volume><prism:pageRange>524-546</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jcp.2015.03.021</prism:doi><pii>S0021999115001680</pii><dc:description>Â© 2015 Elsevier Inc. A numerical approach is presented for the direct numerical simulation of particle motion that combines the MacCormack scheme and the immersed boundary method. It exhibits the advantageous features of the explicit MacCormack scheme which is second-order accurate in time and space with simplicity in programing. The approach solves the compressible Navier-Stokes equations and uses the immersed boundary method to tackle the interactions between the fluid and the suspended particles. The force due to the interaction of two phases is computed via an elastic forcing method. The numerical approach is validated using uniform flow past a stationary circular cylinder, sedimentation of circular discs, and particle motion (orientation and translation) in unidirectional flows. Results are also compared to simulation obtained from a mixture model for solid particles for the same flow conditions.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031707</affiliation-url><afid>60031707</afid><affilname>Michigan State University</affilname><name-variant>Michigan State University</name-variant><affiliation-city>East Lansing</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56593951300</author-url><authid>56593951300</authid><authname>Zhang P.</authname><surname>Zhang</surname><given-name>P.</given-name><initials>P.</initials><afid>60031707</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56603287100</author-url><authid>56603287100</authid><authname>Benard A.</authname><surname>Benard</surname><given-name>A.</given-name><initials>A.</initials><afid>60031707</afid></author><authkeywords>DNS | Fluid-structure interaction | Immersed boundary method | MacCormack | Particle migration | Particulate flows</authkeywords><intid>1785666792</intid><source-id>13191</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84905822472"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84905822472?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84905822472&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84905822472&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915014011666"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84905822472</prism:url><dc:identifier>SCOPUS_ID:84905822472</dc:identifier><eid>2-s2.0-84905822472</eid><dc:title>Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: Results of the DYSlipidemia International Study (DYSIS)</dc:title><dc:creator>Zhao S.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>235</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>463-469</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2014.05.916</prism:doi><pii>S0021915014011666</pii><dc:description>Â© 2014 Elsevier Ireland Ltd. Background: Despite clear guideline recommendations, there is a paucity of data regarding the prevalence and type of persistent lipid profile abnormalities in patients on stable lipid-lowering therapy in China. Methods: This cross-sectional trial included 25,697 patients treated with lipid-lowering agents from 122 centres between April 2012 and October 2012; all underwent clinical examination and had their latest fasting lipid profiles while on lipid-lowering therapy recorded. Logistic regression was performed to assess predictors for lipid abnormalities classified according to current Chinese guidelines. Findings: Overall, 29.1% of patients had no lipid abnormalities, and 38.5% of patients did not achieve the therapeutic goal for low-density lipoprotein cholesterol (LDL-C), either as a single lipid anomaly or associated with low high-density lipoprotein cholesterol (HDL-C), elevated triglycerides, or both. Subjects with low risk were more likely than those with very high and high risk to be at target LDL-C levels. Furthermore, 10.4% of very high-risk patients and 11.1% of high-risk patients who attained the LDL-C goal failed to attain non-HDL-C goals. Diabetes was shown to be a strong predictor of failure in attaining non-HDL-C and both goals (OR 3.03; 3.22, 95% CI 2.58-3.55; 2.73-3.79, respectively). Conclusion: Although great improvements have been made over the past decade, the large majority of very high-risk and high-risk patients treated with lipid-lowing agents still had one or more manifestations of dyslipidaemia. Further clinical evidence is needed to clarify whether adding other lipid-lowering agents to a statin will be associated with additional cardiovascular risk reduction.</dc:description><citedby-count>3</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60082822</affiliation-url><afid>60082822</afid><affilname>Second Xiangya Hospital of Central-South University</affilname><name-variant>Central South University</name-variant><affiliation-city>Changsha</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026707</affiliation-url><afid>60026707</afid><affilname>Capital Medical University China</affilname><name-variant>Capital Medical University</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60088468</affiliation-url><afid>60088468</afid><affilname>China PLA General Hospital</affilname><name-variant>Chinese PLA General Hospital</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60088468</affiliation-url><afid>60088468</afid><affilname>China PLA General Hospital</affilname><name-variant>Chinese PLA General Hospital</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008706</affiliation-url><afid>60008706</afid><affilname>Peking Union Medical College</affilname><name-variant>Peking Union Medical College Hospital</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114757625</affiliation-url><afid>114757625</afid><affilname>The Peopleâs Hospital of Liaoning Province</affilname><name-variant>The People's Hospital of Liaoning Province</name-variant><affiliation-city>Liao Ning</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073652</affiliation-url><afid>60073652</afid><affilname>Tongji University</affilname><name-variant>Tongji University</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007995</affiliation-url><afid>60007995</afid><affilname>Merck &amp; Co., Inc.</affilname><name-variant>Merck Sharp and Dohme Research Laboratories</name-variant><affiliation-city>Readington</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014966</affiliation-url><afid>60014966</afid><affilname>Peking University</affilname><name-variant>Peking University</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><pubmed-id>24950001</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">212</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56488990800</author-url><authid>56488990800</authid><authname>Zhao S.</authname><surname>Zhao</surname><given-name>Shuiping</given-name><initials>S.</initials><afid>60082822</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56014555400</author-url><authid>56014555400</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Yongjun</given-name><initials>Y.</initials><afid>60026707</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56377131700</author-url><authid>56377131700</authid><authname>Mu Y.</authname><surname>Mu</surname><given-name>Yiming</given-name><initials>Y.</initials><afid>60088468</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56489165900</author-url><authid>56489165900</authid><authname>Yu B.</authname><surname>Yu</surname><given-name>Bilian</given-name><initials>B.</initials><afid>60088468</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56489714900</author-url><authid>56489714900</authid><authname>Ye P.</authname><surname>Ye</surname><given-name>Ping</given-name><initials>P.</initials><afid>60088468</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56489027200</author-url><authid>56489027200</authid><authname>Yan X.</authname><surname>Yan</surname><given-name>Xiaowei</given-name><initials>X.</initials><afid>60008706</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56271623900</author-url><authid>56271623900</authid><authname>Li Z.</authname><surname>Li</surname><given-name>Zhanquan</given-name><initials>Z.</initials><afid>114757625</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56488940500</author-url><authid>56488940500</authid><authname>Wei Y.</authname><surname>Wei</surname><given-name>Yidong</given-name><initials>Y.</initials><afid>60073652</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56272544700</author-url><authid>56272544700</authid><authname>Ambegaonakr B.</authname><surname>Ambegaonakr</surname><given-name>Baishaili M.</given-name><initials>B.M.</initials><afid>60007995</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7402585148</author-url><authid>7402585148</authid><authname>Hu D.</authname><surname>Hu</surname><given-name>Dayi</given-name><initials>D.</initials><afid>60014966</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56271580700</author-url><authid>56271580700</authid><authname>Er B.</authname><surname>Er</surname><given-name>Bu Ai Jia</given-name><initials>B.A.J.</initials></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56271362200</author-url><authid>56271362200</authid><authname>Guiwen C.</authname><surname>Guiwen</surname><given-name>Cao</given-name><initials>C.</initials></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:56272842300</author-url><authid>56272842300</authid><authname>Buxing C.</authname><surname>Buxing</surname><given-name>Chen</given-name><initials>C.</initials></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:56272516600</author-url><authid>56272516600</authid><authname>Hong C.</authname><surname>Hong</surname><given-name>Chen</given-name><initials>C.</initials></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:56271901600</author-url><authid>56271901600</authid><authname>Jin C.</authname><surname>Jin</surname><given-name>Chen</given-name><initials>C.</initials></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:56271601500</author-url><authid>56271601500</authid><authname>Jing C.</authname><surname>Jing</surname><given-name>Chen</given-name><initials>C.</initials></author><author seq="17"><author-url>http://api.elsevier.com/content/author/author_id:56271679900</author-url><authid>56271679900</authid><authname>Liefeng C.</authname><surname>Liefeng</surname><given-name>Chen</given-name><initials>C.</initials></author><author seq="18"><author-url>http://api.elsevier.com/content/author/author_id:56272158400</author-url><authid>56272158400</authid><authname>Min C.</authname><surname>Min</surname><given-name>Chen</given-name><initials>C.</initials></author><author seq="19"><author-url>http://api.elsevier.com/content/author/author_id:56272006200</author-url><authid>56272006200</authid><authname>Qiong C.</authname><surname>Qiong</surname><given-name>Chen</given-name><initials>C.</initials></author><author seq="20"><author-url>http://api.elsevier.com/content/author/author_id:56272703000</author-url><authid>56272703000</authid><authname>Shaoliang C.</authname><surname>Shaoliang</surname><given-name>Chen</given-name><initials>C.</initials></author><author seq="21"><author-url>http://api.elsevier.com/content/author/author_id:56272362800</author-url><authid>56272362800</authid><authname>Tielong C.</authname><surname>Tielong</surname><given-name>Chen</given-name><initials>C.</initials></author><author seq="22"><author-url>http://api.elsevier.com/content/author/author_id:24336822200</author-url><authid>24336822200</authid><authname>Xiaofei C.</authname><surname>Xiaofei</surname><given-name>Chen</given-name><initials>C.</initials></author><author seq="23"><author-url>http://api.elsevier.com/content/author/author_id:6602584707</author-url><authid>6602584707</authid><authname>Xiaohong C.</authname><surname>Xiaohong</surname><given-name>Chen</given-name><initials>C.</initials></author><author seq="24"><author-url>http://api.elsevier.com/content/author/author_id:56272777200</author-url><authid>56272777200</authid><authname>You C.</authname><surname>You</surname><given-name>Chen</given-name><initials>C.</initials></author><author seq="25"><author-url>http://api.elsevier.com/content/author/author_id:56271542100</author-url><authid>56271542100</authid><authname>Guoli C.</authname><surname>Guoli</surname><given-name>Cheng</given-name><initials>C.</initials></author><author seq="26"><author-url>http://api.elsevier.com/content/author/author_id:56271635200</author-url><authid>56271635200</authid><authname>Mei C.</authname><surname>Mei</surname><given-name>Cheng</given-name><initials>C.</initials></author><author seq="27"><author-url>http://api.elsevier.com/content/author/author_id:56272869100</author-url><authid>56272869100</authid><authname>Hongliang C.</authname><surname>Hongliang</surname><given-name>Cong</given-name><initials>C.</initials></author><author seq="28"><author-url>http://api.elsevier.com/content/author/author_id:56272665300</author-url><authid>56272665300</authid><authname>Qin C.</authname><surname>Qin</surname><given-name>Cui</given-name><initials>C.</initials></author><author seq="29"><author-url>http://api.elsevier.com/content/author/author_id:56272187500</author-url><authid>56272187500</authid><authname>Shiwei C.</authname><surname>Shiwei</surname><given-name>Cui</given-name><initials>C.</initials></author><author seq="30"><author-url>http://api.elsevier.com/content/author/author_id:56272641000</author-url><authid>56272641000</authid><authname>Yong C.</authname><surname>Yong</surname><given-name>Cui</given-name><initials>C.</initials></author><author seq="31"><author-url>http://api.elsevier.com/content/author/author_id:56271560800</author-url><authid>56271560800</authid><authname>Shudong D.</authname><surname>Shudong</surname><given-name>Dai</given-name><initials>D.</initials></author><author seq="32"><author-url>http://api.elsevier.com/content/author/author_id:56272726700</author-url><authid>56272726700</authid><authname>Henghua D.</authname><surname>Henghua</surname><given-name>Dai</given-name><initials>D.</initials></author><author seq="33"><author-url>http://api.elsevier.com/content/author/author_id:55844425500</author-url><authid>55844425500</authid><authname>Xiaomei D.</authname><surname>Xiaomei</surname><given-name>Deng</given-name><initials>D.</initials></author><author seq="34"><author-url>http://api.elsevier.com/content/author/author_id:56271932200</author-url><authid>56271932200</authid><authname>Yirong D.</authname><surname>Yirong</surname><given-name>Di</given-name><initials>D.</initials></author><author seq="35"><author-url>http://api.elsevier.com/content/author/author_id:56090231200</author-url><authid>56090231200</authid><authname>Xiaoyan D.</authname><surname>Xiaoyan</surname><given-name>Ding</given-name><initials>D.</initials></author><author seq="36"><author-url>http://api.elsevier.com/content/author/author_id:8276249100</author-url><authid>8276249100</authid><authname>Birong D.</authname><surname>Birong</surname><given-name>Dong</given-name><initials>D.</initials></author><author seq="37"><author-url>http://api.elsevier.com/content/author/author_id:56271900800</author-url><authid>56271900800</authid><authname>Yumei D.</authname><surname>Yumei</surname><given-name>Dong</given-name><initials>D.</initials></author><author seq="38"><author-url>http://api.elsevier.com/content/author/author_id:24722272500</author-url><authid>24722272500</authid><authname>Yugang D.</authname><surname>Yugang</surname><given-name>Dong</given-name><initials>D.</initials></author><author seq="39"><author-url>http://api.elsevier.com/content/author/author_id:56273186500</author-url><authid>56273186500</authid><authname>Ping D.</authname><surname>Ping</surname><given-name>Du</given-name><initials>D.</initials></author><author seq="40"><author-url>http://api.elsevier.com/content/author/author_id:56272320900</author-url><authid>56272320900</authid><authname>Lei D.</authname><surname>Lei</surname><given-name>Duan</given-name><initials>D.</initials></author><author seq="41"><author-url>http://api.elsevier.com/content/author/author_id:56272380300</author-url><authid>56272380300</authid><authname>Limei F.</authname><surname>Limei</surname><given-name>Fan</given-name><initials>F.</initials></author><author seq="42"><author-url>http://api.elsevier.com/content/author/author_id:56271339300</author-url><authid>56271339300</authid><authname>Ningyuan F.</authname><surname>Ningyuan</surname><given-name>Fang</given-name><initials>F.</initials></author><author seq="43"><author-url>http://api.elsevier.com/content/author/author_id:56272739300</author-url><authid>56272739300</authid><authname>Lixia F.</authname><surname>Lixia</surname><given-name>Fei</given-name><initials>F.</initials></author><author seq="44"><author-url>http://api.elsevier.com/content/author/author_id:56272359000</author-url><authid>56272359000</authid><authname>Lie F.</authname><surname>Lie</surname><given-name>Feng</given-name><initials>F.</initials></author><author seq="45"><author-url>http://api.elsevier.com/content/author/author_id:56272058100</author-url><authid>56272058100</authid><authname>Jun G.</authname><surname>Jun</surname><given-name>Ge</given-name><initials>G.</initials></author><author seq="46"><author-url>http://api.elsevier.com/content/author/author_id:56491338400</author-url><authid>56491338400</authid><authname>GeWeihong </authname><surname>GeWeihong</surname><given-name/><initials/></author><author seq="47"><author-url>http://api.elsevier.com/content/author/author_id:56272294900</author-url><authid>56272294900</authid><authname>Hongmin G.</authname><surname>Hongmin</surname><given-name>Guo</given-name><initials>G.</initials></author><author seq="48"><author-url>http://api.elsevier.com/content/author/author_id:56272705300</author-url><authid>56272705300</authid><authname>Minxia G.</authname><surname>Minxia</surname><given-name>Guo</given-name><initials>G.</initials></author><author seq="49"><author-url>http://api.elsevier.com/content/author/author_id:56271359500</author-url><authid>56271359500</authid><authname>Qinghua H.</authname><surname>Qinghua</surname><given-name>Han</given-name><initials>H.</initials></author><author seq="50"><author-url>http://api.elsevier.com/content/author/author_id:56272947500</author-url><authid>56272947500</authid><authname>Fengchang H.</authname><surname>Fengchang</surname><given-name>He</given-name><initials>H.</initials></author><author seq="51"><author-url>http://api.elsevier.com/content/author/author_id:55665681400</author-url><authid>55665681400</authid><authname>Dayi H.</authname><surname>Dayi</surname><given-name>Hu</given-name><initials>H.</initials></author><author seq="52"><author-url>http://api.elsevier.com/content/author/author_id:6507332264</author-url><authid>6507332264</authid><authname>Lingzhi H.</authname><surname>Lingzhi</surname><given-name>Hu</given-name><initials>H.</initials></author><author seq="53"><author-url>http://api.elsevier.com/content/author/author_id:6507949234</author-url><authid>6507949234</authid><authname>Xueqiang H.</authname><surname>Xueqiang</surname><given-name>Hu</given-name><initials>H.</initials></author><author seq="54"><author-url>http://api.elsevier.com/content/author/author_id:56272358400</author-url><authid>56272358400</authid><authname>Yaojun H.</authname><surname>Yaojun</surname><given-name>Hu</given-name><initials>H.</initials></author><author seq="55"><author-url>http://api.elsevier.com/content/author/author_id:56177752700</author-url><authid>56177752700</authid><authname>Yiming H.</authname><surname>Yiming</surname><given-name>Hu</given-name><initials>H.</initials></author><author seq="56"><author-url>http://api.elsevier.com/content/author/author_id:56271371100</author-url><authid>56271371100</authid><authname>Zhiping H.</authname><surname>Zhiping</surname><given-name>Hu</given-name><initials>H.</initials></author><author seq="57"><author-url>http://api.elsevier.com/content/author/author_id:56272869700</author-url><authid>56272869700</authid><authname>Fei H.</authname><surname>Fei</surname><given-name>Hua</given-name><initials>H.</initials></author><author seq="58"><author-url>http://api.elsevier.com/content/author/author_id:56272379900</author-url><authid>56272379900</authid><authname>Qi H.</authname><surname>Qi</surname><given-name>Hua</given-name><initials>H.</initials></author><author seq="59"><author-url>http://api.elsevier.com/content/author/author_id:6505834284</author-url><authid>6505834284</authid><authname>Dejia H.</authname><surname>Dejia</surname><given-name>Huang</given-name><initials>H.</initials></author><author seq="60"><author-url>http://api.elsevier.com/content/author/author_id:56272522300</author-url><authid>56272522300</authid><authname>Gewen H.</authname><surname>Gewen</surname><given-name>Huang</given-name><initials>H.</initials></author><author seq="61"><author-url>http://api.elsevier.com/content/author/author_id:56272019700</author-url><authid>56272019700</authid><authname>Hongman H.</authname><surname>Hongman</surname><given-name>Huang</given-name><initials>H.</initials></author><author seq="62"><author-url>http://api.elsevier.com/content/author/author_id:56273182600</author-url><authid>56273182600</authid><authname>Liming H.</authname><surname>Liming</surname><given-name>Huang</given-name><initials>H.</initials></author><author seq="63"><author-url>http://api.elsevier.com/content/author/author_id:35099608900</author-url><authid>35099608900</authid><authname>Qiong H.</authname><surname>Qiong</surname><given-name>Huang</given-name><initials>H.</initials></author><author seq="64"><author-url>http://api.elsevier.com/content/author/author_id:56272596900</author-url><authid>56272596900</authid><authname>Ruowen H.</authname><surname>Ruowen</surname><given-name>Huang</given-name><initials>H.</initials></author><author seq="65"><author-url>http://api.elsevier.com/content/author/author_id:56271403500</author-url><authid>56271403500</authid><authname>Taifu H.</authname><surname>Taifu</surname><given-name>Huang</given-name><initials>H.</initials></author><author seq="66"><author-url>http://api.elsevier.com/content/author/author_id:56272583500</author-url><authid>56272583500</authid><authname>Bin J.</authname><surname>Bin</surname><given-name>Jiang</given-name><initials>J.</initials></author><author seq="67"><author-url>http://api.elsevier.com/content/author/author_id:56271771400</author-url><authid>56271771400</authid><authname>Kai J.</authname><surname>Kai</surname><given-name>Jiao</given-name><initials>J.</initials></author><author seq="68"><author-url>http://api.elsevier.com/content/author/author_id:56272371500</author-url><authid>56272371500</authid><authname>Hui J.</authname><surname>Hui</surname><given-name>Jin</given-name><initials>J.</initials></author><author seq="69"><author-url>http://api.elsevier.com/content/author/author_id:56271781600</author-url><authid>56271781600</authid><authname>Huigen J.</authname><surname>Huigen</surname><given-name>Jin</given-name><initials>J.</initials></author><author seq="70"><author-url>http://api.elsevier.com/content/author/author_id:56272454700</author-url><authid>56272454700</authid><authname>Jinsong K.</authname><surname>Jinsong</surname><given-name>Kuang</given-name><initials>K.</initials></author><author seq="71"><author-url>http://api.elsevier.com/content/author/author_id:56272403700</author-url><authid>56272403700</authid><authname>Bao L.</authname><surname>Bao</surname><given-name>Li</given-name><initials>L.</initials></author><author seq="72"><author-url>http://api.elsevier.com/content/author/author_id:56272162500</author-url><authid>56272162500</authid><authname>Chengjiang L.</authname><surname>Chengjiang</surname><given-name>Li</given-name><initials>L.</initials></author><author seq="73"><author-url>http://api.elsevier.com/content/author/author_id:14060223500</author-url><authid>14060223500</authid><authname>Hongjuan L.</authname><surname>Hongjuan</surname><given-name>Li</given-name><initials>L.</initials></author><author seq="74"><author-url>http://api.elsevier.com/content/author/author_id:23976177900</author-url><authid>23976177900</authid><authname>Li Jun X.</authname><surname>Li Jun</surname><given-name>Xinjiang</given-name><initials>X.</initials></author><author seq="75"><author-url>http://api.elsevier.com/content/author/author_id:56491001900</author-url><authid>56491001900</authid><authname>Li Jun J.</authname><surname>Li Jun</surname><given-name>Jiangsu</given-name><initials>J.</initials></author><author seq="76"><author-url>http://api.elsevier.com/content/author/author_id:36610607200</author-url><authid>36610607200</authid><authname>Nanfang L.</authname><surname>Nanfang</surname><given-name>Li</given-name><initials>L.</initials></author><author seq="77"><author-url>http://api.elsevier.com/content/author/author_id:36913425100</author-url><authid>36913425100</authid><authname>Qifu L.</authname><surname>Qifu</surname><given-name>Li</given-name><initials>L.</initials></author><author seq="78"><author-url>http://api.elsevier.com/content/author/author_id:56271775700</author-url><authid>56271775700</authid><authname>Qiang L.</authname><surname>Qiang</surname><given-name>Li</given-name><initials>L.</initials></author><author seq="79"><author-url>http://api.elsevier.com/content/author/author_id:56272600400</author-url><authid>56272600400</authid><authname>Xin L.</authname><surname>Xin</surname><given-name>Li</given-name><initials>L.</initials></author><author seq="80"><author-url>http://api.elsevier.com/content/author/author_id:56272567900</author-url><authid>56272567900</authid><authname>Xueyou L.</authname><surname>Xueyou</surname><given-name>Li</given-name><initials>L.</initials></author><author seq="81"><author-url>http://api.elsevier.com/content/author/author_id:56263374100</author-url><authid>56263374100</authid><authname>Yanbing L.</authname><surname>Yanbing</surname><given-name>Li</given-name><initials>L.</initials></author><author seq="82"><author-url>http://api.elsevier.com/content/author/author_id:56490554800</author-url><authid>56490554800</authid><authname>Yanping L.</authname><surname>Yanping</surname><given-name>Li</given-name><initials>L.</initials></author><author seq="83"><author-url>http://api.elsevier.com/content/author/author_id:56272583800</author-url><authid>56272583800</authid><authname>Yansheng L.</authname><surname>Yansheng</surname><given-name>Li</given-name><initials>L.</initials></author><author seq="84"><author-url>http://api.elsevier.com/content/author/author_id:56271468700</author-url><authid>56271468700</authid><authname>Yong L.</authname><surname>Yong</surname><given-name>Li</given-name><initials>L.</initials></author><author seq="85"><author-url>http://api.elsevier.com/content/author/author_id:56271944500</author-url><authid>56271944500</authid><authname>Yuling L.</authname><surname>Yuling</surname><given-name>Li</given-name><initials>L.</initials></author><author seq="86"><author-url>http://api.elsevier.com/content/author/author_id:56271321000</author-url><authid>56271321000</authid><authname>Zhanquan L.</authname><surname>Zhanquan</surname><given-name>Li</given-name><initials>L.</initials></author><author seq="87"><author-url>http://api.elsevier.com/content/author/author_id:6504186704</author-url><authid>6504186704</authid><authname>Zhengfang L.</authname><surname>Zhengfang</surname><given-name>Li</given-name><initials>L.</initials></author><author seq="88"><author-url>http://api.elsevier.com/content/author/author_id:56271453300</author-url><authid>56271453300</authid><authname>Li L.</authname><surname>Li</surname><given-name>Liang</given-name><initials>L.</initials></author><author seq="89"><author-url>http://api.elsevier.com/content/author/author_id:56272061800</author-url><authid>56272061800</authid><authname>Yongxue L.</authname><surname>Yongxue</surname><given-name>Liang</given-name><initials>L.</initials></author><author seq="90"><author-url>http://api.elsevier.com/content/author/author_id:56272901000</author-url><authid>56272901000</authid><authname>Zerong L.</authname><surname>Zerong</surname><given-name>Liang</given-name><initials>L.</initials></author><author seq="91"><author-url>http://api.elsevier.com/content/author/author_id:35081415700</author-url><authid>35081415700</authid><authname>Yuhua L.</authname><surname>Yuhua</surname><given-name>Liao</given-name><initials>L.</initials></author><author seq="92"><author-url>http://api.elsevier.com/content/author/author_id:56271400200</author-url><authid>56271400200</authid><authname>Fan L.</authname><surname>Fan</surname><given-name>Liu</given-name><initials>L.</initials></author><author seq="93"><author-url>http://api.elsevier.com/content/author/author_id:56271721100</author-url><authid>56271721100</authid><authname>Hong L.</authname><surname>Hong</surname><given-name>Liu</given-name><initials>L.</initials></author><author seq="94"><author-url>http://api.elsevier.com/content/author/author_id:56271490400</author-url><authid>56271490400</authid><authname>Hui L.</authname><surname>Hui</surname><given-name>Liu</given-name><initials>L.</initials></author><author seq="95"><author-url>http://api.elsevier.com/content/author/author_id:26030010700</author-url><authid>26030010700</authid><authname>Minling L.</authname><surname>Minling</surname><given-name>Liu</given-name><initials>L.</initials></author><author seq="96"><author-url>http://api.elsevier.com/content/author/author_id:56271778800</author-url><authid>56271778800</authid><authname>Qiang L.</authname><surname>Qiang</surname><given-name>Liu</given-name><initials>L.</initials></author><author seq="97"><author-url>http://api.elsevier.com/content/author/author_id:35146733900</author-url><authid>35146733900</authid><authname>Qingsong L.</authname><surname>Qingsong</surname><given-name>Liu</given-name><initials>L.</initials></author><author seq="98"><author-url>http://api.elsevier.com/content/author/author_id:56271492600</author-url><authid>56271492600</authid><authname>Shaokui L.</authname><surname>Shaokui</surname><given-name>Liu</given-name><initials>L.</initials></author><author seq="99"><author-url>http://api.elsevier.com/content/author/author_id:56490482300</author-url><authid>56490482300</authid><authname>Weidong L.</authname><surname>Weidong</surname><given-name>Liu</given-name><initials>L.</initials></author><author seq="100"><author-url>http://api.elsevier.com/content/author/author_id:21744384800</author-url><authid>21744384800</authid><authname>Xueping L.</authname><surname>Xueping</surname><given-name>Liu</given-name><initials>L.</initials></author><message>Author list of 212 truncated at 100; retrieve the full abstract for a complete list of authors.</message><authkeywords>Cardiovascular diseases | Dyslipidaemia | LDL cholesterol | Lipid-lowering agents | Non-HDL cholesterol | Statin</authkeywords><intid>32040177</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84921505006"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84921505006?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84921505006&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84921505006&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915014012118"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84921505006</prism:url><dc:identifier>SCOPUS_ID:84921505006</dc:identifier><eid>2-s2.0-84921505006</eid><dc:title>Niacin decreases leukocyte myeloperoxidase: Mechanistic role of redox agents and Src/p38MAP kinase</dc:title><dc:creator>Ganji S.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>235</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>554-561</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2014.05.948</prism:doi><pii>S0021915014012118</pii><dc:description>Â© 2014 Elsevier Ireland Ltd. Objectives: Leukocyte myeloperoxidase (MPO) is a major player in the pathogenesis of various chronic diseases including atherosclerosis. This study proposes the novel concept that niacin, through reactive oxygen species (ROS)-mediated signaling, decreases neutrophil MPO release and its activity, protects apolipoprotein-AI (apo-AI) modification and improves HDL function. Methods: Human blood leukocytes and leukocytic cell line HL-60 cells were treated with niacin, and stimulated with phorbol myristate acetate (PMA). Cellular and released MPO activity in the medium was measured by assessing chlorination of MPO-specific substrate. MPO protein release in the medium and apo-AI degradation was measured by Western blot analysis. Monocyte adhesion to human aortic primary endothelial cells was measured to assess biological function of HDL/apo-AI. Results: PMA significantly increased leukocyte MPO activity in both intracellular extract and medium. Niacin (0.25-0.5mM) decreased PMA-induced MPO activity (cellular and released in the media). Niacin also decreased MPO protein mass in the medium without affecting its mRNA expression. Increased NADPH oxidase and ROS production by PMA were also significantly inhibited by niacin. Studies with specific inhibitors suggest that ROS-dependent Src and p38MAP kinase mediate decreased MPO activity by niacin. Niacin blocked apo-AI degradation, and apo-AI from niacin treated cells decreased monocyte adhesion to aortic endothelial cells. Conclusions: These findings identify niacin as a potent inhibitor of leukocyte MPO release and MPO-mediated formation of dysfunctional HDL. Niacin and niacin-related chemical entities may form important therapeutic agents for MPO-mediated inflammatory diseases.</dc:description><citedby-count>1</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014232</affiliation-url><afid>60014232</afid><affilname>VA Medical Center</affilname><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007278</affiliation-url><afid>60007278</afid><affilname>UC Irvine</affilname><name-variant>University of California, Irvine</name-variant><affiliation-city>Irvine</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><pubmed-id>24956528</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6701401111</author-url><authid>6701401111</authid><authname>Ganji S.</authname><surname>Ganji</surname><given-name>Shobha H.</given-name><initials>S.H.</initials><afid>60014232</afid><afid>60007278</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6701401111</author-url><authid>6701401111</authid><authname>Ganji S.</authname><surname>Ganji</surname><given-name>Shobha H.</given-name><initials>S.H.</initials><afid>60014232</afid><afid>60007278</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004251880</author-url><authid>7004251880</authid><authname>Kamanna V.</authname><surname>Kamanna</surname><given-name>Vaijinath S.</given-name><initials>V.S.</initials><afid>60014232</afid><afid>60007278</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004251880</author-url><authid>7004251880</authid><authname>Kamanna V.</authname><surname>Kamanna</surname><given-name>Vaijinath S.</given-name><initials>V.S.</initials><afid>60014232</afid><afid>60007278</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005970960</author-url><authid>7005970960</authid><authname>Kashyap M.</authname><surname>Kashyap</surname><given-name>Moti L.</given-name><initials>M.L.</initials><afid>60014232</afid><afid>60007278</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005970960</author-url><authid>7005970960</authid><authname>Kashyap M.</authname><surname>Kashyap</surname><given-name>Moti L.</given-name><initials>M.L.</initials><afid>60014232</afid><afid>60007278</afid></author><authkeywords>Apolipoprotein AI | Atherosclerosis | High density lipoproteins | Myeloperoxidase | Niacin</authkeywords><intid>34652568</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929376992"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929376992?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929376992&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929376992&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006841"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929376992</prism:url><dc:identifier>SCOPUS_ID:84929376992</dc:identifier><eid>2-s2.0-84929376992</eid><dc:title>Complete atrioventricular block can be a long-term complication of radiation therapy</dc:title><dc:creator>Cucunato M.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>676-677</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.421</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115241677</affiliation-url><afid>115241677</afid><affilname>Endoscopy and Gastroenterology</affilname><name-variant>Endoscopy and Gastroenterology</name-variant><affiliation-city>Messina</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112960721</affiliation-url><afid>112960721</afid><affilname>Papardo-Piemonte Hospital</affilname><name-variant>Papardo-Piemonte Hospital</name-variant><affiliation-city>Messina</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644998900</author-url><authid>56644998900</authid><authname>Cucunato M.</authname><surname>Cucunato</surname><given-name>M.</given-name><initials>M.</initials><afid>115241677</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56641835700</author-url><authid>56641835700</authid><authname>CannavÃ  G.</authname><surname>CannavÃ </surname><given-name>G.</given-name><initials>G.</initials><afid>112960721</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:23982063600</author-url><authid>23982063600</authid><authname>CurrÃ² A.</authname><surname>CurrÃ²</surname><given-name>Alessio</given-name><initials>A.</initials><afid>115241677</afid><afid>112960721</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:23982063600</author-url><authid>23982063600</authid><authname>CurrÃ² A.</authname><surname>CurrÃ²</surname><given-name>Alessio</given-name><initials>A.</initials><afid>115241677</afid><afid>112960721</afid></author><authkeywords>Hodgkin lymphoma | Pacemaker | Radiotherapy | Third degree atrioventricular block</authkeywords><intid>1535944494</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929340086"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929340086?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929340086&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929340086&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006014"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929340086</prism:url><dc:identifier>SCOPUS_ID:84929340086</dc:identifier><eid>2-s2.0-84929340086</eid><dc:title>Is the use of risk scores an indicator of guideline adherence for patients with acute coronary syndromes? Insights from the EYESHOT registry</dc:title><dc:creator>De Luca L.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>80-83</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.343</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60103314</affiliation-url><afid>60103314</afid><affilname>European Hospital</affilname><name-variant>European Hospital</name-variant><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026556</affiliation-url><afid>60026556</afid><affilname>Fondazione IRCCS Policlinico San Matteo</affilname><name-variant>IRCCS Policlinico S. Matteo</name-variant><affiliation-city>Pavia</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003882</affiliation-url><afid>60003882</afid><affilname>Azienda Complesso Ospedaliero San Filippo Neri</affilname><name-variant>S. Filippo Neri Hospital</name-variant><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100314667</affiliation-url><afid>100314667</afid><affilname>ANMCO Research Center</affilname><name-variant>ANMCO Research Centre</name-variant><affiliation-city>Florence</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017293</affiliation-url><afid>60017293</afid><affilname>Universita degli Studi di Napoli Federico II</affilname><name-variant>University of Naples Federico II</name-variant><affiliation-city>Naples</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100336270</affiliation-url><afid>100336270</afid><affilname>Ospedale Civile dell'Annunziata</affilname><name-variant>Ospedale Civile dell'Annunziata</name-variant><affiliation-city>Cosenza</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019304</affiliation-url><afid>60019304</afid><affilname>Ospedale V. Cervello</affilname><name-variant>Ospedale V. Cervello</name-variant><affiliation-city>Palermo</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112932363</affiliation-url><afid>112932363</afid><affilname>Garibaldi-Nesima Hospital</affilname><name-variant>Garibaldi Nesima Hospital</name-variant><affiliation-city>Catania</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7201912322</author-url><authid>7201912322</authid><authname>De Luca L.</authname><surname>De Luca</surname><given-name>Leonardo</given-name><initials>L.</initials><afid>60103314</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36059439800</author-url><authid>36059439800</authid><authname>Leonardi S.</authname><surname>Leonardi</surname><given-name>Sergio</given-name><initials>S.</initials><afid>60026556</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7004208329</author-url><authid>7004208329</authid><authname>Tubaro M.</authname><surname>Tubaro</surname><given-name>Marco</given-name><initials>M.</initials><afid>60003882</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6506024547</author-url><authid>6506024547</authid><authname>Gonzini L.</authname><surname>Gonzini</surname><given-name>Lucio</given-name><initials>L.</initials><afid>100314667</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6701559007</author-url><authid>6701559007</authid><authname>Lucci D.</authname><surname>Lucci</surname><given-name>Donata</given-name><initials>D.</initials><afid>100314667</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7103084272</author-url><authid>7103084272</authid><authname>Trimarco B.</authname><surname>Trimarco</surname><given-name>Bruno</given-name><initials>B.</initials><afid>60017293</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7004116262</author-url><authid>7004116262</authid><authname>Misuraca G.</authname><surname>Misuraca</surname><given-name>Gianfranco</given-name><initials>G.</initials><afid>100336270</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7004691292</author-url><authid>7004691292</authid><authname>Ledda A.</authname><surname>Ledda</surname><given-name>Antonietta</given-name><initials>A.</initials><afid>60019304</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:6602178489</author-url><authid>6602178489</authid><authname>Gulizia M.</authname><surname>Gulizia</surname><given-name>Michele Massimo</given-name><initials>M.M.</initials><afid>112932363</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7005676518</author-url><authid>7005676518</authid><authname>De Servi S.</authname><surname>De Servi</surname><given-name>Stefano</given-name><initials>S.</initials><afid>60026556</afid></author><authkeywords>Acute coronary syndromes | Antithrombotic therapy | CRUSADE | GRACE | Guidelines | Risk stratification</authkeywords><intid>1535944542</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929338051"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929338051?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929338051&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929338051&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007019"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929338051</prism:url><dc:identifier>SCOPUS_ID:84929338051</dc:identifier><eid>2-s2.0-84929338051</eid><dc:title>Reasons for non-adherence to practice guidelines on stroke prevention in patients with atrial fibrillation a cross-sectional study in primary care</dc:title><dc:creator>Van Doorn S.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>525-526</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.429</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032724</affiliation-url><afid>60032724</afid><affilname>University Medical Center Utrecht</affilname><name-variant>University Medical Center Utrecht</name-variant><affiliation-city>Utrecht</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55041707600</author-url><authid>55041707600</authid><authname>Van Doorn S.</authname><surname>Van Doorn</surname><given-name>Sander</given-name><initials>S.</initials><afid>60032724</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644834900</author-url><authid>56644834900</authid><authname>Hartman-Weide F.</authname><surname>Hartman-Weide</surname><given-name>Floor</given-name><initials>F.</initials><afid>60032724</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6504570020</author-url><authid>6504570020</authid><authname>Geersing G.</authname><surname>Geersing</surname><given-name>Geert Jan</given-name><initials>G.J.</initials><afid>60032724</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8529889900</author-url><authid>8529889900</authid><authname>Oudega R.</authname><surname>Oudega</surname><given-name>Ruud</given-name><initials>R.</initials><afid>60032724</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35370614300</author-url><authid>35370614300</authid><authname>Hoes A.</authname><surname>Hoes</surname><given-name>Arno W.</given-name><initials>A.W.</initials><afid>60032724</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7005091114</author-url><authid>7005091114</authid><authname>Rutten F.</authname><surname>Rutten</surname><given-name>Frans H.</given-name><initials>F.H.</initials><afid>60032724</afid></author><authkeywords>Anticoagulation | Atrial fibrillation | General practice | Guideline adherence</authkeywords><intid>2035941128</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928403143"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928403143?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928403143&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928403143&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0165032715002104"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928403143</prism:url><dc:identifier>SCOPUS_ID:84928403143</dc:identifier><eid>2-s2.0-84928403143</eid><dc:title>Moderation of antidepressant and placebo outcomes by baseline severity in late-life depression: A systematic review and meta-analysis</dc:title><dc:creator>Locher C.</dc:creator><prism:publicationName>Journal of Affective Disorders</prism:publicationName><prism:issn>01650327</prism:issn><prism:eIssn>15732517</prism:eIssn><prism:volume>181</prism:volume><prism:pageRange>50-60</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jad.2015.03.062</prism:doi><pii>S0165032715002104</pii><dc:description>Â© 2015 Elsevier B.V. All rights reserved. Background Baseline severity is a crucial moderator of trial outcomes in adult depression, with the advantage of antidepressants over placebo increasing as severity increases. However, this relationship has not been examined in late-life depression. Methods PubMed, Embase, Web of Science, PsycINFO, and Cochrane were searched for studies published through September 2014. Randomized, acute phase, and double-blind studies comparing an antidepressant group with a placebo group in depressed elderly patients were included. Results Nineteen studies met all inclusion criteria. Within-group effect sizes revealed significant improvement in antidepressant groups (g=1.35, p&lt;.000), as well as in placebo groups (g=.96, p&lt;.000). Change in depressive symptoms assessed by Hamilton Depression Rating Scale (HDRS) was moderated by baseline severity in antidepressant groups (Z=2.67, p=.008) and placebo groups (Z=4.46, p&lt;.000). However, this would be expected as a result of regression toward the mean, and mean differences between groups did not increase (r=.19, p=.469) as a function of baseline severity. Limitations Limited to published data and information was only analyzed at the level of treatment groups. Conclusion Baseline severity was not associated with an antidepressant-placebo difference and placebo responses are large in the treatment of depressed elderly people. We propose a stepwise approach, i.e., to initially offer elderly depressed patients psychosocial interventions and only consider antidepressants if patients do not respond.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023588</affiliation-url><afid>60023588</afid><affilname>Universitat Basel</affilname><name-variant>University of Basel</name-variant><affiliation-city>Basel</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030521</affiliation-url><afid>60030521</afid><affilname>Children's Hospital Boston</affilname><name-variant>Children's Hospital</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002746</affiliation-url><afid>60002746</afid><affilname>Harvard Medical School</affilname><name-variant>Harvard Medical School</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002746</affiliation-url><afid>60002746</afid><affilname>Harvard Medical School</affilname><name-variant>Harvard Medical School</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60099404</affiliation-url><afid>60099404</afid><affilname>Swiss Federal Institute of Technology, Collegium Helveticum</affilname><name-variant>University of Zurich</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55839401900</author-url><authid>55839401900</authid><authname>Locher C.</authname><surname>Locher</surname><given-name>Cosima</given-name><initials>C.</initials><afid>60023588</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35085121100</author-url><authid>35085121100</authid><authname>Kossowsky J.</authname><surname>Kossowsky</surname><given-name>Joe</given-name><initials>J.</initials><afid>60023588</afid><afid>60030521</afid><afid>60002746</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35085121100</author-url><authid>35085121100</authid><authname>Kossowsky J.</authname><surname>Kossowsky</surname><given-name>Joe</given-name><initials>J.</initials><afid>60023588</afid><afid>60030521</afid><afid>60002746</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35085121100</author-url><authid>35085121100</authid><authname>Kossowsky J.</authname><surname>Kossowsky</surname><given-name>Joe</given-name><initials>J.</initials><afid>60023588</afid><afid>60030521</afid><afid>60002746</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6602110060</author-url><authid>6602110060</authid><authname>Gaab J.</authname><surname>Gaab</surname><given-name>Jens</given-name><initials>J.</initials><afid>60023588</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7102863523</author-url><authid>7102863523</authid><authname>Kirsch I.</authname><surname>Kirsch</surname><given-name>Irving</given-name><initials>I.</initials><afid>60002746</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:46061803800</author-url><authid>46061803800</authid><authname>Bain P.</authname><surname>Bain</surname><given-name>Paul</given-name><initials>P.</initials><afid>60002746</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:8776884500</author-url><authid>8776884500</authid><authname>Krummenacher P.</authname><surname>Krummenacher</surname><given-name>Peter</given-name><initials>P.</initials><afid>60023588</afid><afid>60099404</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:8776884500</author-url><authid>8776884500</authid><authname>Krummenacher P.</authname><surname>Krummenacher</surname><given-name>Peter</given-name><initials>P.</initials><afid>60023588</afid><afid>60099404</afid></author><authkeywords>Antidepressants | Baseline Severity | Depression | Elderly | Meta-analysis | Placebo</authkeywords><intid>535780045</intid><source-id>16245</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929338633"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929338633?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929338633&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929338633&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527314023833"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929338633</prism:url><dc:identifier>SCOPUS_ID:84929338633</dc:identifier><eid>2-s2.0-84929338633</eid><dc:title>Traditional acupuncture and myocardial ischemia</dc:title><dc:creator>Zhong Y.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>281</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2014.11.202</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60069723</affiliation-url><afid>60069723</afid><affilname>Hospital of Nanjing Medical University</affilname><name-variant>Hospital of Nanjing Medical University</name-variant><affiliation-city>Nanjing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:45161834500</author-url><authid>45161834500</authid><authname>Zhong Y.</authname><surname>Zhong</surname><given-name>Yigang</given-name><initials>Y.</initials><afid>60069723</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56447522900</author-url><authid>56447522900</authid><authname>Wang N.</authname><surname>Wang</surname><given-name>Ningfu</given-name><initials>N.</initials><afid>60069723</afid></author><authkeywords>Ischemic modified albumin | Myocardial ischemia | Traditional acupuncture</authkeywords><intid>535946790</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84908127334"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84908127334?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84908127334&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84908127334&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915014011733"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84908127334</prism:url><dc:identifier>SCOPUS_ID:84908127334</dc:identifier><eid>2-s2.0-84908127334</eid><dc:title>Adiponectin attenuates abdominal aortic aneurysm formation in hyperlipidemic mice</dc:title><dc:creator>Yoshida S.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>235</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>339-346</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2014.05.923</prism:doi><pii>S0021915014011733</pii><dc:description>Â© 2014 Elsevier Ireland Ltd. Objective: Abdominal aortic aneurysms (AAA) are age-associated, life-threatening inflammatory dilations of the abdominal aorta. Human population studies have shown an association between obesity and AAA formation, but the molecular mechanisms underlying this connection remain largely unexplored. Adiponectin is an anti-inflammatory adipokine that is downregulated in obesity. In this study we evaluated the role of adiponectin in a model of AAA using apolipoprotein E/adiponectin double-knockout (Apoe-/- Apn-/-) mice. Approach and results: Angiotensin II (Ang II)-infusion in male Apoe-/- Apn-/- mice led to a higher incidence of AAA and a significant increase of maximal aortic diameter compared with that of Apoe-/- mice (2.12Â±0.07mm vs. 1.67Â±0.09mm, respectively at 28 days). Adiponectin deficiency augmented the early infiltration of macrophages and increased the expression of pro-inflammatory factors in the dilated aortic wall. MMP-2 and MMP-9 activation was also augmented in the aorta of Apoe-/- Apn-/- mice compared to Apoe-/- mice. These data suggest that the downregulation of adiponectin could directly contribute to the elevated incidence of AAA observed in obese individuals. Conclusions: Adiponectin attenuates Ang II-induced vascular inflammation and AAA formation in mice.</dc:description><citedby-count>1</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006385</affiliation-url><afid>60006385</afid><affilname>Boston University School of Medicine</affilname><name-variant>Boston University School of Medicine</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><pubmed-id>24911638</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56489140700</author-url><authid>56489140700</authid><authname>Yoshida S.</authname><surname>Yoshida</surname><given-name>Sumiko</given-name><initials>S.</initials><afid>60006385</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:15072871000</author-url><authid>15072871000</authid><authname>Fuster J.</authname><surname>Fuster</surname><given-name>JosÃ© Javier</given-name><initials>J.J.</initials><afid>60006385</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7403291301</author-url><authid>7403291301</authid><authname>Walsh K.</authname><surname>Walsh</surname><given-name>Kenneth</given-name><initials>K.</initials><afid>60006385</afid></author><authkeywords>Abdominal aortic aneurysm | Adiponectin | Inflammation</authkeywords><intid>1032418350</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929304992"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929304992?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929304992&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929304992&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315005938"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929304992</prism:url><dc:identifier>SCOPUS_ID:84929304992</dc:identifier><eid>2-s2.0-84929304992</eid><dc:title>Progressive aortic dissection following RCA instent angioplasty</dc:title><dc:creator>Iyisoy A.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>309-310</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.335</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026716</affiliation-url><afid>60026716</afid><affilname>Gulhane Military Medical Academy</affilname><name-variant>GÃ¼lhane Military Medical Academy</name-variant><affiliation-city>Ankara</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026716</affiliation-url><afid>60026716</afid><affilname>Gulhane Military Medical Academy</affilname><name-variant>GÃ¼lhane Military Medical Academy</name-variant><affiliation-city>Ankara</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026716</affiliation-url><afid>60026716</afid><affilname>Gulhane Military Medical Academy</affilname><name-variant>GÃ¼lhane Military Medical Academy</name-variant><affiliation-city>Ankara</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6701679254</author-url><authid>6701679254</authid><authname>Iyisoy A.</authname><surname>Iyisoy</surname><given-name>Atila</given-name><initials>A.</initials><afid>60026716</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55332922500</author-url><authid>55332922500</authid><authname>Ozturk C.</authname><surname>Ozturk</surname><given-name>Cengiz</given-name><initials>C.</initials><afid>60026716</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:22233891000</author-url><authid>22233891000</authid><authname>Arslan Z.</authname><surname>Arslan</surname><given-name>Zekeriya</given-name><initials>Z.</initials><afid>60026716</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7006617047</author-url><authid>7006617047</authid><authname>Celik T.</authname><surname>Celik</surname><given-name>Turgay</given-name><initials>T.</initials><afid>60026716</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:21935592800</author-url><authid>21935592800</authid><authname>Unlu M.</authname><surname>Unlu</surname><given-name>Murat</given-name><initials>M.</initials><afid>60026716</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6701739555</author-url><authid>6701739555</authid><authname>Cingoz F.</authname><surname>Cingoz</surname><given-name>Faruk</given-name><initials>F.</initials><afid>60026716</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56644414200</author-url><authid>56644414200</authid><authname>Bozlar U.</authname><surname>Bozlar</surname><given-name>UÊur</given-name><initials>U.</initials><afid>60026716</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:8343534000</author-url><authid>8343534000</authid><authname>Demirkol S.</authname><surname>Demirkol</surname><given-name>Sait</given-name><initials>S.</initials><afid>60026716</afid></author><authkeywords>Aortic dissection | Coronary stenting | Instent restenosis</authkeywords><intid>1535945006</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929485772"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929485772?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929485772&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929485772&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0887233315000843"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929485772</prism:url><dc:identifier>SCOPUS_ID:84929485772</dc:identifier><eid>2-s2.0-84929485772</eid><dc:title>The effects of drugs with immunosuppressive or immunomodulatory activities on xenobiotics-metabolizing enzymes expression in primary human hepatocytes</dc:title><dc:creator>Vrzal R.</dc:creator><prism:publicationName>Toxicology in Vitro</prism:publicationName><prism:issn>08872333</prism:issn><prism:eIssn>18793177</prism:eIssn><prism:volume>29</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:pageRange>1088-1099</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.tiv.2015.04.013</prism:doi><pii>S0887233315000843</pii><dc:description>Â© 2015 Elsevier Ltd. In this paper we investigated the effects of several drugs used in transplant medicine, i.e. cyclosporine A, tacrolimus, rapamycin, everolimus, mycophenolate mofetil, fluvastatin and rosuvastatin, on the expression of major drug-metabolizing enzymes in human hepatocytes. Moreover, we tested the ability of these drugs to affect transcriptional activity of glucocorticoid (GR) and aryl hydrocarbon receptor (AhR).We found that most of tested compounds did not induce expression of CYP1A1/1A2/3A4/2A6/2B6/2C9 mRNAs in human hepatocytes. Slight induction was observed for CYP2A6/2C9 mRNAs and CYP2A6 protein in the rapamycin-treated hepatocytes. Decrease of CYP2A6 and CYP2B6 proteins was observed in rosuvastatin-treated cells. Mycophenolate mofetil antagonized the effects of dexamethasone on GR but it potentiated the action of dioxin on AhR. Induction of CYP1A1 mRNA in HepG2 cells by dioxin was modestly antagonized by mycophenolate mofetil, while the induction by benzo[a]pyren or S-omeprazole was significantly potentiated by this drug.In general, tested compounds can be considered safe in the terms of possible drug-drug interaction caused by induction of drug-metabolizing cytochromes P450. Nevertheless, mycophenolate mofetil is of possible concern and its combination with drugs, environmental pollutants or food constituents, which activate AhR, may represent a significant toxicological risk.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003367</affiliation-url><afid>60003367</afid><affilname>Univerzita Palack&amp;eacute;ho v Olomouci</affilname><name-variant>PalackÃ½ University</name-variant><affiliation-city>Olomouc</affiliation-city><affiliation-country>Czech Republic</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008462</affiliation-url><afid>60008462</afid><affilname>University Hospital Olomouc</affilname><name-variant>University Hospital</name-variant><affiliation-city>Olomouc</affiliation-city><affiliation-country>Czech Republic</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8676824100</author-url><authid>8676824100</authid><authname>Vrzal R.</authname><surname>Vrzal</surname><given-name>Radim</given-name><initials>R.</initials><afid>60003367</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56648182300</author-url><authid>56648182300</authid><authname>Zenata O.</authname><surname>Zenata</surname><given-name>Ondrej</given-name><initials>O.</initials><afid>60003367</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7004146911</author-url><authid>7004146911</authid><authname>Bachleda P.</authname><surname>Bachleda</surname><given-name>Petr</given-name><initials>P.</initials><afid>60008462</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:44861288800</author-url><authid>44861288800</authid><authname>Dvorak Z.</authname><surname>Dvorak</surname><given-name>Zdenek</given-name><initials>Z.</initials><afid>60003367</afid></author><authkeywords>Cytochrome P450 | Drug interaction | Human hepatocytes | Transplant drugs | Xenoreceptors</authkeywords><intid>1035958301</intid><source-id>25224</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84921479419"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84921479419?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84921479419&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84921479419&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915014002056"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84921479419</prism:url><dc:identifier>SCOPUS_ID:84921479419</dc:identifier><eid>2-s2.0-84921479419</eid><dc:title>A new piece in the puzzling effect of n-3 fatty acids on atherosclerosis?</dc:title><dc:creator>Le Goff W.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>235</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>358-362</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2014.03.038</prism:doi><pii>S0021915014002056</pii><dc:description>Â© 2014 Elsevier Ireland Ltd. Omega-3 fatty acids (n-3) FA are reported to be protective against cardiovascular disease (CVD), notably through their beneficial action on atherosclerosis development. In this context dietary intake of long-chain marine eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) is recommended and randomised trials largely support that EPA and DHA intake is associated with a reduction of CVD. However, mechanisms governing the atheroprotective action of n-3 FA are still unclear and numerous studies using mouse models conducted so far do not allow to reach a precise view of the cellular and molecular effects of n-3 FA on atherosclerosis. In the current issue of Atherosclerosis, Chang etal. provide important new information on the anti-atherogenic properties of n-3 FA by analysing the incremental replacement of saturated FA by pure fish oil as a source of EPA and DHA in Ldlr-/- mice fed a high fat/high cholesterol diet.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000905</affiliation-url><afid>60000905</afid><affilname>Inserm</affilname><name-variant>INSERM</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001422</affiliation-url><afid>60001422</afid><affilname>Universite Pierre et Marie Curie</affilname><name-variant>UniversitÃ© Pierre et Marie Curie</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015622</affiliation-url><afid>60015622</afid><affilname>Hopital Pitie Salpetriere</affilname><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><pubmed-id>24926537</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>no</subtype><subtypeDescription>Note</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602254841</author-url><authid>6602254841</authid><authname>Le Goff W.</authname><surname>Le Goff</surname><given-name>Wilfried</given-name><initials>W.</initials><afid>60000905</afid><afid>60001422</afid><afid>60015622</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602254841</author-url><authid>6602254841</authid><authname>Le Goff W.</authname><surname>Le Goff</surname><given-name>Wilfried</given-name><initials>W.</initials><afid>60000905</afid><afid>60001422</afid><afid>60015622</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602254841</author-url><authid>6602254841</authid><authname>Le Goff W.</authname><surname>Le Goff</surname><given-name>Wilfried</given-name><initials>W.</initials><afid>60000905</afid><afid>60001422</afid><afid>60015622</afid></author><authkeywords>Atherosclerosis | Inflammation | Lipoprotein lipase | Macrophage | N-3 Fatty acids</authkeywords><intid>1784654211</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929304013"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929304013?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929304013&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929304013&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0960076015001259"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929304013</prism:url><dc:identifier>SCOPUS_ID:84929304013</dc:identifier><eid>2-s2.0-84929304013</eid><dc:title>Lazaroid U-74389G inhibits the osteoblastic differentiation of IL-1Î²-indcued aortic valve interstitial cells through glucocorticoid receptor and inhibition of NF-ÎºB pathway</dc:title><dc:creator>Sun F.</dc:creator><prism:publicationName>Journal of Steroid Biochemistry and Molecular Biology</prism:publicationName><prism:issn>09600760</prism:issn><prism:eIssn>18791220</prism:eIssn><prism:volume>152</prism:volume><prism:pageRange>114-123</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jsbmb.2015.05.001</prism:doi><pii>S0960076015001259</pii><dc:description>Â© 2015 Elsevier Ltd. Abstract Background Aortic valve calcification is characterized as the active process of aortic valve interstitial cells (AVICs), and considered as an inflammatory disease. As an antioxidant, the anti-inflammatory activity of Lazaroid has been exhibited in various models. We hypothesized that Lazaroid U-74389G would inhibit the osteoblastic differentiation of AVICs induced by IL-1Î². Methods Normal tricuspid aortic valve leaflets were collected from patients with acute aortic dissection (Type A) undergoing the Bentall procedure. AVICs were isolated and stimulated with IL-1Î² in presence or absence of U-74389G in culture. Cell lysates were analyzed for osteogenic markers and nuclear factor-ÎºB using real-time PCR and Immunoblotting. Culture media was analyzed for IL-6 and IL-8 with enzyme-linked immunosorbent assay. Alizarin Red Staining was adopted to demonstrate the calcium deposition. Results The expression of alkaline phosphatase and bone morphogenetic protein, accompanied by the production of IL-6 and IL-8, was up-regulated in response to IL-1Î² and was inhibited by the addition of U-74389G. The NF-ÎºB pathway was activated by IL-1Î² and involved in the suppression of U-74389G on osteoblastic differentiation in AVICs. The negative effects of U-74389G on ostengenic gene expression and mineralization of AVICs were blocked by glucocorticoid receptor antagonist mifepristone and the NF-ÎºB inhibitor Bay 11-7082. Conclusions U-74389G inhibits the pro-osteogenic response to IL-1Î² stimulation in AVICs. The osteoblastic differentiation and mineralization of AVICs were inhabited by U-74389G though the modulation of NF-ÎºB activation, and this pathway could be potential therapeutic targets for medical treatment of calcified aortic valve disease.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025761</affiliation-url><afid>60025761</afid><affilname>Huazhong University of Science and Technology</affilname><name-variant>Huazhong Univ. of Sci. and Technol.</name-variant><affiliation-city>Wuhan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018554</affiliation-url><afid>60018554</afid><affilname>Zhengzhou University</affilname><name-variant>Zhengzhou University of Light Industry</name-variant><affiliation-city>Zhengzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56643674200</author-url><authid>56643674200</authid><authname>Sun F.</authname><surname>Sun</surname><given-name>Fuqiang</given-name><initials>F.</initials><afid>60025761</afid><afid>60018554</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56643674200</author-url><authid>56643674200</authid><authname>Sun F.</authname><surname>Sun</surname><given-name>Fuqiang</given-name><initials>F.</initials><afid>60025761</afid><afid>60018554</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55859764900</author-url><authid>55859764900</authid><authname>Shi J.</authname><surname>Shi</surname><given-name>Jiawei</given-name><initials>J.</initials><afid>60025761</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56253856700</author-url><authid>56253856700</authid><authname>Chen S.</authname><surname>Chen</surname><given-name>Si</given-name><initials>S.</initials><afid>60025761</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:37035882700</author-url><authid>37035882700</authid><authname>Deng C.</authname><surname>Deng</surname><given-name>Cheng</given-name><initials>C.</initials><afid>60025761</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55496335400</author-url><authid>55496335400</authid><authname>Hu X.</authname><surname>Hu</surname><given-name>Xingjian</given-name><initials>X.</initials><afid>60025761</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56003065100</author-url><authid>56003065100</authid><authname>Li H.</authname><surname>Li</surname><given-name>Huadong</given-name><initials>H.</initials><afid>60025761</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56643334700</author-url><authid>56643334700</authid><authname>Li G.</authname><surname>Li</surname><given-name>Geng</given-name><initials>G.</initials><afid>60025761</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55742220800</author-url><authid>55742220800</authid><authname>Liu Y.</authname><surname>Liu</surname><given-name>Yi</given-name><initials>Y.</initials><afid>60025761</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7005861079</author-url><authid>7005861079</authid><authname>Dong N.</authname><surname>Dong</surname><given-name>Nianguo</given-name><initials>N.</initials><afid>60025761</afid></author><authkeywords>Aortic valve | IL-1Î² | Lazaroid U-74389G | NF-ÎºB | Osteoblastic differentiation</authkeywords><intid>1535944540</intid><article-number>4411</article-number><source-id>14102</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929459075"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929459075?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929459075&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929459075&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0887233315000557"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929459075</prism:url><dc:identifier>SCOPUS_ID:84929459075</dc:identifier><eid>2-s2.0-84929459075</eid><dc:title>Genome-wide gene expression profiling of low-dose, long-term exposure of human osteosarcoma cells to bisphenol A and its analogs bisphenols AF and S</dc:title><dc:creator>Fic A.</dc:creator><prism:publicationName>Toxicology in Vitro</prism:publicationName><prism:issn>08872333</prism:issn><prism:eIssn>18793177</prism:eIssn><prism:volume>29</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:pageRange>1060-1069</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.tiv.2015.03.014</prism:doi><pii>S0887233315000557</pii><dc:description>Â© 2015 Elsevier Ltd. The bisphenols AF (BPAF) and S (BPS) are structural analogs of the endocrine disruptor bisphenol A (BPA), and are used in common products as a replacement for BPA. To elucidate genome-wide gene expression responses, estrogen-dependent osteosarcoma cells were cultured with 10. nM BPA, BPAF, or BPS, for 8. h and 3. months. Genome-wide gene expression was analyzed using the Illumina Expression BeadChip. Three months exposure had significant effects on gene expression, particularly for BPS, followed by BPAF and BPA, according to the number of differentially expressed genes (1980, 778, 60, respectively), the magnitude of changes in gene expression, and the number of enriched biological processes (800, 415, 33, respectively) and pathways (77, 52, 6, respectively). 'Embryonic skeletal system development' was the most enriched bone-related process, which was affected only by BPAF and BPS. Interestingly, all three bisphenols showed highest down-regulation of genes related to the cardiovascular system (e.g., NPPB, NPR3, TXNIP). BPA only and BPA/BPAF/BPS also affected genes related to the immune system and fetal development, respectively. For BPAF and BPS, the 'isoprenoid biosynthetic process' was enriched (up-regulated genes: HMGCS1, PDSS1, ACAT2, RCE1, DHDDS). Compared to BPA, BPAF and BPS had more effects on gene expression after long-term exposure. These findings stress the need for careful toxicological characterization of BPA analogs in the future.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031106</affiliation-url><afid>60031106</afid><affilname>University of Ljubljana</affilname><name-variant>University of Ljubljana</name-variant><affiliation-city>Ljubljana</affiliation-city><affiliation-country>Slovenia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021802</affiliation-url><afid>60021802</afid><affilname>University of Ljubljana Faculty of Medicine</affilname><name-variant>University of Ljubljana</name-variant><affiliation-city>Ljubljana</affiliation-city><affiliation-country>Slovenia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029170</affiliation-url><afid>60029170</afid><affilname>Lunds Universitet</affilname><name-variant>University of Lund</name-variant><affiliation-city>Lund</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012311</affiliation-url><afid>60012311</afid><affilname>Karolinska Institutet</affilname><name-variant>Karolinska Institutet</name-variant><affiliation-city>Stockholm</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55336499900</author-url><authid>55336499900</authid><authname>Fic A.</authname><surname>Fic</surname><given-name>A.</given-name><initials>A.</initials><afid>60031106</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36523059600</author-url><authid>36523059600</authid><authname>JurkoviÄ Mlakar S.</authname><surname>JurkoviÄ Mlakar</surname><given-name>S.</given-name><initials>S.</initials><afid>60031106</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6507897381</author-url><authid>6507897381</authid><authname>Juvan P.</authname><surname>Juvan</surname><given-name>P.</given-name><initials>P.</initials><afid>60021802</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:25637284700</author-url><authid>25637284700</authid><authname>Mlakar V.</authname><surname>Mlakar</surname><given-name>V.</given-name><initials>V.</initials><afid>60031106</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7006701288</author-url><authid>7006701288</authid><authname>Marc J.</authname><surname>Marc</surname><given-name>J.</given-name><initials>J.</initials><afid>60031106</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56065828900</author-url><authid>56065828900</authid><authname>Sollner Dolenc M.</authname><surname>Sollner Dolenc</surname><given-name>M.</given-name><initials>M.</initials><afid>60031106</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7003501648</author-url><authid>7003501648</authid><authname>Broberg K.</authname><surname>Broberg</surname><given-name>K.</given-name><initials>K.</initials><afid>60029170</afid><afid>60012311</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7003501648</author-url><authid>7003501648</authid><authname>Broberg K.</authname><surname>Broberg</surname><given-name>K.</given-name><initials>K.</initials><afid>60029170</afid><afid>60012311</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55666048800</author-url><authid>55666048800</authid><authname>Peterlin MaÅ¡iÄ L.</authname><surname>Peterlin MaÅ¡iÄ</surname><given-name>L.</given-name><initials>L.</initials><afid>60031106</afid></author><authkeywords>BPA analogs | BPAF | BPS | Microarray | Osteosarcoma cells</authkeywords><intid>1785965509</intid><source-id>25224</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928997660"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928997660?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928997660&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928997660&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022098115001057"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928997660</prism:url><dc:identifier>SCOPUS_ID:84928997660</dc:identifier><eid>2-s2.0-84928997660</eid><dc:title>Evidence of partial deferment of digestion during diving in Steller sea lions (Eumetopias jubatus)</dc:title><dc:creator>Rosen D.</dc:creator><prism:publicationName>Journal of Experimental Marine Biology and Ecology</prism:publicationName><prism:issn>00220981</prism:issn><prism:volume>469</prism:volume><prism:pageRange>93-97</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jembe.2015.04.017</prism:doi><pii>S0022098115001057</pii><dc:description>Â© 2015. Past foraging success of diving air-breathing vertebrates can adversely affect future foraging capabilities and costs through changes in circulation or increased metabolic costs associated with digestion that are incompatible with efficient diving. This study tested the physiological interaction between digestion and diving by comparing the cost of diving in fasted and pre-fed trained Steller sea lions foraging under controlled conditions in the open ocean. Pre-dive and post-dive surface metabolism and diving metabolic rate were all higher in the pre-fed animals than the fasted animals, indicating an effect of digestion on metabolism. However, the sea lions displayed a significant reduction in the apparent additive effect of digestion during diving. The increase in rate of oxygen consumption associated with digestion was reduced by 54% during diving compared to the increase observed in pre-dive metabolism. This truncation of the additional cost of digestion rapidly disappeared following cessation of diving. The results suggest that Steller sea lions diving to depth demonstrate a partial deferment of digestion while actively foraging and that the classically held view that digestion and diving are incompatible processes may be much more variable and adaptable to specific diving conditions and behaviors than previously thought.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010365</affiliation-url><afid>60010365</afid><affilname>The University of British Columbia</affilname><name-variant>University of British Columbia</name-variant><affiliation-city>Vancouver</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7202022602</author-url><authid>7202022602</authid><authname>Rosen D.</authname><surname>Rosen</surname><given-name>David A S</given-name><initials>D.A.S.</initials><afid>60010365</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:52263606500</author-url><authid>52263606500</authid><authname>Gerlinsky C.</authname><surname>Gerlinsky</surname><given-name>Carling D.</given-name><initials>C.D.</initials><afid>60010365</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7004036666</author-url><authid>7004036666</authid><authname>Trites A.</authname><surname>Trites</surname><given-name>Andrew W.</given-name><initials>A.W.</initials><afid>60010365</afid></author><authkeywords>Digestion | Diving | Foraging | Metabolism | Sea lion</authkeywords><intid>2035878545</intid><source-id>29606</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929378103"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929378103?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929378103&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929378103&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0149763415001177"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929378103</prism:url><dc:identifier>SCOPUS_ID:84929378103</dc:identifier><eid>2-s2.0-84929378103</eid><dc:title>Oxytocin and the modulation of pain experience: Implications for chronic pain management</dc:title><dc:creator>Tracy L.</dc:creator><prism:publicationName>Neuroscience and Biobehavioral Reviews</prism:publicationName><prism:issn>01497634</prism:issn><prism:eIssn>18737528</prism:eIssn><prism:volume>55</prism:volume><prism:pageRange>53-67</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.neubiorev.2015.04.013</prism:doi><pii>S0149763415001177</pii><dc:description>Â© 2015 Elsevier Ltd. In an acute environment pain has potential protective benefits. However when pain becomes chronic this protective effect is lost and the pain becomes an encumbrance. Previously unheralded substances are being investigated in an attempt to alleviate the burden of living with chronic pain. Oxytocin, a neuropeptide hormone, is one prospective pharmacotherapeutic agent gaining popularity. Oxytocin has the potential to modulate the pain experience due to its ubiquitous involvement in central and peripheral psychological and physiological processes, and thus offers promise as a therapeutic agent. In this review, we discuss previous effective applications of oxytocin in pain-free clinical populations and its potential use in the modulation of pain experience. We also address the slowly growing body of literature investigating the administration of oxytocin in clinical and experimentally induced pain in order to investigate the potential mechanisms of its reported analgesic actions. We conclude that oxytocin offers a potential novel avenue for modulating the experience of pain, and that further research into this area is required to map its therapeutic benefit.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019578</affiliation-url><afid>60019578</afid><affilname>Monash University</affilname><name-variant>Monash University</name-variant><affiliation-city>Melbourne</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112771656</affiliation-url><afid>112771656</afid><affilname>Caulfield Pain Management and Research Centre</affilname><name-variant>Caulfield Pain Management and Research Centre</name-variant><affiliation-city>Caulfield</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112741448</affiliation-url><afid>112741448</afid><affilname>National Aging Research Institute</affilname><name-variant>National Aging Research Institute</name-variant><affiliation-city>Melbourne</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56058708700</author-url><authid>56058708700</authid><authname>Tracy L.</authname><surname>Tracy</surname><given-name>Lincoln M.</given-name><initials>L.M.</initials><afid>60019578</afid><afid>112771656</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56058708700</author-url><authid>56058708700</authid><authname>Tracy L.</authname><surname>Tracy</surname><given-name>Lincoln M.</given-name><initials>L.M.</initials><afid>60019578</afid><afid>112771656</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6602316824</author-url><authid>6602316824</authid><authname>Georgiou-Karistianis N.</authname><surname>Georgiou-Karistianis</surname><given-name>Nellie</given-name><initials>N.</initials><afid>60019578</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56073147900</author-url><authid>56073147900</authid><authname>Gibson S.</authname><surname>Gibson</surname><given-name>Stephen J.</given-name><initials>S.J.</initials><afid>112771656</afid><afid>112741448</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56073147900</author-url><authid>56073147900</authid><authname>Gibson S.</authname><surname>Gibson</surname><given-name>Stephen J.</given-name><initials>S.J.</initials><afid>112771656</afid><afid>112741448</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8313949000</author-url><authid>8313949000</authid><authname>Giummarra M.</authname><surname>Giummarra</surname><given-name>Melita J.</given-name><initials>M.J.</initials><afid>60019578</afid><afid>112771656</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8313949000</author-url><authid>8313949000</authid><authname>Giummarra M.</authname><surname>Giummarra</surname><given-name>Melita J.</given-name><initials>M.J.</initials><afid>60019578</afid><afid>112771656</afid></author><authkeywords>Analgesia | Chronic pain | Intranasal | Oxytocin | Pain</authkeywords><intid>2035941024</intid><source-id>18045</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928710940"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928710940?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928710940&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928710940&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0149763415001001"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928710940</prism:url><dc:identifier>SCOPUS_ID:84928710940</dc:identifier><eid>2-s2.0-84928710940</eid><dc:title>Connecting prosocial behavior to improved physical health: Contributions from the neurobiology of parenting</dc:title><dc:creator>Brown S.</dc:creator><prism:publicationName>Neuroscience and Biobehavioral Reviews</prism:publicationName><prism:issn>01497634</prism:issn><prism:eIssn>18737528</prism:eIssn><prism:volume>55</prism:volume><prism:pageRange>1-17</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.neubiorev.2015.04.004</prism:doi><pii>S0149763415001001</pii><dc:description>Â© 2015. Although a growing body of evidence suggests that giving to (helping) others is linked reliably to better health and longevity for the helper, little is known about causal mechanisms. In the present paper we use a recently developed model of caregiving motivation to identify possible neurophysiological mechanisms. The model describes a mammalian neurohormonal system that evolved to regulate maternal care, but over time may have been recruited to support a wide variety of helping behaviors in humans and other social animals. According to the model, perception of need or distress in others activates caregiving motivation, which in turn, can facilitate helping behavior. Motivational regulation is governed by the medial preoptic area of the hypothalamus, interacting with certain other brain regions, hormones, and neuromodulators (especially oxytocin and progesterone). Consideration of neurohormonal circuitry and related evidence raises the possibility that it is these hormones, known to have stress-buffering and restorative properties, that are responsible, at least in part, for health and longevity benefits associated with helping others.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026415</affiliation-url><afid>60026415</afid><affilname>Stony Brook University State University of New York</affilname><name-variant>State University of New York at Stony Brook</name-variant><affiliation-city>Stony Brook</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025778</affiliation-url><afid>60025778</afid><affilname>University Michigan Ann Arbor</affilname><name-variant>University of Michigan</name-variant><affiliation-city>Ann Arbor</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001795</affiliation-url><afid>60001795</afid><affilname>Pacific Lutheran University</affilname><name-variant>Pacific Lutheran University</name-variant><affiliation-city>Tacoma</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36812735200</author-url><authid>36812735200</authid><authname>Brown S.</authname><surname>Brown</surname><given-name>Stephanie L.</given-name><initials>S.L.</initials><afid>60026415</afid><afid>60025778</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36812735200</author-url><authid>36812735200</authid><authname>Brown S.</authname><surname>Brown</surname><given-name>Stephanie L.</given-name><initials>S.L.</initials><afid>60026415</afid><afid>60025778</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:15831382700</author-url><authid>15831382700</authid><authname>Brown R.</authname><surname>Brown</surname><given-name>R. Michael</given-name><initials>R.M.</initials><afid>60001795</afid></author><authkeywords>Altruism | Bonding | Caregiving | Evolution | Health | Helping | Neuropeptide | Neuroscience | Oxytocin | Progesterone | Prosocial behavior | Stress</authkeywords><intid>535840517</intid><source-id>18045</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929337230"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929337230?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929337230&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929337230&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0195666315002263"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929337230</prism:url><dc:identifier>SCOPUS_ID:84929337230</dc:identifier><eid>2-s2.0-84929337230</eid><dc:title>Factors influencing the frequency of children's consumption of soft drinks</dc:title><dc:creator>Pettigrew S.</dc:creator><prism:publicationName>Appetite</prism:publicationName><prism:issn>01956663</prism:issn><prism:eIssn>10958304</prism:eIssn><prism:volume>91</prism:volume><prism:pageRange>393-398</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.appet.2015.04.080</prism:doi><pii>S0195666315002263</pii><dc:description>Â© 2015 Elsevier Ltd. Among other focus areas, interventions designed to improve children's diets need to address key factors contributing to children's consumption of sugar-sweetened beverages. The present study employed structural equation modelling to investigate the relationship between a broad range of predictor variables and the frequency with which Australian children consume soft drinks. In total, 1302 parents of children aged 8 to 14 years responded to an online survey about their children's food consumption behaviours. Soft drink consumption frequency was primarily influenced by parents' attitudes to soft drinks, children's pestering behaviours, and perceived social norms relating to children's consumption of these products. Importantly, pestering and social norms had significant direct effects on consumption frequency in addition to indirect effects via their impact on parents' attitudes to soft drink.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031226</affiliation-url><afid>60031226</afid><affilname>Curtin University</affilname><name-variant>Curtin University of Technology</name-variant><affiliation-city>Perth</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009734</affiliation-url><afid>60009734</afid><affilname>Cancer Council New South Wales</affilname><name-variant>NSW Cancer Council</name-variant><affiliation-city>Woolloomooloo</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112733138</affiliation-url><afid>112733138</afid><affilname>South Australian Health and Medical Research Institute</affilname><name-variant>South Australian Health and Medical Research Institute</name-variant><affiliation-city>Adelaide</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009512</affiliation-url><afid>60009512</afid><affilname>University of Adelaide</affilname><name-variant>University of Adelaide</name-variant><affiliation-city>Adelaide</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:12545715600</author-url><authid>12545715600</authid><authname>Pettigrew S.</authname><surname>Pettigrew</surname><given-name>Simone</given-name><initials>S.</initials><afid>60031226</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56079257800</author-url><authid>56079257800</authid><authname>Jongenelis M.</authname><surname>Jongenelis</surname><given-name>Michelle</given-name><initials>M.</initials><afid>60031226</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56548149200</author-url><authid>56548149200</authid><authname>Chapman K.</authname><surname>Chapman</surname><given-name>Kathy</given-name><initials>K.</initials><afid>60009734</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:26425166400</author-url><authid>26425166400</authid><authname>Miller C.</authname><surname>Miller</surname><given-name>Caroline</given-name><initials>C.</initials><afid>112733138</afid><afid>60009512</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:26425166400</author-url><authid>26425166400</authid><authname>Miller C.</authname><surname>Miller</surname><given-name>Caroline</given-name><initials>C.</initials><afid>112733138</afid><afid>60009512</afid></author><authkeywords>Behavioural determinants | Children | Soft drinks | Structural equation modelling</authkeywords><intid>35943462</intid><source-id>29994</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928348974"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928348974?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928348974&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928348974&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1751616115001186"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928348974</prism:url><dc:identifier>SCOPUS_ID:84928348974</dc:identifier><eid>2-s2.0-84928348974</eid><dc:title>The biaxial active mechanical properties of the porcine primary renal artery</dc:title><dc:creator>Zhou B.</dc:creator><prism:publicationName>Journal of the Mechanical Behavior of Biomedical Materials</prism:publicationName><prism:issn>17516161</prism:issn><prism:eIssn>18780180</prism:eIssn><prism:volume>48</prism:volume><prism:pageRange>28-37</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jmbbm.2015.04.004</prism:doi><pii>S1751616115001186</pii><dc:description>Â© 2015 Elsevier Ltd. The mechanical response of arteries under physiological loads can be delineated into passive and active components. The passive response is governed by the load-bearing constituents within the arterial wall, elastin, collagen, and water, while the active response is a result of vascular smooth muscle cell (SMC) contraction. In muscular blood vessels, such as the primary renal artery, high SMC wall content suggests an elevated importance of the active response in determining overall vessel behavior. This study is a continuation of our previous investigation, in which a four-fiber constitutive model of the passive response of the primary porcine renal artery was identified. Here we focus on the active response of this vessel, specifically in the case of maximal SMC contraction, and develop a constitutive model of the active stress-stretch relations. The results of this study demonstrate the existence of biaxial active stress in the vessel wall, and suggest the active mechanical response is a critical component of renal arterial performance.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018179</affiliation-url><afid>60018179</afid><affilname>University of South Carolina</affilname><name-variant>University of South Carolina</name-variant><affiliation-city>Columbia</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024147</affiliation-url><afid>60024147</afid><affilname>Bulgarian Academy of Sciences</affilname><name-variant>Bulgarian Acad of Sciences</name-variant><affiliation-city>Sofia</affiliation-city><affiliation-country>Bulgaria</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018179</affiliation-url><afid>60018179</afid><affilname>University of South Carolina</affilname><name-variant>University of South Carolina</name-variant><affiliation-city>Columbia</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55816781300</author-url><authid>55816781300</authid><authname>Zhou B.</authname><surname>Zhou</surname><given-name>Boran</given-name><initials>B.</initials><afid>60018179</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6701826976</author-url><authid>6701826976</authid><authname>Rachev A.</authname><surname>Rachev</surname><given-name>Alexander</given-name><initials>A.</initials><afid>60024147</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:24802674700</author-url><authid>24802674700</authid><authname>Shazly T.</authname><surname>Shazly</surname><given-name>Tarek</given-name><initials>T.</initials><afid>60018179</afid><afid>60018179</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:24802674700</author-url><authid>24802674700</authid><authname>Shazly T.</authname><surname>Shazly</surname><given-name>Tarek</given-name><initials>T.</initials><afid>60018179</afid><afid>60018179</afid></author><authkeywords>Active stress | Biaxial active response | Constitutive model | Porcine renal artery | Vascular mechanics</authkeywords><intid>535768081</intid><source-id>8000153139</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929395580"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929395580?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929395580&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929395580&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167488915001469"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929395580</prism:url><dc:identifier>SCOPUS_ID:84929395580</dc:identifier><eid>2-s2.0-84929395580</eid><dc:title>Mechanical dynamics in live cells and fluorescence-based force/tension sensors</dc:title><dc:creator>Yang C.</dc:creator><prism:publicationName>Biochimica et Biophysica Acta - Molecular Cell Research</prism:publicationName><prism:issn>01674889</prism:issn><prism:eIssn>18792596</prism:eIssn><prism:volume>1853</prism:volume><prism:issueIdentifier>8</prism:issueIdentifier><prism:pageRange>1889-1904</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbamcr.2015.05.001</prism:doi><pii>S0167488915001469</pii><dc:description>Â© 2015 Elsevier B.V. Three signaling systems play the fundamental roles in modulating cell activities: chemical, electrical, and mechanical. While the former two are well studied, the mechanical signaling system is still elusive because of the lack of methods to measure structural forces in real time at cellular and subcellular levels. Indeed, almost all biological processes are responsive to modulation by mechanical forces that trigger dispersive downstream electrical and biochemical pathways. Communication among the three systems is essential to make cells and tissues receptive to environmental changes. Cells have evolved many sophisticated mechanisms for the generation, perception and transduction of mechanical forces, including motor proteins and mechanosensors. In this review, we introduce some background information about mechanical dynamics in live cells, including the ubiquitous mechanical activity, various types of mechanical stimuli exerted on cells and the different mechanosensors. We also summarize recent results obtained using genetically encoded FRET (fluorescence resonance energy transfer)-based force/tension sensors; a new technique used to measure mechanical forces in structural proteins. The sensors have been incorporated into many specific structural proteins and have measured the force gradients in real time within live cells, tissues, and animals.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018310</affiliation-url><afid>60018310</afid><affilname>Nanjing Medical University</affilname><name-variant>Nanjing Medical University</name-variant><affiliation-city>Nanjing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025371</affiliation-url><afid>60025371</afid><affilname>University of Alabama</affilname><name-variant>University of Alabama</name-variant><affiliation-city>Tuscaloosa</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032083</affiliation-url><afid>60032083</afid><affilname>University at Buffalo State University of New York</affilname><name-variant>State University of New York at Buffalo</name-variant><affiliation-city>Buffalo</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:9635348600</author-url><authid>9635348600</authid><authname>Yang C.</authname><surname>Yang</surname><given-name>Chao</given-name><initials>C.</initials><afid>60018310</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56103293500</author-url><authid>56103293500</authid><authname>Zhang X.</authname><surname>Zhang</surname><given-name>Xiaohan</given-name><initials>X.</initials><afid>60018310</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56571692500</author-url><authid>56571692500</authid><authname>Guo Y.</authname><surname>Guo</surname><given-name>Yichen</given-name><initials>Y.</initials><afid>60025371</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7201913184</author-url><authid>7201913184</authid><authname>Meng F.</authname><surname>Meng</surname><given-name>Fanjie</given-name><initials>F.</initials><afid>60032083</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35586122700</author-url><authid>35586122700</authid><authname>Sachs F.</authname><surname>Sachs</surname><given-name>Frederick</given-name><initials>F.</initials><afid>60032083</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7404489976</author-url><authid>7404489976</authid><authname>Guo J.</authname><surname>Guo</surname><given-name>Jun</given-name><initials>J.</initials><afid>60018310</afid></author><authkeywords>Fluorescence-based force sensors | Mechanical dynamics | Mechanosensors | Motor proteins | Structural force</authkeywords><intid>1535955727</intid><source-id>18408</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929307989"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929307989?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929307989&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929307989&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008049"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929307989</prism:url><dc:identifier>SCOPUS_ID:84929307989</dc:identifier><eid>2-s2.0-84929307989</eid><dc:title>Giant left coronary artery aneurysms: Review of the literature and report of a rare case diagnosed by transthoracic echocardiography</dc:title><dc:creator>Wang L.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>267-271</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.082</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025761</affiliation-url><afid>60025761</afid><affilname>Huazhong University of Science and Technology</affilname><name-variant>Huazhong Univ. of Sci. and Technol.</name-variant><affiliation-city>Wuhan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003531</affiliation-url><afid>60003531</afid><affilname>George Washington University Medical Center</affilname><name-variant>George Washington Univ. Med. Center</name-variant><affiliation-city>Washington</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025761</affiliation-url><afid>60025761</afid><affilname>Huazhong University of Science and Technology</affilname><name-variant>Huazhong Univ. of Sci. and Technol.</name-variant><affiliation-city>Wuhan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025761</affiliation-url><afid>60025761</afid><affilname>Huazhong University of Science and Technology</affilname><name-variant>Huazhong Univ. of Sci. and Technol.</name-variant><affiliation-city>Wuhan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644276300</author-url><authid>56644276300</authid><authname>Wang L.</authname><surname>Wang</surname><given-name>Lei</given-name><initials>L.</initials><afid>60025761</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55983712600</author-url><authid>55983712600</authid><authname>Wang J.</authname><surname>Wang</surname><given-name>Jing</given-name><initials>J.</initials><afid>60025761</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35232149300</author-url><authid>35232149300</authid><authname>Cheng T.</authname><surname>Cheng</surname><given-name>Tsung O.</given-name><initials>T.O.</initials><afid>60025761</afid><afid>60003531</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35232149300</author-url><authid>35232149300</authid><authname>Cheng T.</authname><surname>Cheng</surname><given-name>Tsung O.</given-name><initials>T.O.</initials><afid>60025761</afid><afid>60003531</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55561008700</author-url><authid>55561008700</authid><authname>Xie M.</authname><surname>Xie</surname><given-name>Mingxing</given-name><initials>M.</initials><afid>60025761</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55982787000</author-url><authid>55982787000</authid><authname>Wang X.</authname><surname>Wang</surname><given-name>Xinfang</given-name><initials>X.</initials><afid>60025761</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56643405600</author-url><authid>56643405600</authid><authname>Song Y.</authname><surname>Song</surname><given-name>Yue</given-name><initials>Y.</initials><afid>60025761</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56644172900</author-url><authid>56644172900</authid><authname>Liu J.</authname><surname>Liu</surname><given-name>Jinping</given-name><initials>J.</initials><afid>60025761</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:8635536800</author-url><authid>8635536800</authid><authname>Wei F.</authname><surname>Wei</surname><given-name>Fen</given-name><initials>F.</initials><afid>60025761</afid></author><authkeywords>Coronary artery aneurysm | Echocardiography</authkeywords><intid>1535944343</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84923356974"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84923356974?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84923356974&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84923356974&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2352250X15000512"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84923356974</prism:url><dc:identifier>SCOPUS_ID:84923356974</dc:identifier><eid>2-s2.0-84923356974</eid><dc:title>Integrating NIMH Research Domain Criteria (RDoC) into depression research</dc:title><dc:creator>Woody M.</dc:creator><prism:publicationName>Current Opinion in Psychology</prism:publicationName><prism:issn>2352250X</prism:issn><prism:volume>4</prism:volume><prism:pageRange>6-12</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.copsyc.2015.01.004</prism:doi><pii>S2352250X15000512</pii><dc:description>Â© 2015 Elsevier Ltd. The NIMH Research Domain Criteria (RDoC) initiative grew out of the agency's goal to develop 'new ways of classifying mental disorders based on behavioral dimensions and neurobiological measures' [1]. In this article, we review how depression research can be meaningfully conducted within an RDoC framework, with a particular focus on the Negative Valence Systems construct of Loss. New efforts to understand depression within the context of RDoC must seek an integrative understanding of the disorder across multiple units of analysis from genes to neural circuits to behavior. In addition, the constructs or processes must be understood within the context of specific environmental and developmental influences. Key concepts are discussed, and we end by highlighting research on rumination as a prime example of research that is consistent with RDoC.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020273</affiliation-url><afid>60020273</afid><affilname>Binghamton University State University of New York</affilname><name-variant>State University of New York</name-variant><affiliation-city>Binghamton</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55181516200</author-url><authid>55181516200</authid><authname>Woody M.</authname><surname>Woody</surname><given-name>Mary L.</given-name><initials>M.L.</initials><afid>60020273</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004538229</author-url><authid>7004538229</authid><authname>Gibb B.</authname><surname>Gibb</surname><given-name>Brandon E.</given-name><initials>B.E.</initials><afid>60020273</afid></author><intid>534961358</intid><source-id>21100372442</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927673753"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927673753?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927673753&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927673753&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S003193841500205X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927673753</prism:url><dc:identifier>SCOPUS_ID:84927673753</dc:identifier><eid>2-s2.0-84927673753</eid><dc:title>Evidence for a synchronization of hormonal states between humans and dogs during competition</dc:title><dc:creator>Buttner A.</dc:creator><prism:publicationName>Physiology and Behavior</prism:publicationName><prism:issn>00319384</prism:issn><prism:eIssn>1873507X</prism:eIssn><prism:volume>147</prism:volume><prism:pageRange>54-62</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.physbeh.2015.04.010</prism:doi><pii>S003193841500205X</pii><dc:description>Â© 2015 Elsevier Inc. Social interactions with humans have been shown to influence hormonal processes in dogs, but it is unclear how the hormonal states of humans factor into this relationship. In this study, we explored the associations between changes in the cortisol levels of dogs with humans' hormonal changes, behavior, and perceptions of their performance at an agility competition. A total of 58 dogs and their handlers (44 women, 14 men) provided saliva samples before and after competing. Dogs' saliva samples were later assayed for cortisol and humans' samples for cortisol and testosterone. Following the competition, handler-dog interactions were observed for affiliative and punitive behavior towards their dogs, and handlers completed questionnaires that included personal ratings of their performance. Structural equation modeling revealed that elevations in handlers' cortisol levels were associated with increases in their dogs' cortisol levels. Handlers' affiliative and punitive behaviors towards their dogs following competition were associated with their ratings of their performance, but these variables were unrelated to changes in their own cortisol levels and their dogs', implying their behavior did not mediate the relationship. These findings suggest that changes in the hormonal states were reflected between humans and their dogs, and this relationship was not due to handlers' perceptions of their performance or the behaviors we observed during post-competition social interactions. This study is one of the first to provide evidence for a synchronization of hormonal changes between species.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018988</affiliation-url><afid>60018988</afid><affilname>University of Nebraska at Omaha</affilname><name-variant>University of Nebraska at Omaha</name-variant><affiliation-city>Omaha</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55985490400</author-url><authid>55985490400</authid><authname>Buttner A.</authname><surname>Buttner</surname><given-name>Alicia Phillips</given-name><initials>A.P.</initials><afid>60018988</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56591436000</author-url><authid>56591436000</authid><authname>Thompson B.</authname><surname>Thompson</surname><given-name>Breanna</given-name><initials>B.</initials><afid>60018988</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7102071616</author-url><authid>7102071616</authid><authname>Strasser R.</authname><surname>Strasser</surname><given-name>Rosemary</given-name><initials>R.</initials><afid>60018988</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6603711633</author-url><authid>6603711633</authid><authname>Santo J.</authname><surname>Santo</surname><given-name>Jonathan</given-name><initials>J.</initials><afid>60018988</afid></author><authkeywords>Agility competition | Cortisol | Dog | Hormonal synchronization | Interspecies interactions</authkeywords><intid>2035642903</intid><source-id>24007</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928820450"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928820450?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928820450&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928820450&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0268005X15001514"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928820450</prism:url><dc:identifier>SCOPUS_ID:84928820450</dc:identifier><eid>2-s2.0-84928820450</eid><dc:title>Influence of droplet clustering on the rheological properties ofemulsion-filled gels</dc:title><dc:creator>Oliver L.</dc:creator><prism:publicationName>Food Hydrocolloids</prism:publicationName><prism:issn>0268005X</prism:issn><prism:volume>50</prism:volume><prism:pageRange>74-83</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.foodhyd.2015.04.001</prism:doi><pii>S0268005X15001514</pii><dc:description>Â© 2015 Elsevier Ltd. The aim of this work was to determine the effect and magnitude of fat droplet clustering on the rheological properties of emulsion-filled gels. To this end, we investigated experimentally the effect of fat hardness and emulsion droplet clustering in gelatin gels. Fat droplet clustering was induced or avoided by changing the temperature at which the emulsion was mixed with the gelatin. Rheological properties of the filled gels were investigated by uniaxial compression. The obtained experimental data show that next to changes in droplet hardness and matrix hardness, also droplet clustering contributes to the gel stiffness; even in the absence of discrete bonds between adjacent droplets. The experimental data was compared with the Kerner model, the Kerner model corrected by the effective volume fraction approach and the Kerner model considering an inhomogeneous distribution of the droplets. The Kerner model gives a good prediction for the gels filled with liquid droplets without clustering. The correction for an inhomogeneous distribution of the droplets best described the influence of emulsion droplet clustering in emulsion-filled gels, showing a quantitative evaluation on the role of droplet clustering in the rheological behaviour of emulsion-filled gels. This may provide guidelines for developing a strategy to control certain product properties.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60084278</affiliation-url><afid>60084278</afid><affilname>TI Food and Nutrition</affilname><name-variant>TI Food and Nutrition</name-variant><affiliation-city>Wageningen</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013902</affiliation-url><afid>60013902</afid><affilname>NIZO food research</affilname><name-variant>NIZO</name-variant><affiliation-city>Ede</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004156</affiliation-url><afid>60004156</afid><affilname>Wageningen University and Research Centre</affilname><name-variant>Wageningen University and Research Centre</name-variant><affiliation-city>Wageningen</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:37461873300</author-url><authid>37461873300</authid><authname>Oliver L.</authname><surname>Oliver</surname><given-name>Laura</given-name><initials>L.</initials><afid>60084278</afid><afid>60013902</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:37461873300</author-url><authid>37461873300</authid><authname>Oliver L.</authname><surname>Oliver</surname><given-name>Laura</given-name><initials>L.</initials><afid>60084278</afid><afid>60013902</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56613326600</author-url><authid>56613326600</authid><authname>Berndsen L.</authname><surname>Berndsen</surname><given-name>Lieke</given-name><initials>L.</initials><afid>60004156</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55666367100</author-url><authid>55666367100</authid><authname>van Aken G.</authname><surname>van Aken</surname><given-name>George A.</given-name><initials>G.A.</initials><afid>60084278</afid><afid>60013902</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55666367100</author-url><authid>55666367100</authid><authname>van Aken G.</authname><surname>van Aken</surname><given-name>George A.</given-name><initials>G.A.</initials><afid>60084278</afid><afid>60013902</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003881123</author-url><authid>7003881123</authid><authname>Scholten E.</authname><surname>Scholten</surname><given-name>Elke</given-name><initials>E.</initials><afid>60084278</afid><afid>60004156</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003881123</author-url><authid>7003881123</authid><authname>Scholten E.</authname><surname>Scholten</surname><given-name>Elke</given-name><initials>E.</initials><afid>60084278</afid><afid>60004156</afid></author><authkeywords>Droplet clustering | Emulsion-filled gels | Gelatin | Rheology | Solid fat</authkeywords><intid>1785851333</intid><source-id>22597</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929340434"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929340434?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929340434&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929340434&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006683"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929340434</prism:url><dc:identifier>SCOPUS_ID:84929340434</dc:identifier><eid>2-s2.0-84929340434</eid><dc:title>Ethnic variations in length of hospital stay in patients with atrial fibrillation</dc:title><dc:creator>Gorantla R.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>542-544</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.405</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030162</affiliation-url><afid>60030162</afid><affilname>Columbia University in the City of New York</affilname><name-variant>Columbia University</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014551</affiliation-url><afid>60014551</afid><affilname>Aston University</affilname><name-variant>Aston University</name-variant><affiliation-city>Birmingham</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023998</affiliation-url><afid>60023998</afid><affilname>Cardiff University</affilname><name-variant>University of Wales</name-variant><affiliation-city>Cardiff</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>North Western Deanery</affilname><name-variant>Department of Acute Medicine</name-variant><affiliation-city/><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56121706000</author-url><authid>56121706000</authid><authname>Gorantla R.</authname><surname>Gorantla</surname><given-name>Ramakrishna S.</given-name><initials>R.S.</initials><afid>60030162</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56641605000</author-url><authid>56641605000</authid><authname>Nimmagadda M.</authname><surname>Nimmagadda</surname><given-name>Manojna</given-name><initials>M.</initials><afid>60014551</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56641113800</author-url><authid>56641113800</authid><authname>Potluri S.</authname><surname>Potluri</surname><given-name>Siri</given-name><initials>S.</initials><afid>60023998</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:25640375300</author-url><authid>25640375300</authid><authname>Uppal H.</authname><surname>Uppal</surname><given-name>Hardeep</given-name><initials>H.</initials><afid>60030162</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55964764100</author-url><authid>55964764100</authid><authname>Chandran S.</authname><surname>Chandran</surname><given-name>Suresh</given-name><initials>S.</initials><afid/></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:25640088100</author-url><authid>25640088100</authid><authname>Potluri R.</authname><surname>Potluri</surname><given-name>Rahul</given-name><initials>R.</initials><afid>60030162</afid></author><intid>1035940164</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929428965"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929428965?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929428965&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929428965&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022519315002209"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929428965</prism:url><dc:identifier>SCOPUS_ID:84929428965</dc:identifier><eid>2-s2.0-84929428965</eid><dc:title>A theoretical model of the endothelial cell morphology due to different waveforms</dc:title><dc:creator>SÃ¡ez P.</dc:creator><prism:publicationName>Journal of Theoretical Biology</prism:publicationName><prism:issn>00225193</prism:issn><prism:eIssn>10958541</prism:eIssn><prism:volume>379</prism:volume><prism:pageRange>16-23</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jtbi.2015.04.038</prism:doi><pii>S0022519315002209</pii><dc:description>Â© 2015 Elsevier Ltd. Endothelial cells are key units in the regulatory biological process of blood vessels. They represent an interface to transmit variations on the fluid dynamic changes. They are able to adapt its cytoskeleton, by means of microtubules reorientation and F-actin reorganization, due to new mechanical environments. Moreover, they are responsible for initiating a huge cascade of biological processes, such as the release of endothelins (ET-1), in charge of the constriction of the vessel and growth factors such as TGF-Î² and PDGF. Although a huge efforts have been made in the experimental characterization and description of these two issues the computational modeling has not gained such an attention. In this work we study the 3D remodeling of endothelial cells based on the main features of blood flow. In particular we study how different oscillatory shear index and the time average wall shear stresses modify the endothelial cell shape. We found our model fitted the experimental works presented before in in vitro studies. We also include our model within a computational fluid dynamics simulation of a carotid artery to evaluate endothelial cell shape index which is a key predictor of atheroma plaque formation. Moreover, our approach can be coupled with models of collagen and smooth muscle cell growth, where remodeling and the associated release of chemical substance are involved.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026851</affiliation-url><afid>60026851</afid><affilname>University of Oxford</affilname><name-variant>Oxford University</name-variant><affiliation-city>Oxford</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033019</affiliation-url><afid>60033019</afid><affilname>Universidad Publica de Navarra</affilname><name-variant>Univ. PÃºblica de Navarra</name-variant><affiliation-city>Pamplona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016809</affiliation-url><afid>60016809</afid><affilname>Universidad de Zaragoza</affilname><name-variant>University of Zaragoza</name-variant><affiliation-city>Zaragoza</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60085101</affiliation-url><afid>60085101</afid><affilname>CIBER Bioingenieria, Biomateriales y Nanomedicina</affilname><name-variant>Biomateriales y Nanomedicina (CIBER-BBN)</name-variant><affiliation-city>Zaragoza</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36560112400</author-url><authid>36560112400</authid><authname>SÃ¡ez P.</authname><surname>SÃ¡ez</surname><given-name>P.</given-name><initials>P.</initials><afid>60026851</afid><afid>60016809</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36560112400</author-url><authid>36560112400</authid><authname>SÃ¡ez P.</authname><surname>SÃ¡ez</surname><given-name>P.</given-name><initials>P.</initials><afid>60026851</afid><afid>60016809</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35368880900</author-url><authid>35368880900</authid><authname>MalvÃ¨ M.</authname><surname>MalvÃ¨</surname><given-name>M.</given-name><initials>M.</initials><afid>60033019</afid><afid>60016809</afid><afid>60085101</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35368880900</author-url><authid>35368880900</authid><authname>MalvÃ¨ M.</authname><surname>MalvÃ¨</surname><given-name>M.</given-name><initials>M.</initials><afid>60033019</afid><afid>60016809</afid><afid>60085101</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35368880900</author-url><authid>35368880900</authid><authname>MalvÃ¨ M.</authname><surname>MalvÃ¨</surname><given-name>M.</given-name><initials>M.</initials><afid>60033019</afid><afid>60016809</afid><afid>60085101</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56486584900</author-url><authid>56486584900</authid><authname>MartÃ­nez M.</authname><surname>MartÃ­nez</surname><given-name>M. A.</given-name><initials>M.A.</initials><afid>60016809</afid><afid>60085101</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56486584900</author-url><authid>56486584900</authid><authname>MartÃ­nez M.</authname><surname>MartÃ­nez</surname><given-name>M. A.</given-name><initials>M.A.</initials><afid>60016809</afid><afid>60085101</afid></author><authkeywords>CFD | Endothelial cells | Remodeling</authkeywords><intid>535956858</intid><source-id>29663</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929218859"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929218859?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929218859&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929218859&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S016752731500296X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929218859</prism:url><dc:identifier>SCOPUS_ID:84929218859</dc:identifier><eid>2-s2.0-84929218859</eid><dc:title>Structural and functional changes in HDL with low grade and chronic inflammation</dc:title><dc:creator>O'Neill F.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>111-116</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.058</prism:doi><dc:description>Â© 2015 Published by Elsevier Ireland Ltd. Objective: HDL functionality has been shown to be impaired in inflammatory conditions, including coronary artery disease. The present study aims to determine the impact of low grade and acute inflammation on HDL function and structure. Approach and results: i) The endothelial protective effects of HDL were compared between 26 periodontal patients and 26 age and sex matched controls by measuring paraoxonase activity in serum and nitric oxide bioavailability and superoxide production in endothelial cells. Paraoxonase activity and nitric oxide bioavailability were reduced, while superoxide production was increased (p &lt; 0.01) in periodontal patients compared to controls. ii) HDL function, including cholesterol efflux and vascular cell adhesion molecule-1 expression, was subsequently measured in the periodontal patients following an inflammatory stimulus. There was an acute deterioration in HDL's endothelial protective function, without change in cholesterol efflux, after 24 h (p &lt; 0.01 for all). These functional changes tracked increases of inflammatory markers and altered HDL composition. Finally, HDL function returned to baseline levels after resolution of inflammation. Conclusion: This study demonstrates that even minor alterations in systemic inflammation can impair the endothelial protective effects of HDL. These functional changes were independent of cholesterol efflux and were associated with remodeling of the HDL proteome. All measures of HDL's endothelial protective functions recovered with resolution of inflammation. These findings suggest that HDL dysfunction may represent a novel mechanism linking inflammation with progression of atheroma.</dc:description><citedby-count>1</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022148</affiliation-url><afid>60022148</afid><affilname>UCL</affilname><name-variant>University College</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019619</affiliation-url><afid>60019619</afid><affilname>UniversitatsSpital Zurich</affilname><name-variant>University Hospital Zurich</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022148</affiliation-url><afid>60022148</afid><affilname>UCL</affilname><name-variant>University College</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000245</affiliation-url><afid>60000245</afid><affilname>Universite Lille 2 Droit et Sante</affilname><name-variant>University of Lille</name-variant><affiliation-city>Lille</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022148</affiliation-url><afid>60022148</afid><affilname>UCL</affilname><name-variant>University College</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022148</affiliation-url><afid>60022148</afid><affilname>UCL</affilname><name-variant>University College</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012662</affiliation-url><afid>60012662</afid><affilname>UCL Institute of Child Health</affilname><name-variant>UCL Institute of Child Health</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">16</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:37102305600</author-url><authid>37102305600</authid><authname>O'Neill F.</authname><surname>O'Neill</surname><given-name>Francis</given-name><initials>F.</initials><afid>60022148</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:24462475400</author-url><authid>24462475400</authid><authname>Riwanto M.</authname><surname>Riwanto</surname><given-name>Meliana</given-name><initials>M.</initials><afid>60019619</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:8528765700</author-url><authid>8528765700</authid><authname>Charakida M.</authname><surname>Charakida</surname><given-name>Marietta</given-name><initials>M.</initials><afid>60022148</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55862900000</author-url><authid>55862900000</authid><authname>Colin S.</authname><surname>Colin</surname><given-name>Sophie</given-name><initials>S.</initials><afid>60000245</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55744496100</author-url><authid>55744496100</authid><authname>Manz J.</authname><surname>Manz</surname><given-name>Jasmin</given-name><initials>J.</initials><afid>60019619</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56535152300</author-url><authid>56535152300</authid><authname>McLoughlin E.</authname><surname>McLoughlin</surname><given-name>Eve</given-name><initials>E.</initials><afid>60022148</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55485499900</author-url><authid>55485499900</authid><authname>Khan T.</authname><surname>Khan</surname><given-name>Tauseef</given-name><initials>T.</initials><afid>60022148</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56644085100</author-url><authid>56644085100</authid><authname>Klein N.</authname><surname>Klein</surname><given-name>Nigel</given-name><initials>N.</initials><afid>60012662</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56644100800</author-url><authid>56644100800</authid><authname>Kay C.</authname><surname>Kay</surname><given-name>Christopher W M</given-name><initials>C.W.M.</initials><afid>60022148</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:35243226100</author-url><authid>35243226100</authid><authname>Patel K.</authname><surname>Patel</surname><given-name>Kalpesh</given-name><initials>K.</initials><afid>60022148</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:6603703222</author-url><authid>6603703222</authid><authname>Chinetti G.</authname><surname>Chinetti</surname><given-name>Giulia</given-name><initials>G.</initials><afid>60000245</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7102139355</author-url><authid>7102139355</authid><authname>Staels B.</authname><surname>Staels</surname><given-name>Bart</given-name><initials>B.</initials><afid>60000245</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:6507515725</author-url><authid>6507515725</authid><authname>D'Aiuto F.</authname><surname>D'Aiuto</surname><given-name>Francesco</given-name><initials>F.</initials><afid>60022148</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:6602879397</author-url><authid>6602879397</authid><authname>Landmesser U.</authname><surname>Landmesser</surname><given-name>Ulf</given-name><initials>U.</initials><afid>60019619</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:7004333788</author-url><authid>7004333788</authid><authname>Deanfield J.</authname><surname>Deanfield</surname><given-name>John</given-name><initials>J.</initials><afid>60022148</afid><afid>60022148</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:7004333788</author-url><authid>7004333788</authid><authname>Deanfield J.</authname><surname>Deanfield</surname><given-name>John</given-name><initials>J.</initials><afid>60022148</afid><afid>60022148</afid></author><authkeywords>Atherosclerosis | High-density lipoprotein | Inflammation</authkeywords><intid>1535909372</intid><source-id>23774</source-id></entry></search-results>
